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INTRODUCTION
One hundred and eighty years ago, R. Whyfce, then
Professor of Medicine at Edinburgh University, first des¬
cribed tuberculous meningitis in a classic paper entitled
*Observations on Dropsy in the Brain'. This was one of the
earliest types of meningitis to be recorded and was known as
an acute hydrocephalus. Later, in 1825 Serrn proved that this
was of inflammatory origin and in IS30 Papaverine showed that
meningeal and visceral tubercles were identical. Soon the
different types of meningitis became differentiated following
the introduction of lumbar puncture by Quincke (1891) and
meningococcal meningitis due to Weichselbaura'a diplococcus
was distinguished by Comuline, Mailing and 'Wright in 1898.
The uniformly fatal character of the disease first described
by Professor Whyte was widely recognised but, although there
have been reported in the world literature many well authen-
1,2,3**4
ticated cases in which a spontaneous recovery did occur ,
it was not until 19*|2 that Schatz, Bugie and 'Waksman, working
at the New Jersey Experimental Station, New York, produced
an antibacterial substance which offered some hope in altering
this hitherto grave prognosis. This substance they colled
streptomycin after the organism streptomyces griseus from
which it was obtained. This latter belonged to a group of
aerin1-rnyce1 iurn producing and sporulating actinomycstes which
had earlier bean found to give rise, amongst other antibiotics,
to a similar chemical compound streptothricin with, however,
a wider and different antibacterial spectrum.
2,
Streptomycin, it is interesting to note, was not
the first antibiotic or substance found to have an anti-
tuberculous, or tuberculostatic and tubarculocidal effect
but it was the most recent and effective agent that could
be used for practical application of treatment in Man. As
early as 1885, that is three years after the isolation of
the tubercle bacillus by Koch and one year after its dee-
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cription Canfcani , on the basis of observations that the
virulence of tuberculosis in corpses disappeared under the
influence of putrefactive processes, used a common sapro¬
phytic organism, known as bacterium termo. A liquefied
gelatin culture of this organism was given to a woman patient
suffering from pulmonary tuberculosis with cavitation and, as
a result of this early form of bacteriotherapy, the patient
improved markedly, clinically, with reduction in the numbers
of tubercle bacilli in the sputum.
In 1888 Babes demonstrated that products of other
saprophytic organisms had the capacity to inhibit the growth
of tubercle bacilli and further he showed that streptococci,
on the contrary, appeared to favour the development of the
tuberculosis organism.
Somewhat later in 1893 Nannottl® observed that a
tubercular inflammation of the knee joint tended to subside
as a result of the spontaneous occurrence of erysipelas.
9
Prudden later concluded that there was no specific antagonism
and that Naxmotti's results were due simply to the related
inflammatory responses caused by the accompanying organisms.
Between 1910 and 1913 Rappin and Vaudremer ,
working on spore-forming "bacteria and fungi respectively,
established the sensitivity of the tubercle bacillus to the
products of these various organisms.
Gradually it was thus established that the production
of antituberculosis, or tuberculoeidal and tuberculostatic
agents was widespread amongst certain of the higher plants
and amongst the various members of all the major groups of
micro-organisms, namely, bacteria, fungi and actinomycetea.
Further studies elicited that the activity of these agents
was primarily due to certain well-defined chemical compounds
which are now known as antibiotics. At least 11 bacterial
preparations, 16 products of fungi, and 10 antibiotics of
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the actinomycstes have been isolated . Amongst the
bacteria, the bacillus subtilis group yielded subtilin as
the tuberculostatic agent; and amongst the fungi, the
aspergillus fUmigatus group receiving particular attention,
produced four antibiotics of which the common active prin¬
ciple was fumigacin. The actinoniyces also produced four
antibiotics, namely actinomycin, streptothricin, nocardin
end the Important streptomycin.
Of all these various agents, the streptomycin, appear¬
ing in 19ii^> seemed the most promising agent on account of
its desirable physical and chemical properties, its low
toxicity to animals and its pronounced affect on the tubercle
bacillus in vitro and in vivo. This agent fulfilled what
13
was then considered the desirable criteria for a successful
antituberculosis substance.
(a) The agent must be tolerated by the subject without
producing irreversible physiological derangements;
(b) the progressive development of the disease must 'be
reversed to non-progressive, accompanied by resolution,
fibrosis, and calcification;
(c) the virulent infection must be eradicated and
(d) the effect must be produced in a reasonable time.
Following the discovery of streptomycin and its
promise of value in the therapy of tuberculosis, in 19*4*4 and
19*4 5 Feldman, Ilinshaw and Mann^9 pioneered the clinical
investigation of the drug by treating guinea-pigs infected
experimentally with the human type tubercle bacillus. They
noted that streptomycin was well tolerated by the animals,
that it exerted a striking suppressive action, that its
action was probably bacteriostatic rather than bacteriocidal
and concluded that the agent was worthy of trial in human
beings. Garrod (19*48)*^ disagreed in respect of the mode of
action and produced experimental evidence to show that the
drug was bacteriocidal especially in high concentrations,
17
Nevertheless a year later Florey et alia (19*49) supported
the original observation. Reports on the result of the use
of streptomycin in various forms of human tuberculosis follow-
18 19 20
ed rapidly and Hinshaw, Feldman and Pfuetae (19*i6) *
were able to report in a total series of 100 cases 12 ¥/ith
generalised haeraatogenous tuberculosis treated by strepto¬
mycin. Of these twelve cases nine presented clinical
evidence of tuberculous meningitis and of these nine, four
were surviving at the time of the report. These four
patients had had a well developed meningitis proved toae-
teriologically and all showed consistent and prompt improve¬
ment to therapy given toy intramuscular and Intrathecal routes.
The condition of the cerebrospinal fluid improved, the myco-
bacterium (myco.) tuberculosis could no longer be obtained
and recovery was such that treatment in three patients was
discontinued after six months. However one of the three
relapsed later, and all survivors suffered from marked neuro¬
logical sequelae.
In spite of the only moderate success in this small
series a clinical response to treatment, never before ob¬
served, had been obtained. Further series of treated cases
confirmed that streptomycin had a suppressive and possibly
curative action in meningeal tuberculosis and soon this anti¬
biotic was being employed extensively as the main therapeutic
wea oon.
With increasing experience in its use arid improvement
in survival rates there have developed in the years subsequent
to 19*46 many different regimes involving continuous and inter¬
rupted therapy with streptomycin of different types, the use
of varied routes of administration, the employment of adjuvant
drugs, the display of neuro-surgical techniques, treatment
with protein-purified derivative of tuberculin; and more
recently newer agents that may supplant the streptomycin have
become available. The most important of these newer prep¬
arations is iaoniazid, one of two hydrazine derivatives of
isonlcotinic acid. Thus with such variation in details
of treatment it is not surprising that results reported from
.21
different centres have ranged from 11/ survival rate or
J22
lower up to 85% , care being taken in comparison to note
the length of follow-up and whether the cases had been
selected.
It would appear, therefore, that the time was
opportune for a study of the different methods employed
as a sufficient period had now elapsed for a satisfactory
assessment,and so it is proposed to present in this paper a
small series of cases of tuberculous meningitis treated with
streptomycin by the combined intrathecal and intramuscular
routes and in analysing and discussing the results to review
the literature.
ANALYSIS OF RESULTS OF TKSATOIIIT
IN FIPTY-aWQ CA'j^S
During fche period 1st October 19^8 up to and including
31st December 1951 fifty-two consecutive cases, in which a
clinical diagnosis of tuberculous meningitis was mads, were
admitted to a small unit reserved specially for the treatment
of this disease. Complete laboratory facilities and a
full range of specialist and consultant services wars avail¬
able. This series of cases included every admission whether
moribund and dying within a few hours of admission or with
minimal signs and symptoms.
Condition on Admission
The clinical state of cases often varied widely on
admission and therefore the stage of disease was assessed
according to the classification of the Streptomycin Sub-
23
committee of the Scottish Scientific Advisory Committee s-
Early:- Minimal physical signs; no neurological signs;
mental confusion or irritability slight.
Intermediate:- Definite physical signs present; neuro¬
logical signs present; mentally confused or disorientated
and drowsy but able to answer questions or recognise parents.
Late:- In deep coma, or reusable by painful stimuli; un¬
able to recognise parents.
In making the assessment most stress was laid upon
the mental stats as it was considered that this gave a very
reliable criterion to the stage of the disease and reduced
the amount of error that might arise through personal bias.
McCarthy and Mann (1950) mads this point in reporting a
series of cases of tuberculous meningitis in children.
In the 52 admission to the unit lis cases were in
the early stage and 23% died, all of which were found clin¬
ically or later at post-mortem examination to have suffered
also from extensive miliary disease. In the intermediate
stage ware 25 cases of which 6k% died, this including four
with miliary tuberculosis. In the late stage all 13 cases
died and two had miliary disease and this gave, therefore,
an overall mortality of 63.5'** All the cases that suffered
from meningeal and diffuse haematogenous miliary lesions
died. Table I below summarises these results.
Table I




Early 10 (71%) M29%) Ik
Intermediate 9 (36?0 16 (6k%)
(12 + k*)
25
Late 0 13 (100%)
(11 + 2st)
13
Total 19 (36.5$) 33 (63.5^) 52
it
Cases of tuberculous meningitis and miliary disease
Age on Admission
The age of the patient on admission was found to
have a relationship to prognosis, a fact noted early by
those centres employing streptomycin in treatment when the
antibiotic was still under trial. Since the first large
25
series of cases reported , it has almost universally been
confirmed that the prognosis in those patients under three
years old was much more serious than the older groups.
This is demonstrated in Table IX where four patients sur¬
vived out of 20 aged three years or less whilst fifteen sur¬
vived out of thirty-cases above this age period - an
almost 50% recovery rate. It was also noted that a higher
proportion of the younger children were seen in an inter¬
mediate or lata stage of the disease than in the older group
and this is probably a reflection of the greater difficulty
of earlier diagnosis in the very young child, thus giving a
different prognosis for those different age groups.
Table II (A)
Results of Streptomycin Treatment; in Relation to Age









































1 1 0 0 3 0 2 1
1-3 16
(30.8%)
3 2 1 0 13 1 5 7
Li - 6
(13.5%)
k 3 1 0 3 1 2 0
7-12 8
(15.6%)
5 2 3 0 3 1 1 1
13 and 13+ 17
(13.l4f)
6 2 k 0 11 1 6 i*
Total 52 19 10 9 0 33 k 16 13
Table II (B)
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Diagnosis
The diagnosis in each case was baaed on clinical
history, family history especially with regard to contact
with a tuberculous person or relative, the cerebrospinal
fluid findings and bacteriology, the Mantoux reaction, exam¬
ination of the fundus ocull, the radiological picture of the
chest and the physical examination. These points are
accordingly analysed in detail below.
Clinical History and Examination
With a view to ascertaining the most helpful clinical
signs and symptoms that would lead to an early diagnosis the
various manifestations with which the patient presented on
admission were analysed. These are tabulated below in
Table III and it can be seen that those presenting are of
an insidious and non-specific character and often not necess¬
arily pointing towards the nervous system. In fact there
may be a striking absence of signs and symptoms, this being
especially obvious in cases of miliary tuberculosis under¬
going treatment and developing meningitis as a complication.
For example cases may present atypically with alimentary
symptoms and although none were found in this present series
Smith and Vollum (19*48) and Ruble and Mohun (19*49) des¬
cribe such instances.
A further Table IV below shows that there is no hard
and fast relationship between length of history and stage of
disease.
Conditions that appeared to have been precipitating
factors were the respiratory illnesses in four cases, whoop¬
ing cough in one, and measles in two. Trauma was a doubt¬
ful cause in two in one of which the child had received a
minor injury to the head three weeks "before admission, and
in the other - case No. 26 - symptoms dated back to a fall
from a bicycle two weeks prior to admission. However the
stag© of the disease was advanced on admission, the patient
dying after nine days and so it is possible that the fall
was the result rather than the precipitant of the illness.
It is of interest that two cases were examined
thoroughly with full blood and radiological investigations
for a transient pyrexial illness two months before admission.
These examinations were carried out by a consultant physician
and the findings were quite negative but three weeks later
both cases had signs and symptoms suggestive of a tuberculous
meningitis. This helps to stress just how insidious in
onset the disease may be.
Another case illustrative of unusual presentation
was admitted because of overdosage of morphine given by the
practitioner to control a prolonged series of fits and the
correct diagnosis was established the following day.
Study of Table III reveals that those symptoms of
most frequent occurrence were those least specific in point¬
ing to any special diagnosis. They were vomiting and head¬
ache? with lethargy, pyrexia, anorexia, constipation, coma,
malaise and loss of weight less frequent.
13.
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Neck Rigidity UO 0
Kemig and/or Brudsinski
signs present 31 0
Papi11oedema 10 0
Abnormal Eye Signs 3 0
Hypertensive Retinopathy 1 0
Abnormal Chest X-rays 33 0
Choroidal Tubercles 3 0
Paresis 7 0
The wide range of manifestations that can occur
is also shown in the table, varying from thirst, earache,
tonsillitis etc. to a sensory epilepsy. As regards signs,
evidence of admission of meningeal irritation was usually
present, neck rigidity "being found in i|0 cases and positive
Kernig's and/or Brudzinski signs in 31» hut this number is
27
higher than that described by Rubis and Mohun (l%9)
Thus it is important to realise that there are cases of
tuberculous meningitis, apart from those developing this
as a complication to miliary disease and noted above, who
present without the usual typical signs of meningeal irrit¬
ation.
The symptomatology, therefore, is a vague one,
easily overlooked in the small child and furthermore, con¬
fusing in that these symptoms may initially clear up for a
short period before progressive deterioration sets in.
The table also shows that examination of the eyes
is important as 1^ cases had ocular signs and symptoms, all
of which give valuable information towards a diagnosis.
Headache is seen to be the earliest symptom, a finding with
which the authors just mentioned agree but it can easily be
overlooked unless the presence of a primary chest complex
or active tuberculosis in the lungs or elsewhere in the
body alerts one. Irritability, fatigue, failure to gain
weight and personality change did not appear to be pro¬
nounced until the later intermediate stage of the disease
developed.
Table IV
Length of History Related to Stance of Disease and Final Outcome
Length Stage of Disease Result
of History Early Intermed. Late Total Alive Dead
1 week or less 12 3 1 16 9 7
2 weeks 2 8 3 13 k 9
3 weeks 0 5 3 8 2 6
U to 7 weeks 0 k 2 6 1 5
8 weeks or more 1 h U 9 3 6
Table IV reveals one or two Interesting points in
that the general pattern shows that a short history is re¬
lated to the disease in the early stage and thus gives a
better prognosis, and that as the duration of symptoms and
signs lengthens so, as one might expect, more cases are ad¬
mitted at a later stage and the prognosis becomes graver
with a higher mortality. This is true up to two months or
more and then the pattern remains more or less fixed without
a relative increase in mortality. Nevertheless there are
sufficient cases surviving with a long duration of symptoms
and sufficient cases dying even after a history of only one
weeks ill-health to show that one cannot employ the duration
of history before admission as a criterion on which to base
the estimation of the stage of the disease or to assess,
what is more difficult and Important, the prognosis. As
an example of this, one case with a history of under one
week was admitted in an advanced state and conversely one
case was early after an eight weeks history as shown by
the table.
These observations could be criticised on the
grounds of the small numbers of cases involved in each
grouping but they do confirm the impressions gained by
most other clinicians.
Family History
Following admission and the obtaining of a history
of the illness enquiry was next made into the family history
to determine if any contact with a tuberculous person had
occurred. A definite history of contact was obtained in
14 out of 50 cases. Of these 14 the source of the in¬
fection was the father in four, the mother in five, a sib¬
ling in two and a more distant relative in three. In two
cases no family history was obtained and the remainder gave
a negative story of contact. This figure of positive con¬
tact is much less than that quoted by the Medical Research
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Council (1948) but is in keeping with many other centres.
One*s own opinion is that the figure is too low and a
fuller and more vigorous enquiry into the health of the
immediate family circle would increase the total and give
a more accurate result.
Case No. 25 gave no history of contact with a
tuberculous person but the child had been fed on un~
pasteurised milk and later a positive culture from the
cerebrospinal fluid was obtained yielding a bovine strain
of the tubercle bacillus.
17.
Tuberculin Reaction (Mantoux)
This was carried out in i|7 cases as a useful aid
towards diagnosis. The usual technique employed was to
use on the forearm intracutaneously with a control on the
other first a dilution of 1 in 10,000 and to increase the
strength to 1 in 1,000 or further to 1 in 100 if negative
responses were obtained. A skin area of oedema and red¬
ness of one centimetre appearing within forty-eight hours
was considered a positive reaction and this occurred in kk
out of these ii? cases. In the remaining three, a negative
reaction was obtained in one, death taking place before a
stronger test solution could be used,and the two other cases
were advanced and may have been examples of anergy. (Lincoln
28
and Sifontes(1953) believe anergy to be rare).
Five cases remain in which the test could not be
completed because of early death soon after admission.
29
Cathie and Macfarlane (1950) report the use of
1 in 100 dilution only, routinely, and so the custom in
the later cases was to carry out the mantoux test first
with the dilution of 1 in 1,000 tuberculin and discard the
higher dilution. This often saved time and led to no un¬
toward reactions.
Examination of the Eye
Special attention was paid to retinoscopy and exam¬
ination of the eye when the patient was admitted. In the
cases of very young children, especially those irritable and
restless on admission, this entailed considerable patience
anfl some difficulty, 15? horaatropine sulphate being used
to dilate the pupil. At the time this was deemed to be
satisfactory without the additional use of sedation as
30
suggested by Illingworth and Wright (19^8) and Emery and
31
Lcrber (1950)
In this series choroidal tubercles were seen in only
three patients all of whom suffered from a miliary and
meningeal infection. This number gives a much lower in¬
cidence than in the majority of series reported and would
suggest that examination under sedation or* anaesthesia
should be tried in the future.
In these three cases all of whom died eventually
in spite of 102, 110 and days of treatment respectively
changes in the tubercles were observed in that they became
paler and better defined whilst in one pigmentation appeared
around the edge of the lesion. These changes suggested
that healing was occurring and might indicate an improving
prognosis in these cases but nevertheless all succumbed.
However none of these tubercles became parchment white which
Illingworth and Wright in their careful survey stressed, was
the only stage at which one could venture to say that the
prognosis was definitely better, although healing changes
were a good rather than bad sign.
10 cases showed the presence of bilateral papilloedema
and in case No. 15 the papil loederna was followed by the
development of bilateral optic atrophy. In this patient,
the condition deteriorated in spite of therapy with the
appearance of ocular palsies, mental hallucination and
attacks of vomiting -with headache. The cerebrospinal
fluid had a high cell count with moderate increase in the
protein level and was under increased pressure and so a
block to the fluid circulation in the region of the basal
cisterns v/as suspected. Further neuro-surgieal inter¬
vention to relieve the increased intracranial pressure
should have been carried out in this patient earlier, this
case being an example whereby the eye signs gave early
warning of the developing complication.
One other case had an abnormal retinal pattern in
that increased tortuosity and narrowing of the retinal
arteries was present this being accompanied by a blood
pressure of 210/130. This case resembled in this respect
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that described by Cairns and Taylor (19*49) in which the
presence of arterial hypertension was correlated to the
increase in intracranial tension, the hydrocephalus, and
the basal adhesions constricting and affecting hypothalamic
function.
Radiological Findings
Routine chest radiography was positive in 33 cases
and out of the remaining 19, six patients were too ill to
X-ray, three dying shortly after admission and the three
others surviving for a few days in a moribund condition.
The radiological findings consisted of evidence of
pulmonary miliary tuberculosis in ten, enlargement of the
hilar glands with or without evidence of the complete primary
complex in a further ten, and other types of tuberculous
lung lesions in a further nine cases, e.g. apical infiltra¬
tion with or without cavitation, a tuberculous broncho¬
pneumonia, and tuberculous consolidation. The remaining
four patients had pleural effusions without obvious under¬
lying parenchymal disease.
Cases worthy of more detailed mention are Noa. 6, 11,
16, i}3 and k7» In case No. 6, a girl aged 18 years old, no
radiological evidence of pulmonary tuberculosis was apparent
during the treatment of her tuberculous meningitis but later,
when the latter infection seemed undoubtedly cured, she
developed enlargement of the tracheo-bronchial lymph glands
resembling rather the hilar adenitis accompanying the primary
complex in childhood and later, as this latter improved, a
left upper lobe consolidation of tuberculous aetiology
developed. The lung lesion and her general condition in¬
itially responded to further intramuscular streptomycin and
para-aminosalicylic acid (P.A.S.} therapy under sanatorium
conditions and there was no sign of a relapse of her tuber¬
culous meningitis, but subsequent deterioration in the pul¬
monary condition occurred and a left upper lobectomy had to
be performed. The patient is now wall and a photograph of
the lobe removed can be seen in the Appendix.
Case No. 11 had apical tuberculosis with cavitation
on the left side and died from his pulmonary disease after
a second stage thoracoplasty operation. His death
occurred one year after clinical cure of his meningitis and
at post-mortem examination the brain appeared normal in
appearance with only slight thickening of the pia-arachnoid
mater around the base. No tubercles were to be seen along
the vessels in the Sylvian fissures and there was no dila¬
tation of the ventricles. For this reason this case has
been included in the successes of treatment for meningitis.
However the lungs showed extensive tuberculous infiltration
with chronic cavitation and an empyema in the left pleural
cavity. A few small areas of tubercular Invasion were
present in the right lung. Here then is a case where
earlier surgical intervention, for example during the
second half of the treatment of his meningitis, might have
altered the eventual outcome.
Case No. 16 in addition to the lung lesion had a
tuberculous polyserositis affecting pericardium, peritoneum,
pleura and of course the meninges, and she also developed
a paravertebral abscess. The autopsy suggested that death
was due more to the widespread advanced tuberculous lesions
than to the meningitis which histologically v/as in the
early stage.
Case No. 1»3 also had multiple lesions in that a
pleural effusion, a peritonitis and a paravertebral abscess
was present.
Case No. i|? was of interest in that a presumed
serous tuberculous meningitis developed whilst the child
was undergoing treatment for a lesion causing a dense
homogenous shadow in the right upper lobe and spreading to
ths right middle lobe. At various times the pathology
was considered to be an empyema, a consolidation and an epi-
tuberculous allergic reaction but it was not until a lung
puncture was performed and caseous material swarming with
tubercle bacilli obtained that the suspected tuberculous
aetiology was confirmed. Gradual clearing of this shadow,
due therefore to a tuberculous lobar pneumonia, has occurred
and examples of some of the X-ray films taken are shown in
the Appendix. The child*s condition is now excellent.
Tuberculosis elsewhere in those patients with chest
lesions was noted in three other cases in addition to those
described above, one having a peritonitis, one a salpingitis
(presumptive diagnosis) and one a perisplenitis. One other
case with the chest radiologically clear suffered from a
tuberculous osteomyelitis affecting the head and shaft of
the left femur with also involvement of the hip ;Joint on
that side.
Table V stresses what we have already noted that
miliary disease whether pulmonary, or disseminated generally
throughout the body, gives a grave prognosis and in the
Medical Research Countil series (19^3) where recent
primary lung lesions are grouped with miliary this higher
mortality is evidenced. The other types of lung disease
do not appear to have such an adverse bearing on the out¬
come of the meningitis but naturally a clear radiological
picture will give the better prognosis.
23.
Table V - Results Related to Radiological Findings
Radiological Findings
Number
of Cases Alive Dead
1. Enlargement of Hilar
Glands or Primary
Complex
10 6 ( 6030 *4 (U0%)
2. Miliary Lung Disease 10 0 10 (100O
3. Pleural Effusion *4 2 (50?0 2 (50 )
*4. Other Tuberculous Chest
Manifestations
9 5 (55%) *4 (*45 . )
5. Radiologically Clear 13 6 (i*6?0 7 (5*4$)
Bacteriology
Bacteriological proof of the diagnosis was obtained
in 37 cases "by a positive guinea-pig inoculation arid in a
further eight of the remaining 15 cases this proof was
gained by culture and/or post-mortem examination (five cases
by culture and three by autopsy). This leaves seven cases
in which the diagnosis was based on findings other than
bacteriological and these will be presented below. The
routine employed in each case was to examine the cerebro¬
spinal fluid by film, culture and by animal inoculation to
obtain the causative organism. The guinea-pig test was
carried out in 51 of the 52 cases with the above mentioned
positive results, and culture of the fluid was positive in
3*4 of the 50 cases in which it was performed. Culture
yielded a human strain in 30 and a bovine in *4 cases, and
it was positive in 5 patients where the animal inoculation
failed.
In almost all of the 7 cases in which no bacterio¬
logical proof was obtained strong presumptive evidence in¬
cluding response to therapy and pattern of cerebrospinal
fluid changes was present. These seven cases were Noa. 12
29s 39, *40, kU, k5 and U7.
Case No. 12 was a moribund child aged lg- years who
was too ill to X-ray and who died before the raantoux test
could be read. Cerebrospinal fluid however showed the
changes suggestive of an advanced tuberculous meningitis,
with marked reduction in sugar and chloride levels and
elevated protein and cell count levsls5 the latter being
predominantly lymphocytic.
Case No. 29 was a wasted dehydrated child,aged 1-4-
yeara, admitted with a vague three week history of symptoms
a left ptosis, and facial palsy and a spastic left hemi-
paresis. The cell count in the cerebrospinal fluid was
normal until streptomycin was given intrathecally, when a
slight rise took place. The protein level was raised, the
sugar reduced and the chloride normal. Mantoux test was
very strongly positive. Decerebrate rigidity developed
and the child died on the thirteenth day. During life
no fundal changes were observed and the child was too ill
to X-ray. The diagnosis was based on the above clinical
picture and the disease was presumed to be advanced with
extensive basal adhesions.
There are more grounds for argument as to the
correctness of the diagnosis in case No. 39. The marked
25.
fluctuations in the cerebrospinal fluid cell count
(mainly lymphocytic) and protein levels seemed to be re¬
lated to the intrathecal administration of streptokinase
and were not a true reflection of the common pattern found
in tuberculous meningitis. Sugar level was within normal
limits but chloride level was reduced. Bacteriology was
negative but the mantoux test was strongly positive. Differ¬
entiation from other lymphocytic meningitides and influenzal
meningitis was very difficult.
Case 1|0 resembled the latter but there were the
typical spiking in the cell counts and protein levels on a
graph of the changes in the cerebrospinal fluid elements
which suggest tuberculous meningitis. The raantoux test
was strongly positive and the cells and protein were raised*
and the sugar and chloride lowered in the cerebrospinal fluid
on admission. Graphs of the behaviour of the constituents
of the latter are included in the Appendix along with these
two case notes.
Case No. kk was unusual in that she had been admitted
eight years previously for neuro-surgical investigation of
momentary sensory epileptiform attacks and the examination
then was completely negative, an inflammatory focus such as
a tuberculoma or a cortical scar being postulated as the
cause. Symptoms resolved spontaneously during the inter¬
vening period to recur once again heralding in a new illness
in which she became irritable, drowsy and demented, and
wasted. Her sensory phenomena disappeared after admission
but she was now suffering from a tuberculous meningitis
with typical changes in the cerebrospinal fluid suggesting
advanced disease. Permission for autopsy was refused.
In case No. ii5 a very bad family history of tuber¬
culosis, a chest X-ray showing right middle lobe consolida¬
tion and a positive mantoux test all helped towards the
diagnosis of a simple serous tuberculous meningitis as
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described by Lincoln (l9i»7) . The child was aged eight
months and was undergoing treatment for his chest lesion
when a deterioration in condition led to a diagnostic lum¬
bar puncture and this obtained a lymphocytic cerebrospinal
fluid with a normal chemistry and negative bacteriology.
It was considered safer and wiser to treat with a shortened
course of intramuscular and intrathecal streptomycin and
the graph of the behaviour of the cerebrospinal fluid shows
how it returned to normal in eleven weeks after showing a
fluctuating pattern. This behaviour would tend to confirm
the diagnosis and exclude a meningo-encephalitis following
chickenoox the rash of which the child developed a few days
earlier. This latter was very seriously considered for a
time as an alternative diagnosis.
The clinical details of the last case No. kl with a
negative cerebrospinal bacteriology have already been des¬
cribed under the paragraphs on radiological findings (page 23)
This child during treatment of his caseous right upper lobs
pneumonia became irritable, had a headache and developed a
pyrexia which was charted even higher by error. A diag¬
nostic lumbar puncture was accordingly carried out and
revealed a cerebrospinal fluid similar to that in case
No. In view of the whole clinical background strepto¬
mycin was given for a short period by combined routes but
the cerebrospinal fluid rapidly returned to within normal
limits. There was also in this case a family history of
tuberculosis and the mantoux test was strongly positive.
Seven weeks therapy for the presumed serous meningitis was
given in this instance.
Bacterial resistance to streptomycin developed in
three cases. In No. 30 meningitis developed during treat¬
ment of generalised miliary disease and the child eventually
died* the resistant organism being obtained at post-mortem
examination. In No. 33 resistance developed during treat¬
ment for a relapse and a satisfactory response occurred
only when iao-nicotynal hydrazine (isoniazid) was used.
The third case was No. 11 the resistant organism being ob¬
tained from the sputum after clinical cure of his meningitis
as described on page 20 under the heading of radiological
findings.
Differential Diagnosis and the Cerebrospinal Fluid
Differential diagnosis could be difficult in an
atypical case especially in view of the insidious onset and
vague symptomatology and therefore examination of the
cerebrospinal fluid formed the most important part in the
routine of examination, positive bacteriology obtained by
film, by cultural methods or animal inoculation as already
mentioned, clinching the diagnosis.
The normal levels for cerebrospinal fluid con¬
stituents was considered to be:- cells: 0-5 pel* cubic
millimetre (par eu.inm.); protein: 20 - kO milligrams per
cent (mgrns./Q; sugar: U5 - 55 milligrams per cent (mgms.??)
and chlorides: 690 - 750 milligrams per cent (mgms•%).
Various conditions that might have to be considered in
differential diagnosis were poliomyelitis, benign lympho¬
cytic chorio-meningitis, and other virus meningitides and
encephali tides, disseminated sclerosis, intracranial abscess
or neoplasm, haemophilus influenzae meningitis, pyogenic
meningitis, tuberculoma, Weil's disease, glandular fever,
cerebrovascular accident, mumps or whooping cough encephal¬
itis, lateral sinus thrombosis, torulosis, coccidioides etc.
etc. That this range of conditions for consideration is
not too excessive is borne out by the varied presumptive
and actual diagnosis in cases admitted as tuberculous men¬
ingitis to the special centre at Oxford under Smith, Vollum
3L
and Cairns (19*46)
As many cases of poliomyelitis were admitted to
the other wards during the period over which this series of
cases v/as analysed the opportunity is taken to compare the
initial findings in the cerebrospinal fluid (C.S.F.) on
admission in the cases of tuberculous meningitis, polio¬
myelitis and also in some cases of the other types of men¬
ingeal infection, and these results are tabulated below.









































































































































































































































































































































































































































The only figures in the above table which are really
worthy of comparison are those of tuberculous meningitis,
poliomyelitis and other forms of lymphocytic meningitis as
the number of cases in the remaining diseases are too small.
In respect of the cell counts one notes that in the pyogenic
rneningitides and influenzal meningitis the cell counts are
very high and predominantly polymorphonuclear. However,
when the count is mainly lymphocytic, the number of cells
per cubic millimetre does not appear in itself to be of
value in differentiation of disease.
In the case of the protein levels a high proportion
in the virus meningeal infections are within normal limits
as compared with tuberculous meningitis. However there are
a sufficient number within each disease group both within
normal and above normal to show that the protein level on
its own is not an absolute criterion towards diagnosis.
In the remaining diseases the protein levels tended to be
high.
On looking at chart (3) however, sugar levels can
be seen to be much more helpful and a low level accompanying
a predominantly lymphocytic cell count will definitely favour
a tuberculous meningitis and as a corollary if the cell count
has many more polymorphs a pyogenic meningitis is more prob¬
able.
Chloride levels also helped as it was in tuberculous
meningitis that they were characteristically lowered.
Nevertheless one should note that lh cases of the latter
disease had normal chloride values.
Table VI fchus demonstrates the different features
of the cerebrospinal fluid in the diseases mentioned and
the overall picture agrees with that presented in the
standard textbooks. The point to note is the number of
cases which are borderline and cause variation in the typic¬
al cerebrospinal fluid pattern commonly described. Initial
cerebrospinal fluid results may not be easy to evaluate and
therefore assessment should be made, in these instances, on
the results of further lumbar punctures taken in conjunction
with the clinical and radiological picture.
Cerebrospinal Fluid Changes during Therapy
In each case the cerebrospinal fluid was withdrawn
at lumbar or intrathecal puncture and sent for examination.
Owing to the many demands on laboratory staff protein levels
and the cell counts only were estimated on each sample•
Full chemistry and bacteriology was performed on the first
few specimens at the commencement of therapy and then also
at two to three weekly intervals. It was considered that
the protein and cell count levels were of most importance
especially in order to detect early any signs of the develop¬
ment of a spinal block. Later, as cell count and protein
level often took a prolonged time to return to the normal
levels which have been quoted above, it was found chloride
and especially the sugar levels in their return to normal
values were helpful in judging clinical cure, and when to
discontinue therapy.
A constant feature in the majority of cases was a
rise, often very marked, in the number of cells on commence¬
ment of intrathecal therapy and this with other points will
be raised again in the discussion which follows later. In
those patients who mads a satisfactory progress with good
prognosis the protein level and cell counts gradually and
steadily returned to normal with accompanying rise in the
sugar and chloride values. Usually normality was approached
about UO - 60th day of therapy but actual attainment of the
physiological level took much longer with the sugar and chlor¬
ide, then the cell count and finally the protein in that
order reaching their normal figures. This pattern described
is shown in cases Nos. 5, 11, 20, 22, 23, 33, 3k, 33, 38, 39,
kO, ill, 50 and 51.
A second pattern of change was manifest in cases who
deteriorated and the main feature was a falling sugar and
chloride level or one that remained below normal without
rise. This was apparent in cases Nos. 3, 7, 8, 9, 1*4, 15,
19, 25, 26, 27, 28, 32, k3, kQ and 52.
Patients who csied on admission or shortly afterwards
usually presented a cerebrospinal fluid picture in which the
cell count and protein figures were very high and the sugar
and chloride levels very low. This pattern accompanied
advanced disease and gave a bad prognosis. Cases Nos. k,
36 and k9 exemplify.
Improvement in the cell count and protein level was
noted to occasionally occur during rest periods when no
intrathecal therapy was given.
A very high protein value with low cell count -was
present in cases Nos. 1, 6, 18 and 31 and this along with
other signs e.g. xanthochromia,+ve Queekenstedt teat was taken
to indicate a block, possibly in the spinal subarachnoid
space, and in two of these four patients autopsy confirmed
this. In case No. 17 high cell counts accompanied very
high protein levels and this suggested exudate and adhesions
causing a basal cistern or subt3ntorial block along with an
active infection. These raised cell counts were considered
to indicate an active infection and their return to normal
a clearing of the meningifcic process. Some cases were noted
in which death occurred soon after admission with very few
changes in the cerebrospinal fluid. Post-mortem examination
in confirming the diagnosis usually explained this picture
in that marked hydrocephalus and extensive basal adhesions
were present, the latter locking up the foci of infection.
Yet again therapy could control the infection and the late
result of the meningitis, that is these adhesions and a tuber¬
culous arteritis,would kill the patient. Cases 9s 3.3 and
21 exemplify.
In three cases (Nos. 16, 32 and U6) with miliary
disease, death occurred in spite of cerebrospinal fluid exam¬
inations suggesting a mild meningitis.
Streptomycin assays on lumbar and cisternal fluid
were performed in suspected cases of spinal subarachnoid block
and,in one instance, showed no diffusion of the streotoraycin
upwards to the cisterna magna from the lumbar region. As
these assays were carried out in too few eases further
analysis of the results have not heen attempted.
Clinical Course under Treatment
The progress of each case had its own individual
variations "but nevertheless certain common patterns were
discernible and for descriptive purposes could he divided
into a group in which the patients survived and one in
which they died.
In the latter group were those eases which did not
respond to treatment in which a temperature with average
o
peaks of over 100 P. persisted and only became subnormal
in some cases a few days before death. Examples of this
pattern ?/ere cases Nos. 3# *1# 7# 8, 19# 2ks 25, 26, 29# 32,
lili and 52. These patients never showed at any time signs
of improvement and deteriorated steadily. A second pattern
in cases who died was that of an initial satisfactory clinical
response with later deterioration usually from the late
effects of the disease as has been described. Cases Nos. ll»,
15 and 21 fall into this category. Cases Nos. 13# 27, 31,
37 and l\6 also were patients who progressed well initially
and prognosis appeared good only to deteriorate at a late
stage from a recrudescence in some instances when intrathecal
therapy was less intense. Finally there was the group of
cases in which death occurred within a few hours or days of
admission. They remained moribund and temperature was high
or subnormal, death occurring before any clinical effect of
treatment could be obtained. Cases Nos. 2, 10, 16, 28, 36,
I48 and k9 are examples.
Meningitis developed after presumed cure of a pul¬
monary miliary infection in cases Nos. l*j and t»6 and devel¬
oped during treatment of a similar lung infection in cases
Nos. 2I4 and 30. The clinical pattern in cases Nos. 1*4 and
30 was one of progressive deterioration, death in the former
being associated with a spinal subarachnoid 'block and in the
latter with a resistant organism, already noted above.
Both case 2*4 and *46 improved initially and one was
hopeful of eventual cure but later deterioration and death
took place being especially disappointing in case No. *46 who
at one time seemed to be making excellent progress. The
late effects of the disease rather than an active infection
was the cause of death here.
Temperature chart, and pulse and respiratory rates
in these fatal cases described above often bore no relation¬
ship to the seriousness of the patient*s condition in tuber¬
culous meningitis and could be normal for two to three weeks
before death.
In the other group of cases making satisfactory pro¬
gress there were firstly those which showed an uninterrupted
improvement (eases Nos. 5, 11, 20, 22, 23, 3*4, 35, 38, 39*
k09 klf *45, *47, 50 and 51), In the majority of these
patients the temperature averaged 100°F. for the first 10 - 1*4
o
days then fell with average peaking up to 99 F. for a further
three to five weeks, this fall coinciding with a general
clinical response to therapy and this response was then
followed by steady improvement in physical and mental well-
being with weight gain.
39®
Cass No® 1 also showed a steady improvement hut
only after an initial stationary period.
Cases 17 and 33 relapsed after improvement and
following a further complete course of streptomycin therapy
by combined routes became and remained well®
The remaining case that survived is number six an
outline of the radiological findings in the chest being
described under that heading on page 20. This patient
developed subarachnoid block in the thoracic region of the
spinal cord early in therapy and as a result of further
neuro-surgical investigation streptomycin was given into the
ventricles through frontal burr holes. Convulsions follow¬
ed ; the patient became comatose and developed a complete
paraplegia with urinary and faecal incontinence. Subsequent¬
ly streptomycin therapy was administered only by the intra¬
muscular route and the patient surprisingly improved so that
rehabilitation could eventually be commenced. The patient
was left with a complete bilateral nerve deafness and spastic
lower limbs but with the help of special training and exer¬
cises managed to gain control of bowel and bladder function
and walk with the help of calipers. The hearing defect was
successfully overcome by teaching her lip-reading. The
subsequent progress with development of enlarged tracheo¬
bronchial lymph glands, left upper lobe pneumonia and
lobectomy have already been outlined.
These clinical patterns of response to therapy which
have just "been described are in accord with those found by
25
other workers (Med.Res.Co. (19U8) )
ko.
Complications occurring during Therapy op Pound at Autopsy
(in association with the disease process)
Amongst the 52 cases of this series only nine could
be said to have no complications or lesions present in
addition to their tuberculous meningitis and of these nine
cases two were too ill to investigate completely both dying
shortly after admission (eases Nos. 26 and k2). In the
majority of cases the accompanying pathology was in the
chest and in ten instances consisted of a miliary tuber¬
culosis of the lungs as has already been mentioned.
Twenty-three cases were complicated by lung lesions other
than the miliary dissemination and in nine patients a block
in the eerebrospinal fluid circulation was suspected or
confirmed. Of these nine, the block appeared to be in
the region of the basal cisterns in seven, in the thoracic
region of the spinal cord in one (ease No, 6) and in the
last case there was a block present in the upper thoracic
region of the spinal cord and in the basal cisterns close
to the opening of the tentorium cerebelli (case No. 18).
Hydrocephalus was noted clinically or at post-mortem
examination in eleven patients, in three of whom it was mild
in degree (cases Nos. 3j 21 and 2h).
Other complications noted are summarised in Table VII
below.
111.
Table VII - Complications found during Therapy or at
Post-Mortem Examination (excluding those arising from
therapeutic method)
Pulmonary Lesions 23
Pulmonary Miliary Lesions 10
Block in the Cerebrospinal Fluid Circulation 9
Hydrocephalus 11





Tuberculous Myocarditis (1 case with tuber- 3
culous abscess in left ventricular muscle)
Tuberculous Ileitis 1
Tuberculous Salpingitis 1
Tuberculous Renal Lesions 1
Tuberculous Perisplenitis 1
Tuberculous Osteomyelitis 2






Tuberculous Cervical Abscess 1
Median Nerve Palsy 1
Septicaemie Miliary Disease (with lesions
in lungs, liver,, spleen, peritoneum, I4
kidneys etc.)
Post-Mortem Results
Of the 33 cases who died permission for post-mortem
examination was obtained in 17* A constant picture was
noted consisting of a gelatinous basal exudate around the
brain stem with fibrous adhesions which in one case were
actually seen to compress slightly the medulla oblongata.
Hydrocephalus in varying degree was a constant concomitant
and usually the fibrous adhesions seemed to interfere with
the cerebrospinal fluid circulation in the region of the
basal cisterns and around the cerebral peduncles. The
foramina of Luschka and Magendie were clearly seen to be
blocked in four cases. Tubercles were usually seen in
the perivascular spaces alongside the blood vessels and
spread commonly into the Sylvian fissures. Involvement
of the ependyma was noted in seven cases and of the choroid
plexus in three cases. Case No. U2 had a tuberculoma of
the pons and in Case No. 7 tuberculous granulation tissue
surrounded and compressed the optic nerves.
The post-mortem appearances with satisfactory clear¬
ing have already bean described in case No. 11 on page 21.
Case No, 21s who suffered also from miliary pulmonary
disease showed radiological clearing of the latter before
death but at autopsy tubercles were still obviously scatter¬
ed throughout the lung fields.
Case No. h6 who was admitted with a relapse of her
pulmonary miliary disease and a tuberculous meningitis showed
radiological and post-mortem clearing of the lung lesions
although death resulted from the meningitis which was
seen to "be still active. Extensive adhesions present at
post-mortem confirmed the clinical impression "before death
that these were a contributory factor in the failure of
therapy.
Finally case No. 18, in which protein purified
derivative of tuberculin (P.P.D.) was given intrafchecally,
died as a result of hydrocephalus and blocks to the cerebro¬
spinal fluid circulation. At autopsy macroscopically the
disease seemed arrested with many fibrous adhesions present




Streptomycin as the calcium chloride complex or as
the sulphate, or dihydrostreptomycin was employed in each
case in this present series with the exception of two both
of which were moribund on admission. Intrathecal and
intramuscular routes were used in all cases including those
instances of recrudescence or relapse. The dosage factor
varied according to age, expected weight taking into con¬
sideration also body build and height, and the severity of
the disease. Initially adults were given 2 Gm. daily by
the intramuscular route but this was later reduced with no
apparent loss of efficiency to 1 Orn. daily. In children
the dosage was usually about 0,5 Gtau daily suid in infants
a correspondingly smaller total daily dose was given. For
calculation of the latter the factor 0.02 Grn. per pound
body weight per day was employed but In some cases a
slightly less dose than this would have allowed, was given.
The intramuscular dose was divided into injections given
twice daily, i.e. in the morning and the evening.
Intrathecal dosage was 0.1 Gta. for adults and a
proportional dosage between 0.05 Orn. to 0.1 Gta. for
children of five years or more, the streptomycin being
given slowly dilated in 5-10 ccs. of normal saline well
admixed with cerebrospinal fluid. For younger children
and infants less than 0.05 0®* was given the smallest dose
being 0.02 0m. in a seven months old baby. Intrathecal
administration was usually performed six hours after the
morning intramuscular injection! that is to say midway
between the two latter daily doses.
The rhythm and principles of the treatment regime
was here again the same for all cases but varied in detail
from patient to patient according to the stage of the
disease on admission, their clinical progress and the devel¬
opment or otherwise of complications such as blocks to the
cerebrospinal fluid circulation. The rhythm of therapy
consisted of an initial period of seven to fourteen days
intense treatment in which daily intrathecal injections were
given. The next period in certain eases, consisted of the
injections being given on alternate days up to the fourth
or sixth weeks. Then if progress was favourable the in¬
jections were given thrice weekly thus allowing a short
reat at the week-end welcomed by patient and doctor alike.
This thrice weekly routine was employed, however, in the
majority of patients after the initial period of daily
punctures. At the end of 12 - 16 weeks of treatment a
careful review of progress was made to determine if a rest
period off treatment could he safely allowed. In only a
very few exceptional cases was this rest interval permitted
earlier. Throughout this first basic 12 week course
intramuscular treatment was given as detailed above.
After this rest period usually of one to two weeks
duration, if the clinical state and cerebrospinal fluid
findings still suggested that the infection was active, a
further course of treatment was given in the form of weekly
intrathecal injections with the twice daily intramuscular
dosage as before. After four weeks reassessment was done
and if necessary this latter routine repeated after the
second rest period.
Should the clinical assessment at any rest period
suggest the infection was still active, a reversion to
the thrice weekly intrathecal punctures along with the
usual intramuscular schedule was made and after the four
weeks once again the rest period and the assessment.
With improvement the less intense routine would then be
given as detailed above.
When this periodic evaluation at a rest period
suggested that the infection was fully controlled with
cerebrospinal fluid findings approaching normal especially
in respect of the sugar levels then Intrathecal treatment
was discontinued "but intramuscular therapy was given for a
further two months. This latter treatment was carried out
during in-patient and out-patient surveillance but a most
careful follow-up was insisted upon in respect of the latter.
During out-patient attendance the case was admitted for Ij8
hours for complete check every two or three weeks up to the
third month from hospital discharge. Attendances then
became less frequent at monthly intervals: other points in
connection with this follow-up detail will be mentioned later.
In sixteen cases the calcium chloride complex of
streptomycin was used with a survival rate of five. However
there was a high proportion of late and intermediate cases
within this group. Later dihydrostreptomycin was employed
with the hope of greater efficacy and lessened incidence of
vestibular upset and 29 cases were treated, 12 surviving.
A high incidence of deafness followed its use and so the
last four cases in the series were treated with streptomycin
sulphate of which two recovered. Case U6 was treated with
dihydrostreptomycin and a recrudescence of the disease was
then treated with streptomycin sulphate.
If those cases which had repeat courses of treatment
because of a relapse or a recrudescence are included, the
relapse in two further patients was treated with dihydro¬
streptomycin, one dying and one surviving. The relapse in
two other patients was treated with streptomycin sulphate and
both cases survived.
Table VIII in summarising these results shows that
the numbers in each group are too small for statistical
comparison.



































































































Including one relapse treated later with streptomycin
sulphate
+
Including one relapse treated later with streptomycin
sulphate
(In the dihydrostraptomycin group one case relapsed and died
after a further course and a second relapsed and survived
the repeat course).
*48.
B. Use of Adjuvants
It soon became evident that one of the problems of
therapy was the development of adhesions around the base
of the brain with interference in the circulation of the
cerebrospinal fluid. Accordingly streptokinase, a
streptococcal fibrinolysin, was given in seven cases
(Woe. 18, 19, 20, 23, 25, 32 and 39) with the object of
lysing these fibrino-gelatinous adhesions (not wholly
fibrous) occurring earlier in the disease. The articles
35 29
written by Cathie (19149) , Cathie and Macf'arlane (1950)
. .36
and Lorber (1951) refer. Six units of the original
preparation of streptokinase (Burroughs Wellcome and Co.)
were given with each intrathecal injection but no apparent
benefit seemed to ensue and the impression was gained that
the streptokinase caused headache, listlessness and some
vomiting. In one case also (No. 39) it caused a marked
pleocytosis with rise in the protein level in the cerebro¬
spinal fluid thus masking the true picture and accordingly
its administration had to be discontinued. In view of the
importance of following carefully the chemistry and cytology
of the cerebrospinal fluid to assess progress and watch for
complications it was felt that this disadvantage of the
streptokinase outweighed any possible advantages. More
*
This preparation differs in strength from those in use
later in which 1 vial contains 100 Cathie units or
100/6 Christensen units.
recently it has been shown that these toxic effects mentioned
above are due to the hydrolysis of plasminogen by strepto¬
kinase to the actual fibrinolysing agent plasmin and not to
the streptokinase itself per as or the end product plasmin
37
(A. Fletcher (195*4))
Para-arninosalieylic acid (P.A.S.) was given orally
later in the series of cases to those patients who had con¬
current active pulmonary phthisis of adult type (cases 33»
37 and *4l)» It was also used in case Wo. k3 who was an
adult with miliary lung lesions, in case No. kl where a
caseous right upper lobe pneumonia was present and in case
No. 50 where there was an associated primary lung complex.
This latter patient was a child who relapsed and the P.A.S.
was given during the relapse. Two cases Nos. 2*4 and 30
did not tolerate the drug which was at that time given in
fluid form only but later minor symptoms of intolerance,
usually gastro-intestinal upset, were overcome by using
cachets which had become available. Dosage in the adult
consisted of 18 Oms. daily given three hourly in doses of
3 Oms. each and continued as long as the intramuscular
streptomycin was given. Later this dosage was reduced to
12 Qras. daily and the Incidence of gastro-intestinal upset
lessened, evidence having been gained by many workers that
the lesser doss was effective (vide discussion on para-
aminosalicylic acid below). In children the dosage was
6 Gins. daily. The use of this adjuvant in this series was
too sporadic to evaluate and it was only towards the end of
this series that it was decided to give P.A.S. routinely.
It was believed that its use might help to improve results
of therapy in all cases by synergistic action with strepto¬
mycin and furthermore prevent the development of bacterial
resistance in those cases complicated by adult pulmonary
phthisis. This resistance however was seldom found in
tuberculous meningitis alone or in miliary tuberculosis.
Two cases Nos. 18 and 33 were treated with the protein
purified derivative of tuberculin (P.P.D.) according to the
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method described by Smith and Vollum (1950) . Case No. 18
was a child with a primary complex of the lung who developed
early in the treatment of her meningitis a partial spinal
block. Streptokinase was then used and the child improved
temporarily and then relapsed. Streptomycin assay of the
lumbar and cisternal fluids revealed that there was no
diffusion of streptomycin after lumber puncture. Intra¬
thecal therapy was discontinued and once again the patient's
condition improved temporarily. Erythrocyte sedimentation
rate returned to normal and rehabilitation was instituted.
Repeat lumbar and cisternal punctures revealed that the spinal
block was still present and the infection was of low grade
activity. After an interval of improvement however the child
began to vomit and suffer from severs headaches. Early bi¬
lateral papi11oedema was observed and so a developing hydro¬
cephalus was diagnosed and the child transferred for neuro¬
surgical investigation and treatment. Frontal burr holes
were made and the lateral ventricles tapped releasing cerebro-
spinal fluid under pressure. Decerebrate fits occurred
and so P.P.D. was tried in doses 0.00375 increasing to
0.03 ug. given into the ventricles at two or three day inter¬
vals. The fourth, fifth and sixth doses were given into
the cisterna magna. However rigors, and decerebrate fits
persisted and athetoid movements developed and finally after
the sixth and last injection a reaction consisting of hyper¬
pyrexia, flushing and sweating in a conscious child developed.
Death from exhaustion followed and at the post-mortem exam¬
ination it was shown that this had been caused by a commun¬
icating hydrocephalus due to adhesions in the basal cisterns
with in addition a block in the thoracic region of the spinal
cord. The meningitis was well under control.
There was a more fortunate outcome in the second case
(No. 33) who relapsed three months after discharge on to
out-patient surveillance. Treatment v/as recommenced with
the use of streptomycin sulphate by intrathecal and intra¬
muscular routes and with oral para-aminosalicylic acid.
The patient at first improved then deteriorated at the end
of the third month of further therapy with signs suggesting
an impending block to the C. 3. P. circulation. The intra¬
muscular dosage which had been reduced to 1 Gm. on alternate
days was then increased to 2 Gms. daily and P.P.D. was given
intrathecally for two weeks, on each alternate day, by grad¬
ually increasing doses at first, and then every third day for
a further three weeks. Reactions to the intrathecal tuber¬
culin, which was given by the lumbar route with the strepto-
mycln, became gross, but neverfchsless slight improvement
clinically and in the cerebrospinal fluid occurred. Further
progress was slow and unsatisfactory so that at last all
streptomycin and tuberculin treatment was discontinued and
replaced by oral laoniasid (isonicotynal hydraside).
Marked improvement then took place and after three further
months of treatment the cerebrospinal fluid returned to
physiological levels. The dosage of isoniasid was 200 milli¬
grams dally and this was maintained for two months following
the appearance of the normal cerebrospinal fluid.
Isoniazid was also employed in ease No. k6 who was
deteriorating in spite of 30 weeks of intensive streptomycin
therapy by combined routes supplemented also with para-amino-
salicylic acid. However the patient died before the efficacy
of this newer agent could be adjudged.
Neurosurgical intervention was undertaken in two
cases Nos. 6 and 18 whose clinical progress has already been
detailed in pages 39 (under the heading of 'clinical course
during therapy') and 50 respectively.
C. General Won-Specific Therapy
In addition to the use of these agents specified
above a general sanatorium type of regime was enforced,
vitamins A, D and C being given orally in large dosage.
Iron medication was also given and in a few cases comatose
on admission a rectal drip was used. Those patients who
were very ill or noisy on admission were isolated first in
a cubicle ward and later, after clinical improvement trans¬
ferred to the main ward, usually about the second or third
week. In those cases with active pulmonary lesions bed
rest was maintained longer than in the average case* the
duration being partly related to the sedimentation rate.
At about the sixth week rehabilitation treatment was in¬
stituted and after cessation of intrathecal therapy the
patient would be allowed up. At this stage re-education
in walking was important especially in the very young child.
Occupational therapy in the form of games for the children
and handicraft for the adults was also instituted in the
later stages of treatment as and when clinical condition
permitted. To maintain morale film shows were also allowed,
with cartoons for the children.
Injections "both intramuscular and intrathecal were
given at the times already indicated and for each intra¬
thecal puncture special separate packs for each patient, con¬
taining needles and syringes and manometer were autoelaved.
As far as possible the same person performed the punctures
in the same patient and sterile masks and gloves were worn,
the latter being a guard against the acquisition of strepto¬
mycin sensitivity as much as for asepsis.
In the complete periodic assessment every 2nd or 3rd
week of the patient*s progress the type of temperature chart
with graph and list of investigations as shown in the Appendix
was found to be of great help as personally it seemed easy
in the management of such a protracted illness to lose sight
of the overall picture.
Careful charting of any special investigations and
of the results of regular weights taken weekly as soon as
the patient was well enough to sit for a moment in a chair,
was also carried out.
D. Length of Therapy
The duration of specific treatment is recorded he-
low hut in certain instances in survivors a pex*iod of intra¬
muscular treatment as an out-patient is excluded. The tahle
shows that an average of 101 - 250 days were required to
effect a clinical cure thus three months therapy hy combined
routes at the very minimum was essential. Tahle IX also
shows that a number of patients did not survive longer than
twenty days suggesting that their condition on admission was
too advanced for any treatment to he of avail. In fact each
of the 1/4 cases in this group died on or before the thirteenth
day.
Tahle IX - Duration of Specific Treatment
Number of Days Alive Dead Total
1-20 0 Ik lk
21-50 1 5 6
51 - 100 1 k 5
101 - 150 k k 8
151 - 200 5 0 5
201 - 250 k k 8
251 - 300 2 * 2 * k
301 - 350 1 36 0 1
350 and over 1 96 0 1
1 case within each group includes also treatment duration
for a relapse or recrudescence of disease.
53.
Complications following Therapy
The commonest complications in the survivors were
either "bilateral nerve deafness, vertigo or both which signs
were related to the type of antibiotic employed. Of the 19
patients alive after treatment, nine had a bilateral nerve
deafness, two having been treated with the calcium chloride
complex of streptomycin and seven with dihydrostreptomycin,
two of the latter suffering only slightly. In addition
one patient who eventually died (No. £46) also developed
deafness after treatment with dihydrostreptomycin and there¬
fore this would raise the total to eight out of twenty-nine
cases treated by the latter developing this complication
whilst only two out of a total of sixteen cases treated by
calcium chloridQ complex were affected.
Vestibular upset was noted in four survivors, two
being treated by the calcium chloride complex and two by the
dihydrostreptomycin but the vertigo was not so troublesome
to the patient as compensation appeared to occur over the
course of a few months.
In the few cases including relapses treated with
streptomycin sulphate no nerve deafness or vertigo was ob¬
served.
The complications following therapy have already been
mentioned in respect of cases Nos. 6 and 11. Case No. 17 had
a metatarsus varus on walking again following cure of her
relapse of meningitis and this deformity was corrected under
orthopaedic supervision. Case No. 35 developed later a
small gland in ths neck which formed a cold abscess and
eventually resolved under further streptomycin treatment.
An organism of bovine strain was isolated from the pus ob¬
tained and it was still streptomycin sensitive. Her mening¬
itis was also due to the bovine strain which had been isolated
on culture.
Finally, two cases (Nos. 3k and 51) exhibited abnormal
behaviour after completion of therapy. They were both
children and this misbehaviour was manifested by extreme
naughtiness, screaming fits and terror starts and in the
former instance persisted for some months. Their behaviour
resembled that which sometimes occurs in a poat-enesphalitic
patient. Eventually both recovered from this abnormality.
Methods and Detail of the Follow-up
The length of the follow-up of the survivors of this
series varied from one year to four years and eleven months,
the condition on the 31st December 1953 being the final
assessment for this paper. This period of follow-up is
based on the fact that a minimum period of two years is
really advisable in order to assess results of treatment be¬
cause of the danger of a late relapse.
The follow-up period commenced after the discharge of
the patient from hospital and consisted of a first period
during which intramuscular streptomycin was still given daily.
The case was readmitted every fortnight for two days for
assessment and further diagnostic lumbar puncture. If pro¬
gress was satisfactory the period at home was increased to
one month. After 8 - 12 weeks on the fortnightly pattern
the patient would then attend the out-patient clinic at
monthly intervals and eventually the frequency of these visits
would become less if the patient remained well. In addition
the family doctor and the parents or relatives were warned
that the patient was to be sent for readmission immediately,
should any illness or pyrexia develop, even if minor.
During these revisits, whether as in-patient or out¬
patient, a complete physical examination including chest X-ray,
ophthalmoscopy, and check of auditory and vestibular function
by the otologist was carried out. When the patient was ad¬
mitted a full cytological and chemical analysis of the cerebro¬
spinal fluid was made with bacteriological examination of films,
and with inoculation of culture and guinea-pig. A rough
psychometric assessment was performed by enquiry about school
progress reports in children, ability to carry out their occupa¬
tion in adults and the alertness and development of infants
under school age. Perhaps this assessment of the quality of
the survivors could have been made more accurate by the employ¬
ment of the Gisell-Stanford Binet tests for pre-school age,
the Terman-Merrill for older ages, and the Colline-Drever for
38
deaf children as is described by Illingworth and Lorber (1950) ,
The impression was gained that some of the children were more
alert and intelligent after recovery from the meningitis than
before (e.g. cases Nos. 17, 20, 23, 35 and ijO).
Details of the length of the follow-up period with the
condition of the patient on 31st December 1953 are set out below.
58.




































































1 + 4* + — - Vertigo compensated hut falls
in the dark: Hearing improved.
Has had a child: Physically
and mentally well.
59
5 + slight + - - Alive and well. Rides bicycle.
Roller skates.
53
6 + mm + - - Spastic lower limbs. Nerve
deafness. Left upper lobectomy.
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17 slight slight - + - Alive and well. Good school
report. Metatarsus varus.
32
20 + mm — + •* Alive and well. Passed
Grammar School Entrance Exams.
Does P.T. and swims.
35
22 + alight - + - Alive and well. Drives van.
Is very alert.
35
23 - — - + - Alive and well. Good school
report. Swims.
35
33 + slight - + + Condition satisfactory: Still
rather weak.
12
3U + - - + - Behaviour disorder. Physically































































































Top of class in all subjects
for 2 years. Cold abscess
in neck. Occasional head¬
aches.
Alive and well physically
and mentally.
Phyeieally and mentally well.
Physically and mentally well.
Very good school report.
Married and has a child.
Recovered from relapse of
pulmonary tuberculosis.
Physically and mentally well.
Calcification and bronchiect¬
asis in right upper lobe
(tube rculous). 0th©rwise
alive and well.




N.J3. Auditory and vestibular function was in each case
assessed with the aid of audiograms and labyrinthine
function tests.
The cerebrospinal fluid returned to within normal
limits,, as have been defined, in 15 out of the 19 cases sur¬
viving. Normal levels in the majority of patients were
reached within three to ten months, first the sugar, then the
chloride, then the cell count and lastly the protein values
in that order becoming within the physiological limits. The
protein value often remained raised along with a slight in¬
crease in cell count for a considerable period - even up to
six months following the appearance of the normal sugar level
2H
in the cerebrospinal fluid •
In case No. Ij5 where a diagnosis of a simple serous
tuberculous meningitis was made, the fluid became normal in
six weeks.
In four cases abnormalities persisted, in three the
cell count remaining slightly raised and in the fourth the
protein being on the high side. The sugar and chloride
values, however, in all four remained normal.
Relapses and Recrudescences
Cases in which the disease appeared to recur after
marked improvement or cure, were dsfined as recrudescences
2h
or relapses as described by MacCarthy and Mann (1950)
A relapse was considered to have occurred when the patient
had remained well ifithout treatment for a definite period and
the cerebrospinal fluid had returned to normal whereas a re¬
crudescence occurred whenever therapy was discontinued although
the cerebrospinal fluid might have approached normality.
Three cases relapsed within the above definition,
case No, 17 four months after discharge from all treatment,
case No, 33 five months afterwards and case No, 50 three
months afterwards. All these cases responded satisfactorily
to a further full course of treatment, dihydrostreptomycin
"being used for No, 17, dihydrostreptomycin with streptomycin
sulphate for the relapse in No, 33 and calcium chloride complex
and then the sulphate of streptomycin .in No, 50.
Case No, 27 was classified as a recrudescence and
deterioration took place at the end of a second rest period
when all therapy had been discontinued. Up till this time,
the child had improved, raised temperature had settled, weight
was "being gained and the cerebrospinal fluid ivas within normal
limits except for a slight increase in the number of cells per
cubic millimetre. Treatment had to be resumed with dihydro-
strsptomycin using intensive intrathecal therapy but the child
died, A pulmonary miliary tuberculosis was also present.
Signs and symptoms of relapse or recrudescence in each
of these four cases were headache, pyrexia and a personality
change towards irritability. Symptoms usually appeared first
followed by changes in the cerebrospinal fluid and lastly
signs of meningeal irritation reappeared.
Miliary Tuberculosis and Tuberculous Meningitis
Most of the points mentioned below have already been
presented in various parts of the analysis above but for con¬
venience are once again summarised together under this heading,
10 cases in this series suffered from both types of
tuberculosis and they all died in spite of the meningitis being
in the early stage in five* the intermediate in four, and
the late stage in one.
Six of the ten cases were found to have a meningitis
and pulmonary miliary disease on admission. The other four
cases were already known to have suffered from the latter
and developed the meningitis as a complication. In two of
these cases the tneningeal infection appeared after apparent
cure following a course of intramuscular streptomycin for
several months. In the two other cases the meningitis
developed during the intramuscular treatment and, as has "been
emphasised, the striking feature was its insidious onset.
In case No. 30 increase in headache, pyrexia and irritability
were the only changes noted there being no neurological signs
on examination.
Case No. p6, a patient with miliary disease developing
meningitis died in spits of radiological clearing of the
lung confirmed by autopsy. The radiological picture in case
No. 21 also cleared but active lesions were seen at post-mortem
examination. In case No. 2U improvement in the cheat picture
occurred but nevertheless death ensued.
These examples stress the fact that intramuscular
therapy alone is not sufficient to control tuberculous mening¬
itis and further that the progress in the chest picture is not
always a guide to prognosis.
The above ten patients included four who had in addi¬
tion miliary lesions scattered throughout other viscera in
the body.
63.
Summary of the Results of Treatment
Out of 52 unselacted cases of tuberculous meningitis
19 survived this including two patients presumed to have a
serous tuberculous meningitis.
The majority of the survivors were over the age of
three years if considered as a percentage of the total in the
series under and over this age. Thirty-three of these cases
had tuberculous chest lesions confirmed radiologically and in
ten miliary lung disease was present. All the latter died.
Bacteriological or post-mortem confirmation of diagnosis was
present in h5 out of the 32 cases, Nine cases developed a
block in the cerebrospinal fluid circulation and three patients
relapsed. One patient died after a recrudescence of disease,
Calcium chloride complex of streptomycin was used for
treatment in 16 cases, streptomycin sulphate in i}, and di~
hydrostreptomyein in 29 cases. The intrathecal and intra¬
muscular routes were used. Streptokinase, 6 units per
intrathecal injection was given in six cases without apparent
benefit, para-aminosalicylic acid was used in six cases,
protein purified derivative of tuberculin in two cases and
isoniazid in one case. Neurosurgical intervention was
carried out in two patients.
Length of follow-up varied from 59 months to 12 months.
Eight out of the 29 cases treated by dihydrostreptomycin
developed nerve deafness and only two out of 16 treated by
the calcium chloride complex - or taking survivors only,
seven out of 12 treated by the former as compared with two
out of 5 by the latter. The cerebrospinal fluid in 15
out of the 19 survivors returned to normal on an average
within five months from the onset of therapy.
65.
DISCUSSION
Having analysed carefully in detail these 52 un-
selected cases of tuberculous meningitis, let us now turn to
the examination of results obtained by other treatment centres.
In this series just described the mortality has been shown to
be 63.5$ and therefore two out of every three patients were
dying leaving much room for improvement. We soon find on
reviewing the literature on results of therapy that there are
many different survival rates reported with improved figures
in the later years as more experience was gained. We also
find a great diversity of detail in therapeutic measures and
in the use of differing antituberculous agents and therefore
it is proposed to consider these varied regimes and decide
what appears to be the roost advisable type of therapy.
Finally it would be valuable to review future prospects in
view of the effective newer antituberculous agents now available.
Table XI below lists briefly the results reported by
many centres.
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MacCarthy and Mann - Series C
1*6
Capon and Todd
Regime; Intramuscular and intra¬
thecal streptomycin with strepto-
kinase
35
Cathie - Series B
Regime: Intramuscular and intra¬
thecal streptomycin with strepto¬
kinase and a sulphone
29
Cathie and lacfarlane - Series B
Regime: Intramuscular and intra¬
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thecal streptomycin with sulphone
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Naismith - Series 2A and 2B 65 66(67.7%)
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Jamieson 35 28( 80%)
1955 60
Bulkeley - Series 1 31 18( 58%)
Regime: Intramuscular and intra¬
thecal streyt^vcih with tuber¬
culin
1950 61
Chorends et alia - Greek series
1955 56
Smith - Series B
































The above table is interesting in that a study of
these principle series reported shows a gradual improvement
in the results obtained since streptomycin therapy was first
inaugurated. Although the number of series reported later
in each different regime grouping is not sufficient perhaps
for statistical comparison certain trends can nevertheless
be noted. In the group in which the treatment was strepto¬
mycin by intrathecal and intramuscular routes the average
percentage survival rate rises gradually being 29% in 19*48,
29.2? in 19*49, 31*3? in 1950, 39*3% in 1951, U8*5% in 1952
and *41.6$ in 1953- Of course meny factors have to be con¬
sidered in this comparison of results these factors being
improvement in early diagnosis, the age groups, the use of
neurosurgery in selected cases, the dose of streptomycin
employed, the use of interrupted or continuous regimes, the
duration of therapy, the type of streptomycin and the length
of follow-up. These points shall have to be discussed below.
Treatment using streptomycin by the intramuscular
route only (average survival rate 22.9%) may be briefly men¬
tioned here as it can be dismissed readily from discussion.
In spite of the fact that bacteriostatic levels of streptomycin
con be obtained in the cerebrospinal fluid by intramuscular
therapy alone, these levels being higher the more advanced the
stage of disease, it was exceptional to get a satisfactory
25
clinical response • This method of therapy was rapidly
abandoned in this country following the poor results obtained
in the first number of cases so treated, as exemplified by
the aeries reported by the Medical Research Council, Ruble
and Mohun and MaeCarthy and Mann as shown in the table.
The results obtained by Mouriquand have not been confirmed
by other workers and in the article referred to In the table
the period of follow-up was brief and was not detailed.
Many Americans when streptomycin first appeared were rather
chary of using the drug intrathecally, due no doubt to the
toxic effects that arose from the less pure preparations used
at that time and partly from the larger doses employed. One
author went so far as to state dogmatically that he considered
streptomycin should never be used intra thecally and in 19*49
there were still some who considered the intrathecal route
50
dangerous. It was thus that Cairns, Smith and Vollum in
reporting their experience in therapy in the United States in
1950 warned against this concept. Indeed the fact that cases
of pulmonary miliary disease can develop tuberculous meningitis
whilst under treatment with intramuscular streptomycin (cases
30,^6) is sufficient warning that this route alone should
never be employed (if streptomycin is the only antituberculous
agent being given)#
When we next examine the results obtained, using in
addition to streptomycin by combined routes, adjuvants we
find further improvement in survival rates (average 58.3%)
but because of the multiplicity of drugs and methods employed,
it is often difficult to assess whether this improvement is
due to the one or many additions. Reviewing these series
in which adjuvants are displayed it would seem that the
addition of para-aminosalicylic acid was favourable and
more so than the toxic drugs of the sulphone group. The
appearance of isonicotynal acid hydrezide (average survival
rate 73*8^) promises an even better line of therapy but as
yet there has not been time for reports of results of treat¬
ment in sufficient numbers of cases with adequate follow-up
periods.
We shall now proceed to examine in turn each of the
various agents or methods employed in treatment and in so
doing will realise the importance and value of carefully
conducted trials in evaluation of therapeutic measures in a
disease as chronic as tuberculous meningitis and as prone to
relapse after lengthy therapy.
Use of Streotomvcin
"II faufc frapper tree vifce, taais ne pas frap per trop fort" -
hoffler
Since the discovery of streptomycin by Waksrnan and
his associates this antibiotic has been, until recently, the
mainstay in the treatment of tuberculous meningitis. As
has already been mentioned, it was soon found that admin¬
istration by intramuscular route alone, although giving 8 jig.
streptomycin per cubic centimetre (cc.) of cerebrospinal
55
fluid within four hours of injection, was unsatisfactory
and indeed in patients under the age of three years dis-
25
astrous , and therefore the standard practice has been to
give the combined course using intrathecal and intramuscular
routes. Clinical experience in treating cases soon pointed
out. that prolonged therapy was necessary and this fact was
emphasised by the number of cases who relapsed during the
follow-up period. The incidence of the relapse rate within
the first six months from cessation of therapy was highest
and then gradually fell up to a year. After twelve months
survival the prognosis he came brighter with danger of relapse
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still present but more remote . Accordingly most author¬
ities at first favoured a minimum of three months continuous
therapy but now incline towards a more prolonged course up to
six months.
Intramuscular dosage employed at first for adults
varied from 1-3 Gms. daily given in three-hourly divided
doses but the incidence of toxic signs of albuminuria, haemat-
uria and cylindruria with nausea and vomiting was high. The
66
guinea-pig experiments of Feldman, Hinshaw and Karlson (19*»7)
and trials of streptomycin in pulmonary tuberculosis by
67
Barnwell, Buzm and Walker (19*47) suggested that smaller
dosage at less frequent intervals was equally effective and
when this was tried in the therapy of tuberculous meningitis
the incidence of these toxic effects fell without any reduction
of the efficacy of treatment. The current practice of most
clinicians is still to follow the intramuscular dosage schedule
25
as recommended In the Medical Research Council (M.R.C.)
trials in 19*t8 and that is to calculate the dosage on the
scale as used in this series and described in the analysis
under streptomycin therapy up to a maximum of 1 - 2 Grn. daily.
More recent experience in pulmonary tuberculosis has
suggested that streptomycin 1 Gram (Grn.) intramuscularly
twice weekly ' may be as effective as the daily dose,
this time interval being related to the growth and multi¬
plication of the bacterium but recent trials in which the
use of isoniaaid with different schemes of dose of intra¬
muscular streptomycin were compared, showed a higher in¬
cidence of bacterial resistance in the group in which the
twice weekly rather than the daily dosage was given. How¬
ever no series have as yet been reported regarding the use
of this regime in combination with intrathecal therapy in
tuberculous meningitis and considering the different prob¬
lems presenting in the latter disease one doubts if the less
intensive method would be as effective or safe.
Whereas the intramuscular regime suggested by the
25
M.E.G. in 19i»8 (i.e. 0,02 Gra. per pound body weight per day)
has been widely employed there was much more variation in
the concurrent intrathecal dosage. This latter varied
greatly in minor detail and fell into two main groups the
interrupted and fete continuous schedules. The M.R.C. ad¬
vised the interrupted method and considered that the beat
results were obtained with as little intrathecal treatment
as possible with frequent and relatively longer rest periods
off therapy (I.T.) They however modified this view later.
29
Cathie and Maefarlane (1950) recommended a short course of
72
twenty-four intrathecal injections and a Liverpool series
also favoured short interrupted courses.
Mann (19*>o) amongst others has considered that
patients, especially children, have "benefited from frequent
rest periods with improvement in mental and physical well-
being and with less incidence of nausea and vomiting, but
one's own experience would suggest that any rest interval
off therapy before, at the very least, the sixth ?7eek on
treatment, is unwise. Indeed case No, 27 deteriorated at
the first rest interval allowed after three months continuous
treatment and in this series it is the latter schedule that
has been favoured. One also noted that it seemed to upset
the children more when therapy had to be resumed and there¬
fore it was kinder to employ a dosage with later, gradual
decreasing frequency in intrathecal injections, this in it¬
self being an encouragement to the patient that he or she was
38
getting better. Illingworth and Lorber (1951) noted that
deterioration occurred within the first rest period if this
was, as often advised, about the fourth week and Debre (Paris),
73
Dubois (Brussels) and Cocchi (^Florence) all favoured un¬
interrupted and prolonged treatment. A later report of the
IJ9
Medical Research Council recommended more intense intrathecal
therapy the number of days of the latter being at least 50%
of the duration of the intramuscular course,and a study of
350 cases in a report by the Ministry of Health (1950)^
advised that intrathecal treatment should be at least 75% of
the intramuscular course and reported improved results.
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Sonner (1950) confirmed this but warned that intrathecal
streptomycin may precipitate blocks to the cerebrospinal fluid
circulation.
In fact the general trend of intrathecal and intra¬
muscular therapy from the earlier years has "been towards
less intense daily dosage hut more prolonged treatment.
61
Choremis (1950) advises that one should commence
with a small intrathecal dose and then gradually increase
to the maximum tolerated short of producing toxic signs and
he stresses that this is especially important in advanced
cases as he "believes that a large initial dosage might cause
a greater reaction introthecally and thus hasten death.
This method? however, has not been generally employed.
kk
Dubois et alia (29^9) treated six patients by the
intrathecal route alone but the results ware unsatisfactory
and all died.
In this series the form of the intrathecal therapy
has already been described in the analysis under streptomycin
treatment. Briefly after twelve weeks combined therapy with
a short initial intensive intrathecal course rest periods
were instituted arid then the treatment gradually tailed off
according to clinical evaluation at each rest interval.
This latter emphasises the point, which bears repetition,
that no matter whether continuous or interrupted schedules
are employed treatment for each individual case has to be
judged on individual merits. The impression on reviewing
this series was that there was s tendency to undertreat intra-
theeaily and probably initial therapy of daily injections
should have been prolonged up to fourteen days in more cases,
with a higher dosage in children as they require weight for
weight relatively larger doses than adults . Cairns, Smith
50
and Vollum (1950) advise one to overtreafc rather than under-
treat. A consideration of the reports on the different
therapeutic regimes using streptomycin "by combined routes
would suggest that a minimum of six months intramuscular
therapy on a dosage of 0.02 Grn. per pound "body weight per day
up to 1 - 2 Gms., and at least three months continuous intra¬
thecal therapy on a dosage of 0.05 to 0.1 Gm. (graded accord¬
ing to age) in 5 - 10 ccs. normal saline per injection should
be employed, giving approximately hp injections as a minimum.
Then after the three months intrathecal dosage a gradual re¬
duction in the frequency of the latter with intermissions of
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rest periods can b3 safely employed . The mere existence,
however, of such a large variety of minor details in intra¬
thecal therapy would suggest that treatment initially with or
without rest periods does not greatly alter the survival rate
in favour of one or the other routine.
Whilst on the subject of intrathecal therapy it is
worth stressing a few details in technique. It Is undoubtedly
of advantage for the same doctor to perform the lumbar punc¬
tures in the same patients and at the same tin© of day this
latter being at midday from the point of view of maintaining
as high a level of streptomycin in the cerebrospinal fluid as
possible. The former item was emphasised by Cocchi and
22 76
Pasquinucci (1950) and by Sir H. Cairns (19U9) as thereby
the possibility of trauma and the obtaining of bloodstained
fluid is lessened, the doctor being mors familiar with the
best intervertebral space to choose and the correct direction
and angulation for the needle# Furthermore, expertly per¬
formed each lumbar puncture should cause little or no pain
and in children apprehension and future resistance and
difficulties are thus obviated. One^ custom in this series
was for each patient to have his or her own batch of strepto¬
mycin and sterile packs of needles, syringes and manometer
. 77
sterilised by autoclaving.(Minkenhof et alia (19*48) ).
Whilst the streptomycin was being injected it was admixed
well with the cerebrospinal fluid. Sterile masks were worn
at lumbar puncture and also rubber gloves for the reasons
which have already been mentioned. (The subject of strepto¬
mycin sensitivity and desensitioafcion will be mentioned again
below under toxic effects of the antibiotic).
Toxic Effects of Streptomycin and Dihydrostreptomycin
In this series toxic effects that could be attributed
directly to the streptomycin were negligible except for an
incidence of vertigo and/or deafness, the latter being more
frequent in those patients treated with dihydrostrepfcomycin.
Toxic reactions, that have been described, fall into four
.78
main groups (Farrington et alia, 19*47) i-
(a) Histamine group - this is manifested by flushing,
headache, and a fall in blood pressure and these are due to
impurities in the drug and have been abolished by use of the
purer preparations and with treating streptomycin with hista-
minase (McBermofct, 19*47) •
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(b) Anaphylactoid group - this is characterised by skin
rashes frequently ephemeral, conjunctivitis, leucoeytoais,
oedema, eosinophil!a and pyrexia. The pyrexia usually
appears after the 10th - 18th day of therapy and the rashes,
either ?/ith, or without, fever, later at the second to third
week. The rashes may "be morbilliform, blotchy, maculo-
papular and/or pruritic and are often accompanied by peri¬
orbital oedema, superficial scaling of the skin, and enlarged
lymph nodes. An exfoliative dermatitis has also been des¬
cribed as due to streptomycin. Accompanying these rashes may
be headache, nausea, vomiting and joint pains.
These anaphylactoid reactions are probably also re¬
lated to impurities and are reduced by use of purer prepara¬
tions. If these reactions are severe therapy would have to
be discontinued and dessnsitisation carried out,
Sensitisafcion to streptomycin can not only occur in
80
the patient but in the doctor or nurse administering the drug .
A dermatitis in four out of 80 nurses exposed to risk was
81
described in 19*48 by Crofton and Foreman j four cases of epi¬
dermal sensitisation were also described in 19*4? by Strauss
3i2 Q?
and Waring and further cases by Sferingfsllow (19*48) ""'and by
8*4
Rauchwerger et alia (19*48) . Within one's own experience
during the time period of the above series one sister and one
nurse both became sensitised. The rash in both cases was
typical of that described in the above-mentioned reports and
was a pruritic papular erythema on the antecubital fossae, on
the fingers and around the eyes accompanied by periorbital
oedema. This condition can be very disabling and therefore
O jr
a method of dessnsitisation as described by Crofton (1953)
is welcome. Desensitisation in patients is fortunately
easier than in the medical attendants* In both cases in¬
stanced above removal from danger of contact was practical
and was carried out but this fortuitous result is not always
so easy. Therefore nursing and medical staff who have
positive patch tests to streptomycin would be well advised
to wear rubber gloves whan handling this antibiotic.
(c) Renal group - As streptomycin is excreted entirely
through the kidneys, one finds high concentrations in the
urine. Cathie (19^8; found 500 - 1,000 units of strepto¬
mycin per cu.mra. in the urine (1 unit S 1 p.g, streptomycin)
87
even after one daily injection, Cooper and Cohn (19^8)
found - 80$ of the total dosage was excreted in twenty-
, 86
four hours, the National Research Council (19146a) reported
60;' - 80$ of one injection to appear in the urine within
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twenty-four hours and Russell and MacArthur (1950) said that
they found 320 - 3,200 jug. .per millilitre in the twenty-four hour
urine sample after the usual average daily intramuscular and
intrathecal dosage. Therefore it is not surprising that on
high dosage there is a renal group of toxic reactions, these
being albuminuria (usually slight), heematuria and casts which
are more numerous if the urine is acid. Some slight impair¬
ment of renal function occurs on high dosage and recovery will
79
ensue even if streptomycin therapy is continued. However
there follows from this, that one should in the presence of
marked renal impairment modify one* b dosage of streptomycin.
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In a New York series of eases a high incidence of toxic
signs resulted (1) If the dosage was high (2) if the dosage
was moderate and kidney damage was present and (3) if intra¬
thecal dosage was employed. A case of fatal toxic encephalo¬
pathy due to streptomycin is reported by Hunaicult et alia
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(19^8) and the causative factor here was poor renal function,
(d) Neurotoxic group - These are the most important of the
four groups of reactions and consist mainly of vertigo and
nerve deafness. Associated with the former may be headache,
dimness of vision, a transient numbness around the lips, nausea
vomiting and nystagmus. The first symptoms are usually those
of dimness of vision in the evenings and the headache which
may last only twenty-four hours. This occurs about the sixth
week if the dosage is 1 dm. streptomycin intramuscularly per
day and the third week if 2 0ms. daily (Crofton et alia (1951))
With the additional intrathecal therapy the time of onset is
usually about the 3rd - kth week on dosages such as employed
in this series. A lateral nystagmus may or may not accompany
the vertigo or alternatively may alone be present. Symptoms
may be acuta at first and subside after a week, then there is
a period of latent vestibular dysfunction for six to eight
weeks and finally compensation occurs. In those cases
affected to a lass degree it is usually a sudden movement of
the head whilst the patient is turning in bed that produces
the vertigo and first draws attention to it. Labyrinthine
function tests show that the vestibular defect may recover or
persist in which case fortunately as the patient "becomes
ambulant compensation occurs by day and unsteadiness of gait
only troubles at night. This toxic manifestation is there¬
fore not too troublesome to the patient recovered from
tuberculous meningitis.
A bilateral nerve deafness can also occur, and may
v90
be of quite late onset (Sher, 1951) • This is preceded by
a low pitched tinnitus and the earliest loss is usually a
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high tone deafness although Brown and Hinshaw (I9b6)
found the reverse. There is no compensation for this hear¬
ing loss and so it is a much greater handicap to the patient
and indeed to infants who have not yet learnt to speak.
Dihydrostre ptomycin is the main offender in causing deafness
although less toxic to the vestibular apparatus. In this
present case series the only serious toxic manifestations
encountered were those of vertigo and deafness and the follow-
up revealed the latter as the more incapacitating. Dihydro¬
stra ptomycin was employed for treatment in the majority of
cases but this limited experience would suggest that weight
for weight it did not seem to be any taore effective than the
calcium chloride complex of streptomycin for whom it had been
substituted and it resulted in the mors serious toxic effect.
The last cases in this series were treated with strepto¬
mycin sulphate which is 95$ pure and this preparation appeared
to be the most satisfactory salt of the whole group of
streptomycin drugs.
Further toxic manifestations occurring rarely and
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mentioned by McDermott (19^7) are leucopenia and relative
granulocytopenia* One reported case developed thrombo¬
cytopenic purpura on a daily dose of 6 &m. Cocchi and
22
Pasquinucci (1950) believe that large amounts of strepto¬
mycin interfere with immunity development.
The streptomycin drugs also have a local irritant
effect which seems to be related to impurities as they occur
to a much less extent when the mors purified preparations
are used. One of these effects is pain on intramuscular
injection. The other local irritant effect is exhibited on
intrathecal administration in a person with a normal C.S.F.
The latter shows a marked rise In call count, predominantly
polymorphonuclear in type, and in protein level which sub¬
sides rapidly and should be normal within one week.
Streptomycin is poorly tolerated intrathecally if there is
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no meningeal reaction . The irritant effect of strepto¬
mycin is demonstrated further by the frequent development of
root pains on injection and by an erythema of the cord and
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thickening of the leptomeninges at the site of injection .
If streptomycin is given in too large dosage, especially if
by cisternal or ventricular route, convulsions, coma and
hyperpyrexia may follow. If the excessive dosage is not so
great, however, somnolence and urinary retention appear for
a time after injection.
When the streptomycin is injected intrathecally there
occurs in the patient with tuberculous meningitis, a typical
reaction, in addition to that due to its mild irritant effect.
This reaction is characterised by high value spikes in
cell count and protein readings following each intrathecal
injection and most marked in the early days of therapy#
These spikes gradually become less pronounced over a period
of three to four weeks and this pattern, considered to be
pathognomonic of tuberculous meningitis, is shown well in
many of the graphs of the behaviour of the C.8.F. constituents
during therapy which are found with the case records in the
Appendix. This picture, for example, is not seen in a
haemophilus influenzae meningitis where the levels gradually
subside to normal and Smith and Vollum (1930} believe that
these spikes, where ratio of polymorphs to lymphocytes in¬
creases, are due to the release of breakdown products of the
tubercle bacillus which has been affected by the streptomycin.
Thus the latter has two effects intrathecally, one associated
with a mild irritation and one with a therapeutic action.
On combined intrathecal and intramuscular therapy it
has been proved that diffusion into and throughout the
cerebrospinal fluid is satisfactory and bacteriostatic levels
can be maintained, these levels being higher if the meninges
are inflamed. However very little streptomycin diffuses
into the brain tissues and this is a disadvantage should the
source of the meningitis be a tuberculoma sited in the depth
of a deep sulcus.
At first there was some debate as to whether the
neurotoxic reactions were due to the streptomycin and/or its
impurities associated with it or to the tuberculous meningitis
process itself. However if this antibiotic is used in
non-meningeal ibrms of tuberculosis or in non-tuberculous
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infections , these reactions still do occur and furthermore,
if the administration of the antibiotic is stopped when these
toxic manifestations appear, these toxic signs may disappear
and will reappear on resumption of therapy. If the treat¬
ment is not too prolonged, as for example in a non-tuberculous
infection deafness may appear to recover, although this is
not confirmed by audiograms.
The reason for this apparent selective toxic reaction
of streptomycin on the cochlear and vestibular apparatus is
difficult to explain and there is no convincing supporting
histological evidence of their damage or involvement. Nevsr-
9k
the less Stevenson et alia (19*4?) described five cases treated
with streptomycin, four of which had suffered from tuberculous
meningitis, in which a liquefactive necrosis was found in the
cells of the ventral cochlear nucleus in all five and in the
inferior vestibular nucleus in two - both meningeal cases.
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On the other hand, Baggenstoss et alia (19*47) reported
active tuberculous involvement of the eighth nerve and
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Professor Ormerod demonstrated tuberculous infiltration of
the cochlear portion in a streptomycin treated deaf patient
who had had a tuberculous meningitis. Illingworth and Lorber
38
(1951) also noted that very few non-meningeal tuberculous
cases treated with streptomycin develop deafness but the
weight of evidence and the majority favour a specific neuro¬
toxic action of the antibiotic itself. In fact Floberg et alia
(19*49) showed that streptomycin inhibited intracellular
reproduction of nucleic acids and this action appeared to he
elsctively bound to the nerve calls of the vestibular path¬
way.
With the evidence as described above of all these
toxic signs, the commoner ones of which in order of fre¬
quency are fever, vertigo, rashes, vomiting, deafness and
23
nephritis , it is therefore desirable to select a prepara¬
tion of streptomycin that is less likely to give rise to
troublesome side effects. The dihydrostreptomycin salts,
the hydrochloride and the purer sulphate are excluded by
their causing, as we have seen, a higher incidence of deaf-
52,90,97-105
ness and by the fact that they are no more effi-
89,106-108
c-scious although less painful on intramuscular injection
Of the streptomycin salts, the sulphate is the purest, is
very efficient and is less irritant than the double salt
calcium chloride complex and the hydrochloride, and therefore
the sulphate should be used routinely. Furthermore it mixes
better than some of the other salts with streptokinase should
one wish to use the latter adjuvant to therapy - of doubtful
value. If a change in intrathecal therapy from use of the
calcium chloride complex of streptomycin to dihydrostrepto¬
mycin or streptomycin sulphate is made, the precaution of
allowing a few days interval between injections should be
observed as these preparations do not mix and cause precipita¬
tion. With daily intramuscular dosage it may be better not
to exceed in the adult mors than 1 Q-m. daily - that is less
total daily dosage than the factor 0.02 Gnu/lb./day, which
should he reserved for children, would allow - as several
reports have shown that toxic effects increase proportionately
to rises of the daily dose to 2 Ctas. and 3 Gtns. daily res-
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pectively 9 9 9 Intrathecal dosage probably should not
exceed 100 mgms. daily.
If hypersensitivity reactions are encountered it may
be dangerous to continue therapy without desansitisation
and antihistamine therapy. Continuation of therapy may
result in severe liver damage or anaphylactoid shock.
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One such case of severe shock is reported by Rosen (19^8)
Neurotoxic signs, as above, do not indicate necessity for
cessation of therapy but when these and other toxic manifest¬
ations are present especially on moderate dosage, renal
function should always be checked.
Use of Adjuvants
The overall survival rate as shown in table XI for
cases treated with streptomycin by combined routes was
and this left much room for improvement. Accordingly other
antituberculous agents were sought for possible use in mening¬
itis and could be classified into three groups: in the first
group one might consider the thiosendcarbazones, the sulphonss
of which the active principle is diaminodiphenylsulphone
(D.B.S.), and para-aminosalicylic acid. These drugs appeared
to act synergistieally with streptomycin and also to lessen
the incidence of bacterial resistant strains. For the latter
reason they were tried concurrently with streptomycin in
pulmonary tuberculosis especially, and for the former reason
have been employed in meningitis, resistant strains being
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rarer .(Only two cases both with lung infections in this
series developed bacterial resistance as has already been
noted). This problem of resistance is an interesting one
and recent work has shown that the antibiotic appears
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eventually to become an essential nutrient for the organism .
The second group of drugs for consideration are those
employed to try and reduce or overcome the formation of
adhesions, one of the main causes for unsuccessful therapy.
These drugs are (1) protein purified derivative of tuberculin
( P. P.D.) (2) streptokinase (3) adrenocorticotrophic hormone
(b) heparin (5) potassium iodide and related to the employ¬
ment of these drugs neurosurgical measures will also be dis¬
cussed.
In the third group one has placed the more recent
antituberculous agents of the hydrazine derivatives of iso-
nicotinic acid, terramyein, viomycin, neomycin and arrdthiazone
The discussion on this group will be postponed until the end
when future trends of therapy will be reviewed briefly.
Group I - Thiosemicarbazones and aulphones
Of the three types of drugs mentioned within this
group the thiosemicarbazones need be discussed only briefly
as they hove not been used widely outside Germany where they
were employed by Domazek and his associates. These drugs
are very toxic and tend to cause nausea, vomiting, drug rashes
haemolytic anaemia, agranulocytosis, albuminuria and liver
damage and therefore for these reasons have not been used
as adjuvants in tuberculous meningitis.
The sulphones however have been employed more un¬
iversally the clinical derivatives of D.D.8. used for therapy
being sulphetrone, prornin, diasons and promizole, the latter
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being strongly favoured by Lincoln and her co-workers ' '
in the United States. Looking at table XI again it will be
seen that the use of a sulphons has improved the survival
rates giving an average of l}6.l£. On the other hand we
lib hQ
have Madigan et alia (19*47) , Bunn, P.A, (1950) and
Riggins and Gearhart (19u9) who all consider the additional
use of a sulphone - promizole or sulphetrone - a disadvantage.
Bunn comments that on a regime of streptomycin plus sulphe¬
trone there is a poorer survival rate after the sixth month.
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Guinea-pig and rat experiments gave more favourable
supoort to Lincoln*s plan of treatment as best results were
obtained when streptomycin and a sulphone type of drug was
used together, the action of the sulphone being bacterio-
119
static . Clinical trials of the sulphones in Man were
not so encouraging, however, as the animal experiments, promi¬
zole appearing the most effective of the four derivatives
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especially in children. Lincoln and Kinase (19*j9) tried
the latter drug by itself in tuberculous meningitis without
beneficial effect but found it to be of use in miliary tuber¬
culosis.
Promizole is given by the latter workers orally
concurrently with intramuscular and intrathecal streptomycin
therapy. Dosage In infants is 0.5 0m. daily and in older
children 1 0m. daily. This dosage is gradually increased
until blood levels of 1 - 3 ffigraa. per 100 ccs. are obtained
within three hours of the oral dose. Therapy9 as des-
28
cribsd by Lincoln and Sifontes (1953) * is continued for
three years and for at least eighteen months following the
last intramuscular injection of streptomycin. Up to 8 0ms.
daily in adults has been given. Cocchi and Pasquinucci
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(I950) also used a sulphone giving it intravenously as
they considered that the use of this route reduced the in-
cidence of toxic effects. They used a 60% solution with
dosage based on 0.05 - 0.1 0m, per kilogram body weight per
day. A five day rest interval was allowed after each fort¬
night's therapy. Their results were very good but difficult
to assess as other agents were also employed.
Intrathecal sulphetrone was used by Calnan3 Ruble
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and Mohun (1951) as they found that oral and intravenous
medication gave poor concentrations in the cerebrospinal fluid.
This poor diffusion into the C.8.P. had already been noted
in the animal experiments. These authors in two comparable
series* one treated with streptomycin alone and the other
with the additional use of intrathecal sulphetrone* earn© to
the conclusion that the sulphone was of no advantage the sur¬
vival rates in each group being similar.
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Cathie and Macfarlane (1950) also used sulphetrone
intrathecally in addition to streptomycin by combined routes
and intrathecal streptokinase and compared cases so treated
with those on streptomycin alone. They formed the impression
that sulphetrone, which they considered the least toxic of
the salphone groui>, did not influence their results for better
or worse. They also found that the oral and intramuscular
routes did not give high enough cerebrospinal fluid levels of
1.5 rngms. per cent without toxic signs. Their aeries suffered
from the disadvantage of not being strictly comparable.
The balance of evidence does favour improved results
from the additional use of a sulphone but usually at the
expense of severe toxic effects from the high dosage necessary
to obtain satisfactory blood and cerebrospinal fluid levels.
These toxic effects, although less severe or dangerous than
those of the thiosemicarbazones are a contraindication to
their use. These effects may be listed as follows
haemolytic, iron deficiency and nutritional anaemias, goitro¬
genic effect, headache, nausea, vomiting, cyanosis, and drug
rashes, and result from prolonged administration there being
no acute toxic effects of the drug. The sulphones also cause
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a pink colouration of serum and urine. In animals ad¬
ministration of large dosage of the drug causes in addition a
rise in the alkali reserve, a slow absorption from the bowel
and a quick excretion by the kidneys. The sulphone passes
slowly to the cerebrospinal fluid and doesn't penetrate the
brain,
Para-arninosalicylic acid (?.A.S.)
Aa an alternative to the use of a sulphone which we
have seen has certain disadvantages as an adjuvant one may use
para-amlnoaalieyllc acid and table XI,which shows the few
series reported, demonstrates a survival rate of 62.9%,
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Naismith (1952) reports two series of cases, the first
treated "by streptomycin and the second by dihydrostreptomycin
and P.A.S. As has already bean stated, dihydrostreptomycin
is weight for weight no more effective or rather slightly
less effective than streptomycin, bo that this author*s im¬
proved survival rate in the second group might well be due to
the P.A.S. However there is the factor that streptomycin
and dihydrostreptomycin regimes differed slightly in dosage
but this difference is too small to account for the survival
rates of 50$ in the first and 69$ in the second groups. The
, ?1 I
Council on Pharmacy and Chemistry (1951) s Bunn, P.A. (1950)
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Rossi, Yon E. (1950) and Buxton (1951) amongst many
others all consider the addition of this drug as an advance
in therapy and consider it should be given as a routine.
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Cocchi and Pasquinucci (1950) used it as well as other adju¬
vants to therapy. In one* s personal series P.A.S, was only
administered routinely latterly and given in earlier adult
cases only if concurrent pulmonary tuberculous lesions were
present, and where a danger of bacterial resistance might
12k
develop •
Para-aminosalicylic acid can be given orally, by
intravenous drip, or intrathecally. The sodium salt is used
in aqueous solution and dosage, as employed by Cocchi and
22
Pasquinucci was 0,3 Gm. per kilogram body weight per day
divided into three doses. For children they U3Sd 0,1} Grrt.
92.
Intravenous dose given by drip was 0.5 to 0.75 Gm. per Kilo,
body weight per day (in terms of free acid). Intrathecal
dose was 50 - 100 mgms. by lumbar route, 50 mgraa. by cisternal
or ventricular routes and 150 ragms. of a solution sub-
durally. They considered use of P.A.S. very favourably
especially if used when streptomycin resistant organisms
appeared and preferred the drug to be given in high dosage
by intravenous drip therapy. These authors further stated
that P.A.S. was antagonistic to vitamins 0 and K and there¬
fore gave, concurrently, large doses of the latter. The
majority of workers however consider that oral administration
is quite satisfactory. It is given as a 20% solution that
may cause some nausea and vomiting being very unpleasant to
take. It is best administered in small divided dosage three
hourly and then this dose is gradually increased to the
desired maximum. At first it used to be thought that in the
adult 20 Grns. daily were desirable but lesser dosage of
12*4,125
12 - 1*4 Oma. appears to be equally effective . Corres¬
pondingly smaller doses are given in children. This drug
is best given at the end of a meal as it produces intestinal
upset. If the solution is not well tolerated granules or
cachets may be used but absorption is not so reliable and if
the method of gradual build-up in dosage is employed the in¬
cidence of nausea should be small. Treatment with P.A.S. is
continued as long as the intramuscular streptomycin is given.
Among the toxic effects of P.A.S. are commonly the above
mentioned nausea and vomiting and less frequently pyrexia,
diarrhoea and drug rashes. The use of antihistamine drugs
can toe invoked as prophylaxis, and desensitisation, if nec¬
essary, may toe carried out as described toy Professor Crofton
Oe
(1953) • Levels of P.A.S. in the plasma can toe potentiated
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toy the use of toenemid which delays renal excretion and if
hypersensitivity does occur and is resistant to treatment one
can fall hack on the employment of promizoie or sulphetrone.
Para-aminosalicylic acid has "been tried alone in
treatment of the meningitis and miliary forms of tuberculosis
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without success
Group II - Adjuvants
We have now to discuss the second group of adjuvant
agents, members of which have been used In an attempt to
overcome the development of adhesions around the base of the
"brain preventing free circulation of the cerebrospinal fluid
and thus of streptomycin (one of the main causes of failure
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of therapy) and causing hydrocephalus. Post-mortem exam¬
ination almost invariably has shown the most intense changes,
namely greenish-yellow gelatinous exudate and fibrous adhesions,
to toe in the interpeduncular cistern, the cistern of the lamina
terminalis, the cisterna ambiens and extending into the Sylvian
fissures. The exudate was more predominant in early cases
who had had little or no therapy whereas late cases and those
who had had prolonged streptomycin treatment showed the pres¬
ence of many fibrous adhesions often woody-hard with much
fibroblastic activity enclosing active foci of the disease^.
Associated with these changes there was always some degree
of hydrocephalus usually of the communicating type.
A complete "block to the cerebrospinal fluid circulation
was diagnosed during therapy or at post-mortem in nine
patients of this series of 52 cases and in four the hydro¬
cephalus was of the non-communicating type. There was a
spinal block in two cases. Furthermore we have also already
noted that the meningitis was in certain cases controlled
but death had occurred from the reparative late effects of
the disease.
Accordingly an agent that could modify or alter this
new autopsy picture induced by streptomycin therapy as distinct
from that of the more acute type with the gelatinous exudate,,
would be invaluable., and so within this group we shall dis¬
cuss such agents.
Tuberculin
Tuberculin used in the treatment of tuberculous
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meningitis was first described by Don (1907) where a tem¬
porary remission in an eventually fatal case was attributed
129
to its intramuscular use. In 1912 Haranon and Wolman in
their book described the systemic use of tuberculin in two
cases of meningitis with the recovery of one patient. Much
61
more recently Chore®!s et alia (1950) used in addition to
intrathecal and intramuscular streptomycin intravenous in¬
jections of tuberculin gradually increasing the strength of
/ —8, . —Li,
the solutions (1 in 10 ) to(l in 10 ) every four days and
continued thus for four weeks. Their survival rate was
61,k%. This form of supolernentary therapy has not been used
in this manner elsewhere and seemed to be of rather doubtful
efficacy in spite of the satisfactory survival rate.
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However Smith and Vollum (1950) used tuberculin intra-
thecally with the idea of destroying the adhesions and the
tuberculous granulation tissue in order to allow the strepto¬
mycin to reach and attack the enclosed bacillus* Smith (1953)
recommends that the tuberculin as a protein purified deriv¬
ative should be used in minute doses in sensitised patients
and she reports two series, one treated with streptomycin
and the other with streptomycin and P.P.D. The latter group
which all had a graver prognosis showed a better survival
rate than the former. Not all cases of tuberculous mening¬
itis have a positive skin sensitivity as shown by the mantoux
test, sensitivity being often depressed in this and other
fulminating forms of non-meningea'l tuberculosis and bearing no
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relationship to stage of disease . These cases, therefore,
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not being sensitised to the tuberculo-protein ' would not
benefit from the use of intrathecal P.P.D. and, in common
with normal patients, no meningeal reaction would occur.
Sensitivity can still develop during the course of the mening¬
itis and thus P.P.D. might later be of value. Recommended
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dosage is less than 0.000,0035 mgm. being related to in¬
tensity of the rnantoux reaction, and is trebled and quad¬
rupled at four day intervals. Toxic effects can be both
dangerous and alarming and include coma, hyperpyrexia, con¬
vulsions, raised intracranial tension and acute hydrocephalus
with headache and vomiting. As a result of the intense in¬
flammatory reaction of the meninges - a specific tuberculin
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reaction (Swithiribank et alia, 1953) - resolution of
exudate occurs with high levels in cell count (predominantly
polymorphonuclear) and protein rather resembling the spikes
following intrathecal streptomycin injection which latter
presumably causes release of the breakdown products of the
tubercle bacillus. Concurrently with the tuberculin intra-
muscular and intrathecal streptomycin is given to neutralise
the caseous foci thus exposed by tuberculin action (Cairns,
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19149) . Post-mortem specimens of brains from cases who
have received P. P.D. therapy show remarkably few traces of
the basal collar exudate typically found.
In one's own opinion, the severe reactions that
accompany P.P.D. therapy militate against its routine use.
However this seems to be indicated in those sensitised
patients who are not progressing satisfactorily and are be¬
ginning to deteriorate with signs of a block in the cerebro¬
spinal fluid circulation and increase in intracranial tension,
marked rise in protein levels, steady or falling cell counts
and xanthochromia.
Tuberculin given subcutaneously or intramuscularly,
although producing a body reaction, does not penetrate the
meninges.
As has been detailed two cases in this series received
tuberculin treatment, one dying after severe reactions (case
No. 18) and the other also with severe reactions benefiting
temporarily (Case No. 33)•
Streptokinase
Another agent that has heen used to remove exudate
is streptokinase. This is a bacterial product from haemo-
lytic streptococci (strain which activates a profibrino-
lysin which in turn lyses fibrinous exudate. It is standard¬
ised and concentrated 100 times for intrathecal use and is
employed with the object of lysing the fibrino-gelatinous
exudate but is of no value against fibrous adhesions and thus
it is effective in meningitis in the very early and not the
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late stages . It seemed a promising substance from in vitro
experiments but clinical application has not borne out its
early promise. One of its main dra?/backs is that it is
irritant to the meninges and causes pleoeytosis, pyrexia,
listlessness, irritability, drowsiness and headache, these
symptoms developing in the normal patient and being related,
as we have mentioned, to its hydrolysis of plasminogen.
Furthermore streptokinase is only miscible with calcium free
salts of streptomycin, opalescence also resulting on ad¬
mixture with dihydrostreptomycin, so that one has to use
streptomycin sulphate with it. In the series here analysed
seven cases only were treated in part or in toto with the
additional use of streptokinase 6 units being added at each
intrathecal injection. Wo striking benefit seemed to ensue
in these cases and rises in cell count and protein level in
*
This dose refers to the original B.W.& Co. preparation
the cerebrospinal fluid occurred. This and the other toxic
effects made evaluation of the patient*s progress more
difficult and its further use was discontinued. This im¬
pression of streptokinase has been gained also by others and
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Lorber (1931) » Buxton (1951) and Illingworth and Lorber
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(1931) all write to say that they do not consider it to be
of value, Lorber stating that the incidence of blocks in the
C.S.F. circulation is not reduced. On the other hand Cathie
29
and Macfarlane (1950) reported favourable results using
streptokinase and sulphetrone intrathecally along with strepto¬
mycin by combined routes. They found the incidence of blocks
less and the survival rate better in a series so treated as
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compared with one on streptomycin alone. Cathie also be¬
lieves that streptokinase takes a little time to become
effective and reduces the number of intrathecal injections
required.
In spite of the latter views, nevertheless, the
majority do not advocate the use of streptokinase.
Neurosurgical Methods
In addition to the two adjuvants just discussed
neurosurgical methods have been employed to try and overcome
the effects of the basal adhesions. As the incidence of
blocks to the cerebrospinal fluid may be as high as one in
every three cases the decision when and where to use these
methods is important and merits discussion next. Their ob¬
ject is usually twofold in that one is to relieve increased
intracranial tension and the hydrocephalus and the other to
provide an alternative route for intrathecal therapy.
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Smith, Vollum and Cairns (1950) advise the making of
frontal "burr holes routinely for ventricular drainage and
for therapy, especially if P.P.D. has to he used intrathecally.
They state that this method may also help in differential
diagnosis as the tubercle bacillus is more often found in
ventricular fluid and furthermore histology from pieces of
tissue obtained on puncture can be carried out,and the frontal
burr holes may be used for ventriculography as an aid in the
early diagnosis of C.S.P. block and the assessment of degree
of hydrocephalus. If ventricular drainage has to be employed
it should be interrupted and not continuous as the latter
has been shown to give rise to further blocks through increase
in the protein content and in fibrin deposit in the cerebro-
3k , , ,132
spinal fluid . Cairns (19*49) stated that drainage of
the lateral ventricles continuously was of no value especially
in the acute stage and did not lead to lessening of coitia, and
he tried the direct installation of streptomycin (500 - 1,000 jag.
per millilitre (ml.)) through polythene tubes two to four times
daily using up to 6 ml. for ten days. The tubes led to the
usual site of most intense disease i.e. the interpeduncular
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region but success was doubtful and there was a danger of
pyogenic infection. Should one manage to locate the block
to the foramina of Monro, Luschka, Magendie or aqueduct of
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Sylvius a Torkildsen operation (19*47) - a ventriculo~
cisternostomy - may be performed but it is rare for these
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sites alone to be affected as shown by air encephalography.
Major neurosurgical procedures are therefore seldom indicated
in tuberculous meningitis, the only one required being the
simple provision of a pair of frontal burr holes.
Indications for ventricular drainage are increasing
coma or drowsiness, papilloedema or blurred optic disc mar¬
gins, intractable vomiting, headache, and opisthotonic spasms,
the latter three often occurring poroxysmally. Further in¬
dications may be increase in pulse rate (a slow rate occurring
earlier), Cheynes-Stokes respirations, convulsions, changes
in the flow of the lumbar cerebrospinal fluid,and Coechi and
Pasquinucci stress a high protein level with xanthochromia in
both lumbar and cisternal fluid specimens. Indications for
drainage are usually multiple and often occur early in therapy
13il
as demonstrated by pneumo-encephalography (Lorber, 1951)
The Italian authors just mentioned prefer to give ventricular
therapy through an indwelling polythene catheter but Cairns
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and Taylor (19*49) have found that therapy by puncture
through the frontal burr holes equally easy and effective,
the dosage being smaller than that by lumbar route and less
likely to produce a reaction by the ventricular route as by
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the cisternal. Cocchi and Pasquinucci (1950) found that
the more extensive use of the cisternal route reduced their
mortality and punctures under anaesthesia were not required.
As regards spinal block further discussion on the indications
and contraindications for the different possible routes of
intrathecal therapy in audi circumstance will be postponed
until management of cases is considered.
The above workers also describe use of subdural
therapy and ventricular drainage where tentorial "block is
present and believe subdural streptomycin can penetrate
through the altered arachnoid mater to reach the subarach¬
noid exudate* They have also tried hydrostatic counter
pressure to ventricular drainage for hydrocephalus in order
to keep a controlled intracranial tension. They have found
that these neurosurgical methods described above,, when used
in appropriate eases,, to have reduced further their mortality
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rate (Groups III, IV and V - Cocchi and Pasquinucci (1950)) •
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Pontine cisteraostomy is described by Komrower (1950)
with survival of four out of nine cases. He advocates the
use of this procedure if fear of lumbar punctures develops
and morale deteriorates, if cerebrospinal fluid rises and/or
there is a falling diffusion index (which will be mentioned
later) and clinical evidence of an early hydrocephalus.
Two other special methods that have been tried but not found
to be very successful are the intrathecal injections of air
and irrigations with Hartman's solution to prevent adhesions.
It would appear that frontal burr holes should be made
in those cases showing signs of deterioration from hydro¬
cephalus in order to carry out ventricular drainage, and in
certain cases to help if differential diagnosis is difficult
and also to detect the presence and site of a block to the
C.S.P. circulation. The burr holes can also be used to
supplement lumbar route therapy with intraventricular strepto¬
mycin in a non-communicating hydrocephalus, and they can be
used if t>r any reason lumbar or cisternal routes are im¬
practicable (e.g. The lumbar route was difficult to use in
case No. 146 due to Pott's disease of the spine and in case
No. 30 due to a pustular rash). This measure is a simple
one with danger of infection small and perhaps should have
been employed raore frequently in selected cases in this
series.
Adrenocorticotropic Hormone (A.C.T.H. )
Recently this hormone has been tried in tuberculous
meningitis with the purpose of reducing fibroblastic activity.
It had already been used concurrently with streptomycin in
the United States for treatment of pulmonary tuberculosis in
which thick walled cavities were present. However during
this type of therapy some cases have been reported who have
developed a complicating meningitis so presumably the converse
could happen with a flare-up in the lung lesions. I think
one could safely conclude that the use of this hormone would
be unwise as it is potentially dangerous and as yet there have
been no adequate series reported to support its use. In
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one recent article in which different forms of therapy were
compared* one group received A.C.T.H.* isoniazid* intramuscular
streptomycin and P.A.3. but it was difficult to evaluate the
part played by the A.C.T.H. in view of the different agents
employed and the fact that the different series were not
strictly comparable as has been pointed out by Lorber (1953)
A.C.T.H. has also been employed in tuberculous meningitis by
Halikowski (1953)1"^ who presumed that an allergic vasculitis
was causative of decerebrate fits occurring in this disease,
the underlying basis being a hypersensitive reaction of the
altered blood vessels of the brain. He considered the
symptomatology of these "violent neurological reactions" to
resemble those in acute disseminated encephalomyelitis in
, 138,139
which latter disease A.C.T.H. has been used by Miller (1953)
In such cases described Halikowski us3d increasing doses
of the protein purified derivative of tuberculin intra¬
thecals (1 in 10~7 solution) every two to three days in
—ft
doses 0.2, 0.1}, 0.6, 0.8 and 1 ml. and then 1 in 10 sol¬
ution in the same manner until an inflammatory reaction was
produced. He then stopped the P.P.D. and gave A.C.T.H.,
15 to 25 mgms. intramuscularly four times daily and claimed
a mortality reduction from 68$ to 33% with clearing of blocks
to the cerebrospinal fluid circulation. During this therapy
no other drugs were given. The use of A.C.T.H. to modify
the reactions produced by P.P.D. sounds reasonable but danger¬
ous especially without giving streptomycin and one would be
very chary of using his technique.
Overdosage of A.C.T.H. will lead to obesity, a. moon
face, hypertension, oedema, spread of sepsis, and deteriora¬
tion in tuberculous lesions unless controlled by an anti-
tuberculous agent.
Heparin
Heparin has also been tried to reduce fibrin formation
and the development of adhesions. Its use was rapidly dis¬
carded by those few who tried it as it appeared to be in-
effective and formed a precipitate with the streptomycin
salts, It therefore had to "be given "by separate intra¬





One paper also describes the use of potassium
iodide in order to try and reduce the formation of fibrous
tissue and increase the penetration of the active agents on
the analogy of its employment in tertiary syphilis. How¬
ever there was no evidence of its value as an adjuvant to
therapy.
General Non-Specific Therapy
This will include those general measures of a
sanatorium type of regime. In this series vitamins A and
D» the B complex and C were given orally and if this was not
possible by injection until oral therapy could be resumed.
The dosage employed was not as large as those of Gocchi and
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Pasquinucci (1930) . Rectal drips were employed for the
first 2I4 hours following admission in only one or two cases
but in the majority with the exception of the moribund dying
patient it was possible to give diet by mouth. Blood trans¬
fusion or protein hydrolysates by intravenous drip method
were not employed although their use has been reported,
In the early stage with a restless patient should an intra¬
venous drip be required polythene tubing was employed as
this could be threaded some distance up the vein of election
and the danger of the tubing being pulled out by the patient*
105.
restlessness was thus minimised. In those patients with
also active pulmonary lesions bed rest was prolonged if
necessary after cure of the meningitis. Iron medication
was also given almost routinely with vitamin therapy.
Depending on the individual patient*s progress "but
on an average about the sixth week of treatment, physio¬
therapy was instituted provided there was no contraindication
such as active pulmonary lesions as Just mentioned.
Gradually exercises of limbs with preservation of muscle
tons was extended so that the patient could sit up. If
progress remained satisfactory, the patient was permitted
to become ambulant when intrathecal therapy was discontinued
and the cerebrospinal fluid was approximately near normal.
On an average the patient would be allowed up about the 16th
week. Any deformities were splinted under the direction of
the orthopaedic surgeon.
Associated with the above was the institution of
occupational therapy for the older children and adults. This
was found to be quite important from the point of view of
morale during such a treatment arduous to doctor and patient
alike. Morale was further boosted by the arrangement of
cinema shows including cartoons for the young children. One
found that morale was not helped by institution of rest
periods too early as has already been mentioned.
Ill patients were nursed in cubicle wards and this
therefore included all admissions at first and then trans¬
ferred later with improvement to the general ward.
Sedation by use of barbiturates, was found to be
quite satisfactory for use during the day and at night.
Before we discuss finally the third group of the
newer drugs and their relation to possible future trends
there are a few points in the'management of tuberculous
meningitis and in the pathogenesis and pathology and com¬
plications following therapy worthy of consideration.
The Management of Tuberculous Meningitis
The problems that occur during therapy are those
of diagnosis, prognosis, recognition and treatment of blocks
to the cerebrospinal fluid circulation (as the management of
blocks other than that of the spinal subarachnoid space have
been discussed under neurosurgical methods, the latter onl5^
will now be stressed),duration of therapy, and detection of
relapse or recrudescence.
(a) Diagnosis
All authorities stress the importance of early diag¬
nosis and this is confirmed by the results in table I under
analysis of cases. "JVfo of early cases survived whereas
none in the late stage. Therefore consideration of means
to facilitate this early diagnosis is important. Careful
examination and follow-up of children with a primary tuber¬
culous complex and hilar adenitis in the chest should be
carried out as this is the dangerous period for the develop¬
ment of a meningitis before the local lung lesion is con¬
trolled1^. Debre et alia (l9*»7)li4lshowed that l|2 out of 51
cases who developed an allergy to their primary infection
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developed a tuberculous meningitis within six months.
li|2
Wallgren (193*4) has shown that tuberculous meningitis
rarely follows careful treatment of a primary infection and
states that the dangerous period for development of mening¬
itis usually occurs within four to eight weeks of the appear¬
ance of tuberculin sensitivity. But the early diagnosis
of a primary infection is very difficult unless an erythema
nodosum presents. An uncharacteristic fever in a child
merits institution of a period of rest and sanatorium type
of regime. This is essentially the prophylaxis of tuber¬
culous meningitis with which, of course, is closely assoc¬
iated the prophylaxis of tuberculous infection anywhere in
S
the body, e.g. vaccination with the Bacilie-Calmefcte-Guerin
(B.C.Q.), clean milk supplies (case 25 died from meningitis
through a bovine organism obtained in drinking raw milk),
proper isolation of known cases and follow-up of contacts.
An example where prophylactic measures in childhood tuber¬
culosis including meningitis have borne fruit is in Sheffield
where childhood mortality figures have improved markedly.
These measures included thorough contact examination, segre¬
gation, B.C.G. vaccination, streptomycin therapy, and the
establishment of a follow-up clinic for small children in¬
cluding those suffering from a primary lung infection
.1*43
(Lorber, 1953)
Wallgren further proved the relationship of the
primary infection to tuberculous meningL tis by showing
graphs with corresponding peaks of incidence in either
condition there "being a time lag of six to eight weeks
later in the meningitis. These curves also showed that
the peak incidence was in the late or early spring for the
primary infection and the tuberculous meningitis, occurring
six to eight weeks later, had its peaks in late spring or
1^,1^5
early summer . Prophylactic therapy in Gothenberg,
lb 2
Sweden over six years reduced the total incidence of
tuberculous meningitis and therefore, although potent anti-
tuberculous agents are now available, prophylaxis must not
he overlooked as a therapeutic weapon. In this series 19,2%
of cases had evidence of an active primary chest infection.
Occasionally diagnostic lumbar puncture should he
considered during a primary infection if additional symptoms
and signs of headache, vomiting and mental change develop
even without those of meningeal irritation. An early lumbar
puncture may thus reveal a simple, serous tuberculous meningitis
with its better prognosis and easier treatment than the later
£46
sequel of a frank meningitis
Further precautions to aid detection of tuberculous
meningitis early are those of routine lumbar punctures at
commencement of and weekly or fortnightly during treatment of
38,li46
a miliary tuberculosis . Case 30 is an example where
this 3hould have been carried out as earlier recognition of
the meningitis would have been achieved. Often, however
there are no physical signs or symptoms to suggest the onset
of this complication during the course of the miliary disease.
It has been pointed out above that two cases in this series
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developed tuberculous meningitis after completion of therapy
and cure of their miliary tuberculosis,, and Indeed cases
have been reported where this has occurred as late as the
k9
seventh month following treatment . Therefore it would
seem wise to continue with a few diagnostic lumbar punctures
during the follow-up period of such patients.
Apart from alertness during a primary infection,
during miliary disease, and even during tuberculous osteo¬
myelitis of the spine, the analysis suggests that headache,
vomiting, constipation, pyrexia and loss of appetite that
persist and are accompanied by a change in the patient's nor-
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mal personality towards lethargy or apathy , with moments
of irritability, are warning early manifestations and there¬
fore one should not await neck stiffness or a positive
Kernig's sign or other neurological signs which develop at
the end of the prodromal stage or even later. Thus, to
achieve early diagnosis, the above group of symptoms with
Ihii
emphasis on mental change , should be treated with great
respect especially if accompanied by a positive family history
of tuberculous disease or a tuberculous infection of one
type or another (e.g. tuberculous hip disease in case No. IOj
pleural effusion in case No. 17). Early diagnosis facili¬
tates institution of therapy before the exudate organises
into the fibrous adhesions which cause so many of the trouble¬
some late effects.
Differential Diagnosis
Passing from the problem of early diagnosis the next
difficulty encountered is often that of differential diag¬
nosis. Many points in regard to the latter have already
heen mentioned in the analysis and one will try to avoid
repetition. In many cases the diagnosis is not difficult
hut atypical cases occur arid the list of conditions that may
have to "be considered in the patient presenting wi th unusual
features is given in the analysis. Here it is that careful
routine examination on admission pays dividends and therefore
present, past and family history, the mantoux reaction, the
physical examination, examination of eyes and. cerebrospinal
fluid and chest X-ray all play their part.
(i) Clinical History - The history of the present Illness
may not be helpful and is often vague. It may be short or
long and unrelated to the stage of the disease but the ex¬
posure to risk of the intake of raw milk in a child, a
previous precipitating illness such as an infectious fever
or trauma (occurred as a doubtful cause in 2 cases) which
may light up a perifocal reaction around an established
intracranial focus^^t^'^^,^^J^^(four cases in this series),
the story of a recent or past tuberculous infection else¬
where in the body (the primary site maybe thoracic, abdominal,
lii5
cervical or bony , or even a tuberculous otitis media
•JJ.Q
(Crowe,1930) ) may be the factor which helps to tip the
scales in favour of a firm diagnosis. Of greater help in
differential diagnosis is a history of possible contact with
a tuberculous person, usually a member of the family circle
although actual contact may be difficult to prove.
Lorber (1950) found the source of infection in 80% of
123 adequately investigated cases of miliary and/or men¬
ingeal tuberculosis and noted that mismanagement in super¬
vision of tuberculous adults was a serious factor capable of
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correction. Wilson et alia (1952) quote contact figures
of 39*5% for England, 22.8$ for Wales, and 28.9$ for Scotland.
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Lincoln (19*47) found a contact history in 58$ of children
Ofz
with meningitis and the Medical Research Council (19b8)
quoted 33$» I think that in this present series the figure
of 29% of cases with a positive contact history could have
been improved by more diligent search.
(li) Mantoux test - The msntoux test was found to be a
valuable aid in diagnosis in differential diagnosis in the
very young as it is usually positive in tuberculous mening-
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Itis but Taylor, Smith and Vollum (1953) warn that skin
sensitivity on admission can be low or absent irrespective
of stage of the disease. The performance of aerial mantoux
tests are then indicated as sensitivity may develop later.
/ x6l
Choremis (1950) considers that streptomycin reduces tuber¬
culin sensitivity.
(iii) Examination of the eye - A further important step to¬
wards diagnosis is careful examination of the eye and, as has
been mentioned in the analysis, the discovery of choroidal
tubercles is important. These are present in miliary tuber¬
culosis with meningitis more frequently than without the
latter, and the overall incidence quoted in the exhaustive
30
survey by Illingworth and Wright (19£j8) was shown to be 28$
of cases. Tubercles are rarely found in meningitis alone
or in the other forms of tuberculosis and the change in
their appearance during therapy is an aid in prognosis as
will be stressed below. In this series 3 out of 10 patients
with miliary disease and meningitis or three out of the total
52 cases were found to have choroidal tubercles. Debre et
<1 t 1
alia (19*4?) found a very much higher incidence of 75/^J
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Lincoln (19*47) found an overall incidence including cases
of tuberculous meningitis of 10%; Lorber and Emery (1950)"^
reported an overall incidence of 52/ of children with miliary
*43
lung tuberculosis had tubercles; and Bernard et alia (19*47)
found 25% of cases with miliary and/or meningeal tuberculosis,
and if the miliary alone were considered 3k% were so affected.
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Dr. Monbrun (Paris) gave the highest percentage of 87% of
cases with miliary and meningeal tuberculosis or 17% for the
meningitis cases only. Thus the incidence in this series
seems to be too small and could have perhaps been increased
if the sedation technique as described by Illingworth and
Wright had been employed.
Various other eye changes that may be present are
papilloederna, optic atrophy, retrobulbar neuritis and disturb¬
ances in the intrinsic and extrinsic motility of the eye.
Ocular symptoms and signs in meningitis treated by streptomycin
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are well described by Mollaret (19*49) who puts a high in¬
cidence to choroidal changes. Examination of the eye may,
therefore, be of great diagnostic help.
113.
(lv) Radiology - Radiology by revealing the presence of tuber¬
culosis elsewhere, usually, in the lungs, is a further valuable
aid and, as the analysis shows, 33 out of cases X-rayed
had pulmonary lesions, the commonest being ths primary in¬
fection and miliary disease. An interesting point is the
number of adult cases whose pulmonary lesions improved during
therapy for the meningitis only to relapse later or on the
contrary for pulmonary lesions to become apparent after cure
of ths meningitis e.g. case No. 6 where enlargement of para-
trscheal glands appeared; case No, 11 where deterioration
took place, and case No. 1*1 whose pulmonary condition relapsed
later under the strain of a pregnancy. Special consideration
of therapy for both pulmonary lesions and the meningitis is
necessary with prolonged sanatorium treatment, and delay in
allowing too early physical activity and ambulation. Use
of adjuvants to delay or prevent the development of bacterial
resistance is especially important in such cases as much as
their use for synergistic action and one should not hesistate
to use radical surgical methods to eradicate any lung focus
of activity if surgery is indicated once the meningitis is
controlled. Case No. 11 who eventually died from pulmonary
phthisis had a meningeal infection which was controlled mod¬
erately rapidly and it is conceivable that surgery carried out
earlier in his case might have saved his life. He also did
not receive para-aminosalicylic acid which was just becoming
available at this time, and later developed a streptomycin
resistant organism for which thiosemicarbazone was tried with-
Ilk.
out improvement. Thus this eradication as soon as pract¬
icable e.g. after sixth week of intrathecal therapy of a
pulmonary focus which may be active and could give rise to
further metastatic spread appears logical. The presence
of adult phthisis and to a much greater extent miliary disease
makes the prognosis more serious and Smith, Stevens and Pile
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(1951) stress these dangers of pulmonary tuberculosis com¬
plicating a meningitis.
Some examples of the X-ray films of patients in this
series are included in the Appendix, those of cases Nos. 6 and
k7 being especially interesting.
(v) Examination of the cerebrospinal fluid - This is the most
helpful of all the different methods in differential diagnosis.
A rise in protein levels, a lymphocytic increase in the cell
count, a low chloride and a low sugar value, are the most
important diagnostic points, the latter being the most useful.
However it has been shown in the analysis that border line
cases occur in which the sugar and chloride level may even
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be normal and Lincoln (19ii7) describes three such instances.
Chloride levels however are not reliable as they are lowered
by dehydration and vomiting. In the doubtful case the
Levinson test and colloidal gold range could be of limited
help as they are normal if there is no meningeal inflammation.
Repeat lumbar puncture after a few days may help by giving a
more typical picture and, if in the meantime intramuscular
streptomycin is given and cerebrospinal fluid levels show a
rise to 0.5 ^ig* psr ml. or more it would suggest a meningeal
115.
inflammation. Failing "bacteriological confirmation by
film ons must not delay too long for result of culture or
guinea-pig inoculation and should proceed with therapy on
a presumptive diagnosis although realising that ons is sub¬
jecting the patient to a prolonged severe form of treatment.
Subsequent behaviour of the cerebrospinal fluid as regards
protein and cells may show the fluctuations which are pafchog-
50
nomonlc of tuberculous meningitis and which do not occur
with streptomycin given intratheeally in normal cerebrospinal
fluid or in other meningitides such aa hasraophilus influenzal
meningitis.
Differential diagnosis is mad© easy, however, if
tubercle bacilli are actually seen in direct film made from
the cerebrospinal fluid, A spider web clot in the fluid is
significant and a film from the 9spun® sediment of the latter
often reveals the presence of bacilli. Large samples of
fluid for examination increase the chances of obtaining a
k9
positive result but one must exert care in withdrawal if
there is much increase in intracranial tension. Samples by
22 lli *5
cisternal s or to a less extent intraventricular puncture
also increase the chance of a positive result. In this
series the presence of tubercle bacilli was seen in only five
cases and this seems inadequate as other authors report a
much larger number of positive results, e.g. Rubie and Mohun
27 29
(19^9) 58% ; Cathie and Kacfarlane (1950) 88$ using a
technique whereby pinhaad drops of sediment after centrifuging
the cerebrospinal fluid were examined instead of by smear;
126.
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Choramis, K»{1950) 37.8^; Cocehi and Pasquinueci (1950) 91%
by direct microscopy, the latter authors declaring that this
is more reliable than cultural methods; and the Medical
25
Research Council (19^8) k6%, However it is only rarely
in tuberculous meningitis that the presence of tubercle
bacilli is not confirmed by cultural and/or animal inoculation
methods provided samples are examined on repeated occasions
early in therapy. The percentage of positive results obtain¬
ed by these further measures is close to 100?' in all the
series quoted above. In certain selected cases where there
is difficulty, culture and animal inoculation of specimens
of urine, sputa, gastric washings or laryngeal swab should
not be forgotten as means of obtaining the causative organism.
Occasionally the culture will be positive and the animal in¬
oculation negative and vice versa. A survey of this series
would suggest that the guinea-pig inoculation is slightly
more reliable than culture, 37 to 32 positives respectively,
and would agree with the findings of the Medical Research
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Council (19^8) and of Macgregor and Green (1937)
- 1U5
Blackiock and Griffin (1935) however state that the cult¬
ural method is quicker and more reliable for the human strain
whereas the guinea-pig test is better for the bovine strain.
The answer is, of course, that one must employ both methods.
The incidence of the bovine strain was 12,5%, i.e.
four cases out of 32 positive cultures. This figure seems
slightly less than most published series taking into account





The Medical Research Council series (19I48) states that
1 in 33 cases was of "bovine strain hut Blacklock and Griffin
lii5 .15k
(193^1) gave a higher figure of 22.5% and Griffith (193^)
quoted an overall percentage of 25.5 - England 15! cases
with 33 (21.8%) of bovine strain and Scotland 37 cases with
15 (^0.5%). Recent figures given by Wilson and his asso-
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ciates (1952) in their handbook 'Non pulmonary Tuberculosis
of Bovine Origin in Great Britain and Northern Ireland' were
as follows:-
England 19^3-^5 - 28%
t
Wales 19)43-2} 5 - 10.1%
Scotland 19^3-^5 - 11.1%
Nth. Ireland 19k5-50 - 3.k%
155
Munro and Scott (1936) published a series in which 36% of
cases of meningeal tuberculosis were due to the bovine bac-
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illus (21.9% urban and 60.1% rural) and McDougall (19^9)
quotes 2lj.6% for England and 28.6% for Scotland which seem
rather high figures. Most countries other than Denmark
and Britain report a low incidence of bovine tubercle bacilli
causing meningitis.
(v) Simple serous tuberculous meningitis - Positive bacteriol¬
ogy will therefore clinch the diagnosis but before one leaves
this subject mention should be made of simple serous tuber¬
culous meningitis. Two cases in this series were presumed
to fall into this category (cases Nos. I45 and I47). They
both had known active tuberculous lesions in the chest under
treatment and both developed headache, pyrexia and vomiting.
There were no signs of meningeal irritation hut lumbar
puncture in each case revealed a cerebrospinal fluid with
normal chemistry and sugar levels but with an increased
cell count predominantly lymphocytic. No positive films,
cultures or animal inoculations were obtained in either
instance and both resembled cases as described by Lincoln
33
(19^7) as serous tuberculous meningitis. She explains
the mechanism as a perifocal reaction around an older tuber¬
culous cortical focus or as a cortical seeding during a
flare-up in a concurrent chest lesion. Thi3 mechanism
would probably explain many of those cases of tuberculous
meningitis which have in the past been reported as spontan-
1-k
eous cures . Occasionally tubercle bacilli are isolated
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from the C.S.F, of such cases '' 5 and they represent
a potential danger as they may cause a tuberculous meningitis
later this having been confirmed by follow-up. Post-mortem
examination has shown in some who had subsequently died
caseous foci in the cortex without a meningitis but sorce-
3
times there was evidence of a non-specific meningeal reaction
This serous meningitis with a normal chemistry of the cerebro¬
spinal fluid is most liable to occur during a primary in¬
fection, during a flare-up of a tuberculous lesion, during
an infectious fever, after tuberculin testing, or even after
166 , 2'
exposure to strong sunlight . Lincoln and Sifontes (1953)
, . 160
and Choremis, K. (1950) do not advise therapy unless there
is miliary disease present (former authors) but personally
50
one should agree with Cairns, Smith and Vollum (1950) in
119.
carrying out treatment for six weeks or longer. In case
No. h5 it might "be argued that the cerebrospinal fluid change
was due to an encephalitis following the chlckenpox "but I
considered the change to result frora a perifocal reaction
as described above activated by the varicella and the sub¬
sequent behaviour of the cerebrospinal fluid would suggest
the presence of a meningitis rather than an encephalitis
(see Appendix). Therapy with streptomycin by combined
routes is the safer and wiser course and raay well prevent
the fully developed disease occurring later.
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Cohen and Wood (1938) describe cases of exudative
pulmonary tuberculosis in which headache and vomiting
develop but the cerebrospinal fluid is quite normal except
for increase in pressure. These cases resolved spontan¬
eously (as do the simple serous type) as far as the symptoms
were concerned and the authors believed ther3 to be an
allergic exudation into the meninges of clear fluid. They
called these cases cerebral paratuberculosia and distin¬
guished them from the serous meningitis.
Differential diagnosis raay be further helped by
ventriculography as has been mentioned under neurosurgical
methods.
(b) Prognosis
The art of prognosis in respect of life and quality
of survival is a difficult one especially in a disease of
such long duration as tuberculous meningitis where a patient
may progress well or relapse even as much as 12 - 18 months
later. Reference to the analysis of cases presented above
and to other series shows that a favourable factor is early
diagnosis which has already been stressed, this diagnosis
leading to commencement of therapy with the disease in the
early stage. However one may have a case with the mening¬
itis of short duration and concurrent advanced pulmonary or
miliary lung disease and therefore advanced non-meningeal
tuberculous lesions militate strongly against a favourable
outcome. An active primary infection and specimens of
cerebrospinal fluid giving repeated positive cultures and/or
guinea-pig inoculations in spite of therapy all add up to a
2*4
worse prognosis . In this series and many others the
55.162
presence of miliary disease and choroidal tubercles
carried a higher mortality and therefore these complications
demand more prolonged treatment than usual. Illingworth
,38
and Lorber (1951) had survival rates with this combined in¬
fection equalling those of meningitis alone but this exper¬
ience is exceptional. The age of less than three years is
2*4
also an adverse factor as far as prognosis goes and this has
been pointed out in the analysis above with the reasons that
are probably the cause. Here again Illingworth and Lorber
38(1951) found the survival rates in the groups under and over
three years to be similar but again this is contrary to the
general run of experience. Favourable signs during therapy
are early improvement in the mental state, gain in weight
and in general physical well-being usually occurring after
the first six weeks of treatment. A rise in the cerebrospinal
fluid sugar levels is a very good sign, and this is further
reinforced "by a falling cell count, and of lass importance
a falling protein level and a rise in the chlorides. If
streptomycin assays are carried out on the cerebrospinal
fluid and show a fall in content this indicates less mening¬
eal inflammation and so a favourable trend. Choremis et
, .61
alia (1950) uses the alkaline phosphatase levels in the
cerebrospinal fluid as a measure of progress and thus an
aid to prognosis. The phosphatase is uninfluenced in vivo
or in vitro by streptomycin, parallels inorganic phosphate
levels and can be measured in Bodansky units (U.B.) as
follows:-
Normal average l.Ij - 1.6 U.B.)
; Applicable
Advanced disease average Q.k - 0.8 U.B.) to ages
Improved average 0.8 - 1.1 U.B.
Clinical average 1.0 - l.ij U.B.j




and this appears as if it may be of some value in special
cases. Choremis in another article (I9k8) mentions also
that the cerebrospinal lipase is low in advanced disease and
rises as recovery occurs.
Resolution of papilloedema and other ocular symptoms
and paling of choroidal tubercles, with pigmentation around
their edges and an eventual white parehraent-like central
appearance are all favourable prognostic points. The cor¬
ollary of the appearance of fresh tubercles and failure of
those already present to heal are bad signs. These changes
in tubercles are detailed further by Illingworth and Wright
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(19*48) , by Mollaret sfc alia (19*49) and by Somner (1950) ,
and complete healing usually takes about eight to twelve
weeks, the choroid around them finally paling also.*
Improvement in the radiological picture may also ba
a good sign but some caution hare must be exercised as post¬
mortem examination has confirmed clinical assessment in that
the pulmonary lesions have healed and the meningeal may be
active2^®The reverse also occurs and often the miliary
disease is first revealed at autopsy.
Complications developing during therapy adversely
affect the outcome as might be expected. These complications
are mainly those resulting from fibrous adhesions and exudate
in the interpeduncular region where the disease is commonly
most intense. As a result hydrocephalus and blocks (includ¬
ing spinal) to the C.S.F. circulation and brain softening
from infarcts due to a tuberculous endarteritis occur, and al¬
though the inflammatory process may be quiescent these com¬
plications kill or leave a patient paralysed, hemiplegia and
rarely mentally defective. Amongst other resultant com¬
plications described, there are blindness, bulimia, logorrhoea,
arterial hypertension, glycosuria, sleep disorders, these
latter usually resulting from a hypothalamic or pituitary
3*4
upset' , behaviour upsets (case No, 3*4), terror starts (case
No. 50) and a Korsakow*s psychosis. Too intense intrathecal
therapy appears to leave a poorer quality of survivor.
The presence of neurological complications on admission
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with coma or marked mental upset, a negative mantoux reaction® ,
123,
25,33,110
and bacterial resistance, rare in tuberculous meningitis ,
all indicate a bad prognosis whilst decerebrate rigidity
with intense basal exudate and a tuberculous arteritis with
infercts of the basal ganglia give a virtually hopeless out¬
look. At the other extreme there is the serous type of
meningitis with a very good prognosis.
Thus to prognosticate the whole clinical picture over
a few weeks requires to be assessed and this is helped by
32
using special charts and graphs of the type shown in the
Appendix, in which charts,progress in weight, resolution of
.pyrexia and cerebrospinal fluid trends can be seen at a
glance. In management of this disease regular complete
checks of the patient by physical examination, X-rays,
ophthalmoscopy and diagnostic lumbar puncture are required.
Very often when a block occurs, with its more unfavourable
prognosis, one must remember that it may resolve spontan-
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eoualy (case No. 17) with or without a rest from intrathecal
therapy and then again the rest may often lead to improved
well-being and weight gain. Prognosis therefore, although
guarded, need not always be unduly pessimistic. Another
point, although not quite so obvious, is that these cases
should be treated in centres with the special experience in
their nursing and medical care, and with good laboratory and
specialist services. If relapse or recrudescence doss
occur response to further therapy is usually more favourable .
One should also consider in assessing prognosis the innate
resistance of the individual to the tubercle bacillus and the
12i|.
latterfs virulence, e.g. this resistance i3 lower in the
1*47
Jewish and negroid races •
(c) Recognition and The ran:/ in Spinal Subarachnoid Block
Another important point in therapy is the early
recognition of a spinal "block. Other "blocks to the cerebro¬
spinal fluid with their 3igna and symptoms and treatment have
already "been mentioned under neurosurgical methods page 98.
A "block in the spinal subarachnoid space is shown by a rise
in the protein contents xanthochromia and a fall in the cell
count of the lumbar cerebrospinal fluid with often a scanty
flow of the latter. Radiculitie pains shooting down the
lower limbs, backache and girdle pains, and pain during
lumbar injection are also warning symptoms. The Queeken-
stsdt test showing a failure to rise or a slow rise without
fall in the C.S.F. pressure on jugular compression indicates
a complete or a partial block respectively, and the estimation
of the diffusion index as described by Comparefcti et alia
163(I9h8) may help in the early recognition of this compliea-
ation. This diffusion index is defined as the ratio of the
concentration of streptomycin in cerebrospinal fluid obtained
on cisternal puncture to that in the lumbar fluid eight hours
after the injection of 30 nigms. of streptomycin. When the
index is low, intrathecal injections should be given by
cisternal or ventricular routes. These authors suggest that
the index should be estimated regularly every two or three
weeks during therapy and the use of this index is further
described in relation to a series of cases by Cocchi and
123.
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Pasquinucci (1950) • These authors state that it is
more sensitive and reliable than the protein levels in
cisternal and lumbar fluids, low and high readings res-
161»
pectively suggesting a block. Lorber (1950) also found
the lumbar/cisternal protein ratio was unreliable. Few
indications (usually temporary) present for total abandon¬
ment of lumbar route for intrathecal therapy. As has been
mentioned, when blocks occur with a non-communicating hydro¬
cephalus therapy by ventricular route to supplement the
lumbar route is often of value. Frequently by using the
alternative route and resting the lumbar one the spinal
block may clear spontaneously even after four months of
165
daily cisternal punctures - Florl (1950) • Skin rashes
and vertebral disease may also lead to temporary abandonment
of the lumbar route.
Therefore, should a spinal block develop one would
suggest cisternal punctures on alternate days and weekly
lumbar punctures, therapy being given by the cisternal route.
Should there be no signs of rapid clearing of the block with¬
in two weeks, therapy should be continued by the ventricular
route as being of less danger and inconvenience than the
32
cisternal , until the spinal block resolves (if at all).
The dosage by cisternal or ventricular route should be
slightly less than that by lumbar.
(d) Duration of Therapy
The decision when to discontinue intrathecal therapy
is a difficult one more so than deciding when to stop all
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treatment including that during the follow-up period after
discharge from hospital. Criteria that aid in this decision
regarding intrathecal therapy are the return of the sugar
levels in the cerebrospinal fluid to normal levels and of
lesser importance return of chlorides to their physiological
values. Return of cell count and protein level to approx¬
imate normality (for normal values see analysis) will also
favour cessation of treatment. Other favourable indications
are negative bacteriology as regards films, cultures and
guinea-pig inoculations, the results of the latter two being
referred to specimens withdrawn six to eight weeks earlier.
The patient's improvement in general condition, physical
and mental state, continued rise in weight, a normal temper- _
ature, improvement and clearing in chest complications else¬
where, and healed choroidal tubercles are all further favour¬
able signs that therapy may be discontinued or gradually
tailed off. A normal Lange gold curve or Levinson test * ,
and an alkaline phosphatase returned to norma! are absolute
criteria of the return of the cerebrospinal fluid to normality
but these tests are perhaps too exacting as they often follow
,6:after some months of clinical cure. Chorernis et alia (1950)
states that lessened skin sensitivity to mantoux tests and
an erythrocyte sedimentation rate that has returned to normal
precede the normal C.S.P. Other authorities disagree re¬
garding the skin sensitivity and believe that it rises to a
maximum during the disease and remains at that level.
This decision to stop intrathecal treatment should
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be made on an assessment of several specimens of the
cerebrospinal fluid and on the patient's general progress
during two to three weeks. One would advise, if all is
satisfactory, that the intrathecal course should not be
stopped immediately but should be gradually tailed off with
the intermission of frequent rest periods during which a
careful watch is made for progress or deterioration. The
details of this lessening in intensity of therapy and of
procedure in follow-up has already been detailed under the
analysis of cases.
More prolonged therapy for a further two or three
weeks should be given for cases with extensive pulmonary
lesions of adult phthisis or miliary type. Each case has
to be judged on its merits and no hard or fast rule employed.
On an average it is about the twelfth week of com¬
bined treatment when one begins to consider seriously when
intrathecal treatment can be decreased. If the patient's
satisfactory progress is maintained on the less intense
therapy, this latter may then be discontinued but follow-up
diagnostic lumbar punctures should still be performed at
gradually increasing intervals of time.
During the whole course of the disease and less fre¬
quently in the follow-up period complete assessments as have
already been detailed should be carried out and in between
these, a less complete examination with daily check on pro¬
gress of cells and protein in C.3.P. should suffice unless
complications indicate otherwise. The check on cells and
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protein will then help to warn against the development
especially of a spinal block.
In this series the graphs of the behaviour of the
C.S.P. elements during therapy will show that sugar and
chloride estimations should have been carried out more fre¬
quently but it was not until later that the value of the
sugar level especially was appreciated.
During the follow-up period the intramuscular
streptomycin is given for two to three months after cessa¬
tion of intrathecal treatment and para-aminosalicylic acid
should be continued| concurrently.
(e) Recognition of Relapse or Recrudescence
As has already been stated, prognosis in tuberculous
meningitis has to be guarded in view of the danger of re¬
lapse or recrudescence which terms have already been defined*
The danger of relapse recedes after the first twelve months
from onset of therapy but when it does occur it is usually
heralded in by symptoms and signs which often precede changes
in the cerebrospinal fluid. A fall or failure to rise in
weight, return of headaches, often accompanied by vomiting,
personality change, irritability and lethargy, and pyrexia
are the warning manifestations and it is only later that there
may be a return of the signs of meningeal irritation, i.e.
neck stiffness and positive Kernig and Brudzinski signs*
.. 61
Choremis et alia (1950) state that return of papilloedema
after cessation of therapy is one of the earliest signs of
22
a relapse and Cocchi and Pasquinucci (1950) say that change
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in a Lange colloidal gold curve in the C.3.F. that has been
normal is also one of the earliest warning signs.
Of the changes in the cerebrospinal fluid that
accompany or follow the clinical signs, a low sugar content
even if the other elements be normal and positive bacteriology
obtained by any of the routine methods that had yielded
negative results previously, will indicate that a relapse
of the disease has occurred or is imminent. The mechanism
of this relapse is very often related to foci of infection
which are locked up by adhesions, the cerebrospinal fluid
having become normal after 12 - 16 weeks treatment, and then
with a breakdown of one of these sites of activity the
2h
disease starts afresh . Very soon after the prodromal
symptoms and signs, the C.S.F. will once again show the
characteristic picture.
Recrudescence of the disease occurs whenever therapy
becomes less intense or is discontinued and is manifested by
rising or fluctuating cell counts, falling sugar levels and
rise in streptomycin content in the cerebrospinal fluid.
Deterioration in general condition, stationary or falling
weight curve, and rise in pyrexia also occur as in relapse.
The main problems that occur during the management
of a case of tuberculous meningitis have now been discussed,
along with their relationship to treatment, but before we
consider finally future trends in therapy there are two
subjects worthy of consideration, namely, the complications
that may follow therapy and pathogenesis and pathology.
130.
Complications following Therapy
Ths analysis will show fchat the quality of survivors
in this series was good, the main complications being
deafness or vertigo or hoth due to streptomycin. The
only case with marked physical defect was No. 6 (see Appen¬
dix) and two cases (Nos. 3*4 and 51) hacl behaviour disorders
from which recovery was made. Indeed an impression was
gained that in several of the children (detailed in the
analysis) their mental state regarding intelligence was
better after the disease than before its onset. Cocchi
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and Pasquinucci (1950) also remark on this stating that
mental and physical state in some of their survivors was
better than for many years prior to their illness.
Small intrathecal dosage given over a prolonged
period may be a factor in the satisfactory state of the
survivors but the main reason for ths low incidence of
complications was undoubtedly that it was only the early
cases that survived.
Complications following therapy and resulting from
the disease process that have been described in the litera¬
ture are blindness, optic atrophy, cerebral thrombosis,
hemiplegia usually of facio-brachial type, spastic para-
plegiaj mental deterioration, Korsakov^s syndrome, decere¬
brate rigidity and the hypothalamic disorders that have al¬
ready been mentioned. Two rarer and interesting complica¬
tions were described by Lorber,the first being ectopic cal¬
cification occurring in a case of tuberculous meningitis
131.
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with a spinal block and paraplegia in flexion • The
metastatic foci of ossification appeared about two to six
months after the onset of the paraplegia and most -were
found in the adductors of the thighs. Operative treatment
to remove these foci aggravated a very disabling condition.
The second unusual complication following therapy
which he described, was sexual precocity in a case with the
✓ , 168
manarche at years • A marked hydrocephalus, calci¬
fied intracranial tuberculomata, cerebral cyst and optic-
atrophy with good vision were present and presumably this
precocity was secondary to hypothalamic or pituitary damage
occasioned by the hydrocephalus.
This damage is, no doubt, also related to the
obesity syndrome that occurs in children recovering from
tuberculous meningitis as described by Choremis et alia
. .61 / \1^8(1950) and Lorber (1951) * Similar hypothalamic man¬
ifestations to those just mentioned above and to others
stated earlier have been found to develop in cases with
tumours in the region of the third ventricle,
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Russell and MacArthur (1953) in a h year follow-up
of their cases of treated tuberculous meningitis noted
intracranial calcification in ten out of thirteen patients
surviving long enough for it to occur. This is not perhaps
a complication and might be a useful index of healing but
v 169
Cairns (1951) warns that the exudate in tuberculous
meningitis may persist for many months or indefinitely and
become calcified and therefore calcification is not an in-
\
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fallible sign of healing. He quotes two cases with cal¬
cification who relapsed and died.
Most of these complications which have just "been
described result from the hydrocephalus, the tuberculous
endarteritis and the fibrous adhesions and exudate that
occur in streptomycin treated chronic tuberculous meningitis.
Pathogenesis and Pathology
To understand some of the principles of treatment
of this disease and its complications it is necessary to
mention briefly pathogenesis and pathology, and that is
why no apology is made for introducing this subject to a
discussion on aspects of therapy.
Originally it was believed that tuberculous mening¬
itis resulted from haematogenous spread usually of a miliary
infection leading direct to the meningitis. However Rich
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and McCordock (1929) and (1933) produced very con¬
vincing experimental and morphological evidence that diffuse
tuberculous meningitis resulted from discharge of bacilli
into the cerebrospinal fluid from adjacent older caseous
foci such as cortical tuberculomata or caseous bony disease.
They found such foci after careful search in the brain, the
3pina1 cord, the meninges, the choroid plexus and in the
hones encasing the nervous system in 77 out of 82 cases.
Some of the experimental evidence they produced in support
included their failure to produce tuberculous meningitis
by introduction of virulent tubercle bacilli into the blood¬
stream, their success when the bacilli were introduced into
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the cerebrospinal fluid, the fact that the meninges had
very little tendency to arrest inert circulating particles,
and the fact that at autopsy the age of the visceral tuber¬
cles did not correspond with that of the meningitis, one
being early and the other late or vice versa. They also
demonstrated by the use of carbon particles that tubercle
bacilli can spread retrograde to the flow of the cerebro¬
spinal fluid and thus cause tubercles of the ependyma or
choroid plexus, indeed more frequently than from the blood¬
stream. They also believed that the vascular alterations
were due to the tuberculous exudate in which the vessels
172,173
lay, and were not due to haematogenous spread
Histological examination confirmed this showing most marked
changes in those vessels lying in thick exudate. These
changes were mononuclear infiltration and fibrinoid necrosis
of the adventitia with proliferation of the intima and
173-173
narrowing of the lumen . The meningeal veins might
also be intensely involved, just as the arteries, and
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Schwarz (19^8) believes that a final miliary spread can
occur as a result of haematogenous dissemination from the
phlebitis as well as from cerebral or meningeal tuberculomata.
The theory that these cortical foci seed during a
previous bacillaemia such as might occur in a primary in¬
fection fits in well with all the known facts and would ex¬
plain the mechanism of the simple serous meningitis as al¬
ready suggested, i.e. a perifocal reaction around a meningeal
or cortical tuberculoma during which reaction and before the
13k •
new seeding has "been walled off "by the body's defence
mechanisms, a few bacilli may escape into the cerebrospinal
fluid. Support to the Rich theory is also given by
3*5.3 iti
Macgregor and Green (1937) and Walker (.1935) from
evidence of their autopsy examinations and it is now gen-
1 7A
erally accepted although in 1936 Sagins studied 1*7
patients and stated that in only seven could he find
evidence that an older tuberculous focus had caused a
diffuse meningitis.
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Amongst the changes found at post-mortem many
of which have already been mentioned, are a greenish-yellow
fibro-gelatinous exudate which is thickest in the inter¬
peduncular and associated cisterns. There is lateral ex¬
tension into the Sylvian fissures and the midbrain is en¬
circled. The arteries in association with the circle of
Willis are deeply involved with an endarteritis and narrowing
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of their lumen . Streptomycin therapy aids healing which
occurs by dissolution of fibrin with replacement by actively
proliferating fibroblasts infiltrating or encapsulating foci
of necrosis. The proliferative endarterial reaction is
accelerated by the streptomycin and the stenosis or occlusion
of the vessels leads to cerebral anoxia and worse still, in¬
farction often of the basal ganglia with shrinkage of brain
tissue. It is this latter that leads to most of the irrever¬
sible neurological sequelae and the hypothalamic or pituitary
syndromes.
The intense basal exudate will itself lead to ten¬
torial "block to the cerebrospinal fluid circulation with a
communicating hydrocephalus and eventually this exudate as
it resolves may "become woody hard or calcified. Thus the
outstanding complications pathologically of a streptomycin
treated case are a communicating hydrocephalus and multiple
Ischaemic brain softenings. In most cases the posterior
25
portion of the basal cisterns are clear but Smith, Vollum
and Cairns (19^8)^, and Cairns (19*49)*^2stafce that gravity
acts unfavourably on the meningitis and exudate gravitates
to the posterior horn of the lateral ventricles, and is more
intense on the dorsal than on the ventral surface of the
cord from result of the dorsal decubitus. Ore such case is
specifically quoted by these authors and they suggest that
if possible the patient*s position should be changed now and
then, and they observe, in support of their theory, that a
restless patient often does better than a quiet one.
Two further features described in the literature are
those of a tuberculous encephalitis and ependytnitis. The
25
encephalitis is often found localised in the sulci of the
12?
cerebral and cerebellar hemispheres; the ependyraitis
proceeding to formation of subependymal tubercles and later
gliosis has been described as leading to persistent granu¬
larity of the ependyma.
This latter and the majority of the other appearances
which have just been mentioned were found at post-mortem in
in this Bevies of cases and for further detail the case
records in the Appendix may he consulted.
One canP therefore, deduce that if these vascular
changes and the hydrocephalus are marked a successful result,
whatever form of therapy is employed, is virtually impossible.
Causes of failure in treatment could, thus, be
listed as (l) severe hydrocephalus of communicating or non-
communicating type (2) severe arteritis and cerebral in¬
farction (3) widespread meningitis (h) therapy commenced
too late (5) therapy stopped too soon (6) extensive active
or miliary tuberculosis elsewhere (7) rarely development
of bacterial resistance#
Grouu III - Jsoniazid
Finally, by way of conclusion, there remains the
discussion of the third group of adjuvants or antituberculous
agents with their possible bearing on future trends of therapy
an interesting speculation in view of their promising features.
This applies especially to the most important, namely, iso-
niazid, or isonicotinic acid hydrazide which was first dis¬
covered by American workers in 1951 and found to have a
marked tuberculostatic activity even greater than strepto-
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mycin • At the same time as the latter was under trial
isonicotynal hydrazine which, with isoniazid forms one of
two closely related derivatives of isonicotinic acid, was
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tested but found to be the more toxic . However the toxic
effects in man are not severe and occur on dosage only on
the upper limits required for efficient clinical effect#
These side-effects have "been listed by Selikoff, Bobitzek
and Ornatein (1952) as vertigo, constipation, twitching
of the lower extremities, drowsiness, headache, hyper-
reflexia, dryness of the mouth and delay of the urinary
stream. Isoniazid acts rapidly and is very diffusable and
satisfactory bacteriostatic levels in the cerebrospinal
183
fluid are obtained easily on oral dosage (Fletcher (1953))
Furthermore the drug has the advantage of being cheap and
easy to produce.
So far, the only large scale properly conducted
trials in its use have been reported in respect of pulmonary
tuberculosis. These trials showed that if the drug was
18b,183
used alone bacterial resistance emerged and therefore
one had to employ also an adjuvant. Its use with P.A.3.
was compared with streptomycin and P.A.S. and it was con¬
sidered that both regimes were squally effective but iso-
71
niazid with intramuscular streptomycin gave superior results
This impression has also been gained by Joiner et alia (1952^
.187
and by O-oulding and Robson (1952) after experiments in
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mice. Singh and Mitchison (195*0 showed that streptomycin
in high concentration exhibited a greater bacteriostatic
effect than isoniasid in comparable concentrations and that
streptomycin and isoniazid together had the greatest anti-
tuberculous activity.
These series, so far reported, have all been related
to the drugfe use in pulmonary tuberculosis and therefore one
awaits with great interest, in view of its promising results
138.
so far in therapy, a controlled series in respect of tuber¬
culous meningitis especially as its use with P. A. 3. would
obviate, to a great extent, the necessity for intrathecal
therapy. It would still be necessary, of course, to carry
out diagnostic lumbar punctures twice weekly for the first
three weeks and thereafter weekly to assess progress in
the C.S.P. and guard against complications#
Post-mortem studies by Ritchie, Taylor, and Dick
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(1953) revealed that with streptomycin therapy the em¬
phasis in healing lesions is one of regressive fibrosis
whereas after isoniazid there is increased vascularity,
absorption of caseation and diminution of epithelioid cells
with resultant resolution even in old densely fibrosed
lesions# They sounded a warning note, however, as four
patients out of six who were treated with Isoniazid and
streptomycin showed areas of cerebral softening and haemorr¬
hage and these patients suffered before death from fits which
the authors related to swelling of tuberculomata.
However, the rapid action, lack of cumulative effect,
and diffusibility would suggest from the evidence available
that the best future therapy of tuberculous meningitis would
be the oral administration of isoniazid with intramuscular
streptomycin, diagnostic lumbar punctures and use of neuro¬
surgery or intrathecal tuberculin in certain selected cases
as indicated. The place now for para-aminosalicylic acid
is more difficult to decide and there is a good argument
for the use of isoniazid and P.A.S., thus requiring no
139.
routine intramuscular or intrathecal therapeutic infections.
Streptomycin is then kept in reserve for the deteriorating
patient should "bacterial resistance develop.
Isoniazid has been used intrathecally by Torres-
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Gost (1953) in addition to oral dosage and intramuscular
streptomycin. He describes the use of this regime in 100
cases and reports only 6 deaths but his follow-up period is
too short for true evaluation. Other articles have re¬
ported the employment of isoniazid in tuberculous meningitis
but are also difficult to assess correctly either because the
62,190.191
numbers are too few or the different groups (as so
. 60
often happens) are not really comparable
Recommended dosage is 8 - 10 ragms. per kilogram body
weight per day given in two daily doses for the first week
and then the dose is reduced to 7 ragms. per kilo, per day.
In view of the success of smaller doses (3 - *4 mgms. per kilo*
per day) in pulmonary tuberculosis it could well be that
this dosage is too high. If vomiting does occur, the drug
can be given by the intramuscular route.
Terratnycin. Neomycin. Viomycin and Arnithiazone
Three further antibioties with an antituberculous
12,192
effect are terramycin, neomycin * and viomycin but there
are some dangers attached to their use.
The first one, terramycin. is given orally and does
193
not appear to result in bacterial resistance developing but
its tuberculostatic effect is correspondingly less than that
of streptomycin and it, therefore, has to be given in large
dosage (5-7 ®ma.) which leads to a high incidence of
IQh
gastrointestinal upset, anorexia being very frequent
It can however he used as a substitute for F.A.S. and is
19^5
extremely useful should sensitivity to the latter develop .
Neomycin and viomycin, on the other hand are potent
agents but the former is excluded from use as an alternative
or an an adjuvant agent to streptomycin because of its
1QK IQg
nephrotoxic and ototoxic effects . The latter
viomycin also causes a rather forbidding group of side
effects - disturbances of the eighth nerve, the kidney and
plasma electrolytes. It is possible that there will be a
very limited indication for the use of this agent, in spite
of it causing a high incidence of toxic reactions, in those
cases where streptomycin resistance develops*^. A dosage
of 2 Gin. twice weekly may minimise the side effects and
justify its use in place of the streptomycin.
Amithlazone is a synthetic drug that has been tried
recently in pulmonary tuberculosis and'found wanting'owing to
an only moderate antituberculous effect, high toxicity and
lack of prevention of the development of bacterial resistance
to streptomycin when used in conjunction with the latter"^"*.
It need, therefore, not be considered further.
Using the analogy of a table presented by Crofton
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(1953) for possible chemotherapeutic regimes in pulmonary
tuberculosis we have, therefore, in respect of the present
day treatment of tuberculous meningitis the following alter¬
natives:-
lill.
X. Intrathecal and intramuscular streptomycin - of proved
value especially if the regime is continuous at first anct
interrupted after the twelfth week.
2, Intrathecal and intramuscular streptomycin with the use
of an oral adjuvant, preferably para-atainosalicylic acid -
this is more effective than (l) and the danger of "bacterial
resistance developing is lessened especially with adult pul¬
monary phthisis complicating.
Alternatively to P.A.S. one of the sulphones could
be used.
5. Oral isoniaaid and intramuscular streptomycin - this
regime is under trial, appears safe and promises to be the
most effective and obviates intrathecal therapy, The only
disadvantage is that the development of bacterial resistance
may deprive the patient of both potent agents. The addi¬
tional use of P.A.S. or a sulphone would probably be of no
advantage.
it. Oral isoniaald and para-aaiinosalicylic acid - this treat¬
ment has two advantages in that no injection therapy need
be given and streptomycin can be kept in reserve. Its use
might therefore be reserved for children but often the disease
is severe in the latter thus requiring the more effective
combination of (3)* Simple serous tuberculous meningitis
is an obvious suitable indication for this form of oral
therapy,
5. Terramycin and streptomycin or isoniazid - this could be
a very effective combination. Terramycin, as the subsidiary
agent, need not toe given in too large dose to cause
gastrointestinal upset and might "be tolerated better than
P.A»S. Furthermore isoniazid or streptomycin would still
be kept in reserve, but the latter would require to be
given by combined routes.
Only further clinical trials of treatments 3, b and
5 with variation in details of dosage of the different con¬
stituents will help to decide which is the regime to favour#
Vlomyctn may have a very limited place as a last
resort substitute for streptomycin.
However, in tuberculous meningitis one can dog¬
matically say that the following regimes are contraindicated:
(a) Use of intramuscular streptomycin alone
(b) Para-aminosalicylic acid or stiiphone alone
(c) Neomycin is too toxic and amithiszone ineffective
(d) Terramycin alone,- however may be useful substitute
for P. A. S.
In addition one must not forget the employment of
the other measures, neurosurgical, P.P.D. etc. and regarding
each individual case,the management which has already been
outlined above, and which still applies whatever specific
ehemotherapeutie routine is used.
Therapy of the future, therefore, promises to produce,




Since fehe discovery of streptomycin by Waksman and
his associates in 19*4 2 the cure of many cases of tuberculous
meningitis has become possible.
Prom an analysis of 52 cases treated by intrathecal
and intramuscular streptomycin it was seen that one case
in three survived, thus comparing favourably with the
average survival rates of earlier series reported by other
workers. However with increasing experience in management
of the disease and use of adjuvant agents and neurosurgical
methods the survival rates have improved so that now, just
over one case in three did not survive.
It would seem that the form of therapy of proved
value is intrathecal streptomycin of a dosage of 0.1 dm.
in 5 - 10 ccs. normal saline with reduced doses down to
0.05 U«i. proportional to age, given at midday, daily, for
the first fourteen days and then three or three and a half
times weekly up to the twelfth week. Thereafter Intrathecal
therapy is interrupted by rest periods and the frequency of
injection gradually reduced and tailed off as the clinical
condition permits. The intrathecal therapy should be at
least 50$ of the intramuscular and preferably about 75$ for
the first 12 weeks. Associated with the latter intra¬
muscular streptomycin is given on a dosage 0.02 dm.per
pound body weight per day up to a maximum 1-2 Gms. (or
0.02 dm. per kilogram per day) in a divided dose morning
and evening and should "be continued for at least two months
after cessation of intrathecal treatment with an average of
six months total duration. The "best type of streptomycin
to use is the streptomycin sulphate.
Associated with the streptomycin an adjuvant is
given and of promizole, promin, aulphetrone, thioserai-
carbazone and para-aminosalicylic acid the latter named
is best, as it is equally effective given orally and least
toxic. Dosage should be 12 - 16 &m. daily in three-hourly
doses, preferably of the solution, given after meals when
possible and with corresponding reductions for children
according to age.
Should a block to the cerebrospinal fluid cir¬
culation develop with a communicating hydrocephalus inter¬
mittent ventricular drainage through frontal burr holes is
indicated. Should the block develop with a non-communicat¬
ing hydrocephalus streptomycin in reduced dose should be
given intraventricularly concurrently with drainage and at
the same time as lumbar route therapy. Should the block
be in the spinal subarachnoid space and spontaneous clearing
not occur readily intrathecal therapy will have to be con¬
tinued by cisternal or ventricular route.
With deterioration in spite of these measures out¬
lined above protein purified derivative of tuberculin given
intrathecally in minute and increasing doses in the sensit¬
ised patient may then be tried to help resolution of the block.
IkB.
Should bacterial resistance develop to the strepto¬
mycin, isoniasid in dosage 5-7 mgms. per kilogram per day
in divided dose twice daily may he given orally in sub¬
stitution for the streptomycin.
Supplementing these measures are a sanatorium type
of light nutritious diet and regime with vitamins, iron
therapy and intravenous fluids if required. Physiotherapy
and occupational therapy are instituted as soon as the
patient's condition permits and this will include re¬
education in walking and splinting of deformities under
the direction of the orthopaedic specialist.
In the management of the disease important points
are early diagnosis and in the difficult case to institute
therapy without awaiting the necessary bacterial confirmation.
At the onset of treatment, periodically during treatment,
at the end of treatment, and in the follow-up, a full assess¬
ment of each case should be carried out including physical,
radiological, bacteriological and ophthalmologlcal examina¬
tion. On admission a careful history and enquiry into
possible tuberculous contacts is required. Initial, and in
some cases serial, mantoux tests should always be performed.
Progress and prognosis are assessed at these regular
examinations and is aided by the use of special temperature
charts and graphs of the weight and of the behaviour of
cerebrospinal fluid constituents. Favourable trends are
falling temperature, weight rise, rising sugar and chloride
levels and falling protein and cell count value in the C.S.F.
In this respect the most valuable constituent to watch is
the behaviour of the cerebrospinal fluid sugar which is the
first to return to normal, the protein being last#
Healing of choroidal tubercles and clearing of lesions
in radiological pictures are favourable# Delay in diagnosis,
age under 3 years, advanced disease on admission, marked
neurosurgical signs and coma, tuberculosis elsewhere in the
body, miliary disease, too early cessation of therapy, resist¬
ant organisms, hydrocephalus, tuberculous cerebral endarteritis,
cerebrospinal fluid blocks and an innate weak resistance of
the individual, are all unfavourable prognostic points.
In addition to the periodic full examination of the
cerebrospinal fluid, estimation of cell count and protein
value on each specimen after every lumbar puncture is necess¬
ary as a fall In the former and a rise in the latter will give
early warning of a spinal subarachnoid block. Other signs
(xanthochromia,+ve Queckenstedt test) will also be present
and indicate the necessity for confirming the suspicion by
use of the diffusion index. For bacteriological examination
large samples of cerebrospinal fluid should be used.
Very careful follow-up with watch for signs of relapse
or recrudescence after cessation of therapy must be carried
out over the next few years and final results should not be
assessed earlier than the two year period. The cessation
of therapy should be decided after consideration of progress
in all aspects over 2-3 weeks and during the follow-up
period the routine examination as detailed above should be
supplemented by psychometric assessment and evaulafcion of
hearing and vestibular function.
The agents streptokinase, A.C.7.H., heparin, potass¬
ium iodide, neomycin and amithiazone are not of value and
viomycin is of limited use.
In the future it is likely that isoniazid will 'become
the principle agent for use tout until fully controlled trials
have toreen carried out and reported the wisest course might
toe to keep this agent in reserve for the deteriorating case.
Isonlasid with P.A.S., isoniazid and terraraycin,
isoniazid with intramuscular streptomycin, and to a less ax-
tent terramycin with streptomycin toy combined routes, are
the regimes worthy of comparison with the older therapy of
streptomycin and P.A.S. and of these newer groupings the
evidence that is available would suggest that streptomycin
and isoniazid as the most promising.
Whatever regime is employed, all accessory and neuro¬
surgical measures,points in the management of tie disease and
frequent diagnostic lumbar .punctures must not be neglected.
Prophylaxis of tuberculous meningitis by follow-up
clinics of children suffering from primary complexes, by
careful supervision of tuberculous contacts, by provision of
a safe milk supply, by routine lumbar puncture in miliary
tuberculosis, and B.C.(I. vaccination should not be forgotten.
And so, whether the old or the new therapy is employed
there is still required the nursing and medical care of
specialised centres that have available the full resources of
a laboratory and wide range of specialist services. This
latter9 the newer chemotherapeutic weapons, and the manage¬
ment of the disease as outlined above, will give, in the near
future, the case suffering from tuberculous meningitis at
least 75$ chance of survival, a dramatic and fast changing
picture from that of ten years ago when death was almost
certain. There will still remain those few cases whose
disease is advanced on admission with the late effects of
hydrocephalus and arteritis whose treatment will be in¬
tractable, and it is those cases that will form the stimulus
to further advances in treatment and in prophylaxis.
Addendum; The use of a further new derivative of nicotinic
acid, with antituberculous effect, has recently been des¬
cribed by McDarmotfc, W. et alia in the Am. Hev. Tubere, (19S&),
Vol. 69, Ho.3. He used this drug with isoniasid in pulmonary
tuberculosis but although found to be a very effective com¬
bination, signs of liver damage in many patients have appeared.
This may contraindicate its wider use in other forms of tuber¬
culosis e.g. meningeal, unless future trials show reduction




An analysis of the results of treatment in 52 cases
of tuberculous meningitis in which intrathecal and intra¬
muscular streptomycin was used, is presented* These results
are compared with those obtained by other workers and the
variations in the different treatment schedules and the
specific cheraotherapeutic agents employed since the dis¬
covery of streptomycin are reviewed#
Opportunity is taken to discuss the different
factors in diagnosis* prognosis, management, therapy, follow-
up, pathogenesis and pathology of the disease#
Finally the newer antituberculous agents and possible
future trends of therapy are briefly considered#
150,
BIBLIOGRAPHY
(The numerical reference system has Been employed in preference
to the Harvard one to avoid making the text too cumbersome).
1. HOBSON, F.G. ; Case of tuberculous meningitis with re¬
covery: Lancet (1955). ls 933-
2. MARTIN, A.E. : Occurrence of remissions and recovery in
tuberculous meningitis: Brain (1909), 32, 209
3. McMAHON, B.T.: Recovery from tuberculous meningitis:
Am, Rev, Tuberc. (1926). 13# 216.
k* MACGREGOR, A.R., KIKKPATRICK, H.J.R., and CRAIG, W.S.:
Three cases of tuberculosis of the central nervous system
in children with apparent recovery; Lancet (I93h). 2, 18.
5. SCI IATZ, A., BUGIE, E., and WAKSMAN, 3.A.: Streptomycin,
a substance exhibiting antibiotic activity against gram-
positive and gram-negative bacteria; Proc. Soc» Bxoer.
Biol. & Med. (19kk), 55# 66.
6. CANTANI, A. ; Vereach uber bacteriotherapic; Centralbl. f.d.
med. Wlsseneh. (1885). 23# 513.
7. BABES, V.: Sur lea associations bacteriennes da la tub¬
erculosa: Con;>;r. o. l*etude de la tuberc. (1888). p.5k2.
8. NANNOTTI, A.: Ossarvazione clinics a rieerehe sperimenfcali
interna alia influenza dells inflammazioni da streptococco
nalle afficioni tubercular! (abstracted): Centralbl. f,
Bakt (1893). Ik, 601.
9. PRUDDSN, M.: Concurrent infection and formation of cavities
in the acute pulmonary tuberculosis: New York J. Med.
(189U). W, 1.
10. RAPPIN, M.: Action exercee par lea diastases.do quelques
especes saprophytes sur la tuberculosa experimental© du
cobage: Gaz. med. de Nantes (1912). p. 958.
11. VAUDREMER, A.: Action de lfextrait filtre dfaspergillus
fumigatus sur les bacilles tuberculeux: Cornot. Rend. Soc.
Biol. (1915), pp.278 and 752.
12. WAKSMAN, S.A.: Streatomycin and neomycin: Brit. M« J. (1950).
2, 595.
13. WAKSMAN, S.A.: Antibiotics and tuberculosis: J.A.M.A. (!9h7K
135# W.
Ik* FSLDMAN, W.H., and HINSHAW, H.C.: Effects of streptomycin
in experimental tuberculosis in guinea-pigs; Proe. Staff
Meet. Mayo Clin. (19Wi). 19# 593. ~ " *
151.
15. FELDMAN, W.H., HINSHAW, H.C. , and MANN, F.C.: Streptomycin
in experimental tuberculosis: miu Rev. Tuberc. (19L5I.
52, 269.
16. GARROD, L.P.i Bacfceriocidal action of streptomycin:
Brit. M.J. (19L8). 1, 382.
17. FLOREY, H.W. et ALIA : Antibiotics Vols. I & II : Oxford
Univ. Press, London.
18. FELBMAN, W.H., and HINSHAW, E.G.: Streptomycin in treat¬
ment of clinical tuberculosis: Proc. Staff Meet. Ma.vo
Clin. (19L5). 20, 313.
19. FELDMAN, W.H., HINSHAW, E.G., and PPUETZE, K.H.:
Streptomycin in clinical tuberculosis: Am. Rev. Tuberc.
nsM» ». 191.
20. FELDMAN, W.H., HINSHAW, H.C., and PFUETZS, K.H.:
Treatment of tuberculosis with streptomycin: J. A.M. A.
(19L6). 132, 778.
21. TRANSACTIONS OF THIS NINTH CONFERENCE ON STREPTOMYCIN OF
THE VETERANS ADMINISTRATION? (U.S.A.f<1950) PP. li5~and
1§3.' See als'd^ref. no." 48.
22. C0CCHI, C., and PASQUINUCCI, G,: Treatment of tuberculous
meningitis: Bull. World Health Organ. (1950). 3, 215.
23. STREPTOMYCIN 3UBCQMKITTE OP SCOTTISH SCIENTIFIC ADVISORY
COMMITTEE: Tuberculous meningitis treated with strepto¬
mycin: Brit. M. J. (I9L9), 1. 628.
2k. McCarthy, D., and MANN, T.P.s Tuberculous meningitis in
children: Lancet (1950). 1, 3^1.
25. STREPTOMYCIN IN TUBERCULOSIS TRIALS COMMITTEE, MEDICAL
RESEARCH COUNCIL: Streptomycin treatment of tuberculous
meningitis: Lancet (19L8). 1, 582.
26. SMITH, H.V., and V0LLU1I, R.L.: Effects of intrathecal
tuberculin and streptomycin in tuberculous meningitis:
Lancet (1950). 2, 275.
27. RUBIE, J. and MOHUN. A.F.: Tuberculous meningitis:
Brit. M. J. (19U9). 1, 338.
28. LINCOLN, E.M., and 3IFONTE3, J.E.: Tuberculous meningitis
in children: K. Clin. North America (1953). 37* 3*45.
,29. CATHIE, I.A.B., and IIACFARLANE, J.C.W.: Adjuvants to
streptomycin in treating tuberculous meningitis in
children: Lancet (1950). 2, 78lj.
152.
30. ILLINGWORTH, R.3., and WRIGHT, T.: Tubercles of the
choroids Brit. M. J. (I9h8). 2, 365.
31. EMERY, J.L., and LORBER, J.: Radiological and patho¬
logical correlation of miliary tuberculosis of the lung
in children with special reference to choroidal
tubercles'. Brit, if. J. (1950). 2, 702.
32. CAIRNS, H*, and TAYLOR, M.s Review Of treatment of
tuberculous meningitis with streptomycins Prop. R. 3oe.
Msa. (191191. 142, 155.
33. LINCOLN, B,M.:3erous fcuLarculous meningitis: Am, J, TuLqpc.
(mY) . 55, 95.
3h. SMITH, H.V., VOLLUM, R.L., and CAIRNS, H.s Treatment of
tuberculous meningitis with streptomycins Lancet (I9h8).
1, 627*
35. CATHIE, I.A.B.s Streptoraycin-streptokinase treatment of
tuberculous meningitis: Lancet (l%9>. 1, Wtl.
36. LORBER, J.: Streptokinase as an adjuvant in treatment of
tuberculous meningitis: iangLLiiaai» i9 133k,
37. FLETCHER, A. (195k): in the press.
38. ILLINGWORTH, K.S., and LORBER, J.s Results of streptomycin
treatment in tuberculous meningitis: Lancet (1951). 2, 511.
39. DEBRE, R., THIEFFRY, S., and 3RI3SAUD, II.E.: Tuberculous
meningitis and acute miliary tuberculosis in children
treated with streptomycin: Presse Red. (19U7). 56, 121.
i|0. MANN, T.P.: Streptomycin in treatment of tuberculous
meningitis: Proc. R. Soc. Mad. (19148). hi, 671.
hi. TODOROVIC, K., MILOSEVIC, M., and SOURLIC, D,: Effect of
streptomycin on development of tuberculous meningitis:
Arch. Serb, de med« (19h9). h7, 3.
h2. FOUQUET, J., HEIMANN, V., MEYER, B., and HENNEQUET, J.:
Results of 2 years treatment of tuberculous meningitis
in children: Bull, et mem. Soc. med. hop, Paris (I9h9) .
65, 553. •
h3- BERNARD, E., KREIS, B., LOTTE, A., CHICHI, P., and
PALSY, P.V.: Tuberculous meningitis in adults treated
with streptomycin - a 2 years experience: Semaine hoa.
Paris jlgMl, 25, 2053. ~
hh. DUBOIS, R., LING, R., DELCOURT, R., and VAN WIEN, H.:
Trials with streptomycin in treatment of tuberculous
meningitis^ Acta. Pediat. Beige. (I9h9). 3, 5.
153.
1(5* HOOFf, C., and DENEVS, V.: Streptomycin in treatment
of tuberculous meningitis: Rev* mid* Liege (19U9). 1(,11.
146. CAPON, N.B., and TODD, R.McL.: Current therapeutics;
XVIII-Streptoraycins Practitioner (19U9). 162, I1II4.
i»7. ARIZTIA, VON A., LATORRE, M. , and VARGGS, A. s Treatment
of tuberculous meningitis: Helvet* paediat. acta, (1950)*
5* 18.
1(8. TRANSACTIONS OP THE 9TH. CONFERENCE ON STREPTOHYCIN OF
THE VETERANS ADMINISTRATION: Miliary"and meningeal
tuberculosis: (1950) pp. 118 and 123,
1(9. MEDICAL RESEARCH COUNCIL AND THE MINISTRY OP HEALTH:
Streptomycin in therapy of tuberculous meningitis:
Brit. M. J. (1950). 2, 1(13.
50. CAIRNS, H., SMITH, H.V., and VOLLUM, R.L.: Tuberculous
meningitis: J,A.M.A, (1950). XUk, 92.
51. CALNAN, W.L., RUBIE, J., and MOHUN, A.P.: Tuberculous
meningitis treated with streptomycin: Brit. M. J. (1951).
1, 791(.
52. NAISMITH, J.T.: Deafness from use of dihydrostreptomycin
in tuberculous meningitis? Brit. M.J. (1952). 1, 796.
53« ROBERTSON, F. (1952): Personal communication.
5U. SMITH, H.V.: Chemotherapy of tuberculosis; Proc. R. Soc«
Me^Jl25Jlf 1(6, 588.
55. RUSSELL, S.J.M., and MACARTHUR, P.: Treatment of tuber¬
culous meningitis with streptomycins Lancet (19gO), 1,59.
56. RUSSELL, S.J.M. and MACARTHUR, P.: Tuberculous meningitis
treated with streptomycin - i» year follow-up: Br it.M.J.
(12531, i» 192.
57. MOURIQUAND, G.: The streptomycin treatment centre at
Lyons (Children): Press® md.* (19*48). 56, 135.
58. LEVINSON, A.: Treatment of tuberculous meningitis with
streptomycin: Am. J. Pis. Child. (19U9). 77, 96.
59. JAMIESON, S.R.: Treatment of tuberculous meningitis using
streptomycin and para-aminosalicylic acid: Brit.M.J.(l952).
1, 83.
60. BULKELEY, W.C.M.: Tuberculous meningitis treated with
A.C.T.H. and isoniazids Brit. M. J. (1953). 2, 1127.
1514
61. CHOREMIS, K. , ZKRVOS, N. , PANTAZIS, S. , PRIFTH3, N., and
PAPATHEODOROU, N.s Streptomycin in the treatment of
tuberculous meningitis: Acta tuberc. scandinav. (1950).
25, 8. '
62. ANDERSON, T., KERR, M.R., and LANDSMAN, J.B.: Treatment
of tuberculous meningitis with isoniazid: Lancet (1953).
63. TORRES-GOST, J.: Treatment of tuberculous meningitis with
isoniazid and streptomycin: IBID (195?), 2, 693.
6k• LOFFLER, W.: Clinical experience with streptomycin treat¬
ment in tuberculous meningitis; Schweiz. Zfcsehr.f. Tuberk.
Basle (19148). 5, 368.
65. WAKSMAN, 3.A.: Antibiotics and tuberculosis: J.A.M.A. (19k?).
135, U78.
66. FELDMAN, W.H., HIN3HAW, H.C., and KARL30N, A.G.: Frequency
of administration of streptomycin: Am. Rev. Tuberc.(19L7).
55, *435. ' " """"
67. BARNWELL, J.B., BUNN, P.A., and WALKER, M.: Streptomycin
in pulmonary tuberculosis: Am. Rev. Tuberc. (19L7). 56.L85.
68. LEADER: Streptomycin and dihydrostreptomycin: Brit.M.J.
(12521, 1, 1076.
69. HURPORD, J.V.: Chemotherapy of tuberculosis:
Practitioner (1952). 169, 79.
70. COUNCIL ON PHARMACY AND CHEMISTRY: Chemotherapy of tuber¬
culosis in Man; J.A.M.A. (1951). li»7, 253.
71. MEDICAL RESEARCH COUNCIL: Isoniazid in combination with
streptomycin or P.A.S. in treatraent of pulmonary tuber¬
culosis: Brit. I.'. J. (1953). 2, 1005.
72. PROCEEDINGS OP LIVERPOOL MEDICAL INSTITUTION; Chemotherapy
of tuberculosis: Brit. M> J, (1951). 1, 297.
73* UNICEP: Conference on streptomycin in childhood:
Lancet (1950). 1, 365.
7L. MINISTRY OP HEALTH: Streptomycin in treatment of tuberculous
meningitis: Tubercle (1950). 31, 21*4.
75. SOWNER, A.R.; Tuberculous meningifci s: Brit. 1*. J. (19501,
2, 356.
76. CAIRNS, H.: Gross morbid anatomy of central nervous system
of cases of tuberculous meningitis treated with strepto¬
mycin: Proc. R» 3oc. Med. (19L9). *42, 173.
155*
77. MINKSNHOF, J.E., SANG8TER, E. , WISSEL, C. , and BACCHINX-
ZWAAGDIGK, T.S,: Treatment of tuberculous meningitis
wi th streptomycin; Maandsehr. v. klndergenaesk. Le.vden
<J2!£1. 16, 192.
78. FARRINGTON, R.F,, HALL-SMITH, H., BUNK. P. A., McDERMOTT,W.:
Streptomycin toxicity: J.A.MA. (19U7). 13*4, 679*
79. McDERMOTT, W.: Toxicity of streptomycin: Am. ,J. Med. (19147).
2, 1*91.
80. MINISTRY OF HEALTH: Sensitisation of nursing staffs to
antibiotics: Brit. M. J. (1953). 2, 39.
81. CROFTOR, J., and FOREMAN, H.M.: Streptomycin dermatitis
in nurses: Brit. 1. J. (19lt8). 2, 71.
82. STRAUSS, M.J., and WARRING, F.C. Jnr.: Epidermal sensitis¬
ation to streptomycin: J. Invest. Dermat. (19147). 9, 99.
83. STRINGFSLLQW, C.: Case of skin sensitisation to strepto¬
mycin: Brit. M. J. (19148). 2, 387.
8I4. RAUCHWERGSR, S.M., EESKINS, F.A. , and NALLS, W.L.s
Streptomycin sensitivity: J.A.M.A.(19^8). 136, 16U.
85. CROFTON, J.: Desensitisation to streptomycin and P.A.S.:
Brit. U. J. f 1953). 2, 10U(.
86. CATHIE, I.A •B.: Streptomycin treatment of tuberculous
meningitis: Postgrad. M. J. (191*8), 2I4, 351.
87. COOPER, H.J., and COHN, M.L.i Use of streptomycin in
tuberculosis: J.A.M.A. (191*8). 137, 351.
88. HUNNICULT, T., GRAF, W.J., HAMBURGER, M., FERRIS, E.B.,
and SCHSINKER, I.II.: Fatal toxic encephalopathy caused
by streptomycin: J.A.M.A. (19I48). 137, 599.
89. BIGNALL, J.R., CROFTON, J., and THOMAS, J.A.B.: Effect
of streptomycin on vestibular function: Brit. M. J. (1951).
1, 55*4.
90. SHBR, N.: Deafness from streptomycin: Brit. M. J. (1951).
2, 1521.
91. FOWLER, E.P. and SELIOMAN, 5.: Otic complications of
streptomycin therapy: J.A.M.A. (19147). 133, 87.
92. BROWN, H.A. and HIN8HAW, H.C.: Toxic reactions of strepto¬
mycin on the 8th nerve apparatus: Proc. Staff Meet. Mayo
Clin, (19*46). 21, 3147.
93. LEADER: Streptomycin in non-tuberculous infections:
Lancet (19146). 2, 757.
156.
9*4. STEVENSON, L.D., ALVORD, E.G., and CGRRELL, J.7!. :
Degeneration and necrosis of neurones in eighth cranial
nuclei caused by streptomycin: Proc. Soc. Exper. Biol.
& Med. (19*47). 65, 86.
95. BAGGEN8T03S, A.H., FELDMAN, W.H., and HINSHAW, H.C.:
Streptomycin in miliary tuberculosis; Am. Rev. Tuberc.
il2*Ol> 55, 5*4.
96. FLOBERG, L.S., HAMBERGER, C.A., and HEYDSN, H.: Inhibition
of nucleic acid production in vestibular nerve cells
by streptomycin; Acta. Otolarvng. SuppI. (19*49). 75, p.36.
97. ROLAND, P.E.; Deafness from dihydrostreptomycin;
Brit, M. J, (1951),, 2, 1221.
98. GRANT, J.; Deafness from dihydrostreptomycin; X3XD, (1951).
2, 1221.
99. SAVY, P.; Deafness from dihydrostreptomycin; IBID. (1951).
2, 1520.
100. ADAMS, W.S.; Deafness from dihydrosfcreptomycin; IBID.
11251), 2, 1520.
101. 0 'CONNOR, J.B., CHRISTIE, P.J. , and HOWLETT, K.S. ;
Neurotoxicity of dihydrostreptomycin: Am. Rev. Tuberc.
(195D. 63, 312.
102. DON, C., and GREGORY, J.: Toxicity of dihydrostreptomycin
sulphate for the auditory nerve; Lancet(1952). 1. 72.
103. MINKENHOP, J.E.: Dihydrostreptomycin contraindicated for
prolonged treatment: Nederl. tydsehr.geneeak:. (1950).
3, 2129. '™ - ~ —
10i». GLORIG, A.: Effect of dihydrostreptomycin hydrochloride
and sulphate on the auditory mechanism; Ann. Qtol. Rhin.
and Laryngol. St. Louis (1951). 60, 327.
105. BIAGI, R.W.: Deafness from dihydrostreptomycin;
Brit. Li. Jff (12511, 2, 651.
106. CATHIE, I.A.B., and GARROW, D.H.: Poor results with di-
hydrostreptornycin: Brit. U. J, (1951). 2, 735.
107. SOMNER, A.R,: Poor results with dihydrostrsDtomyein:
IBID (1951). 2, 970.
108. RIGGINS, H.McL., and HINSHAW, H.C.; Streptomycin and
dihydrosfcreptomycin in tuberculosis: Nat. Tuberc. A. Tr.
(19M9). p. 157.
109. ROSEN, F.L.: Sensitivity to streptomycin: J. A.M. A. (19*i8).
137, 1128.
137
110. CR0FT0N, J*, and KITCHISON, D.A.: Streptomycin resistance
in pulmonary tuberculosis: Brit. M. J. (19L8),, 2, 1009.
111. LEADER: Uses of streptomycin: Brit. M. J. (l9L9).2fl 1098.
112. LINCOLN, E.M., and KIRM3E, T.W,: Streptomycin and promi-
sole in miliary tuberculosis and tuberculous meningitis
in children: Lancet (19L9). 1, 76?.
113. LINCOLN, E.M., and KIRMSS, T.W,: Streptomycin-promisole
therapy of miliary and meningeal tuberculosis in
children: Am. Rev. Tuberc. (1950). 61, 59.
Ilk. MADIGAN, D.G., SWIFT, P.N., BROWNLEE, 0., and WRIGHT, G.P.:
Treatment of tuberculosis with streptoroycin and sul-
phetrone: Lancet (19L7). 2, 897.
115. RIGGINS, H.mcL., and GEARHART, R.P.: Combined chemotherapy
in clinical tuberculosis: Effect on emergence of strepto¬
mycin and dihydrostreptoinycin resistant strains:
Nat. Tuberc. A. Tr. 19L9.
116. BROWNLEE, G., and KENNEDY, C.R.: Chsmotherapeutic action
of promin, sulphetrone, and streptomycin in experi¬
mental tuberculosis: Brit. J. Pharmacol. (19L8). 3, 37.
117. SMITH, M.I., and MeCLOSKY, W.T.i Chemotherapeutic action
of streptomycin and promin in experimental tuberculosis:
Pal;. Health Rep. (I9h<5). 60, 1129.
118. SMITH, U.I., MoCLOSKY, W.T., and EtiMART, B.W.: Influence
of streptomycin and promin on proliferation of tubercle
bacilli In tissues of albino rat: IBID (19L6). 62, 157.
119. BROWNLEE, G., and KENNEDY, C.R.: Treatment of experi¬
mental tuberculosis with sulphetrone: J» Path. Baet.
(19U8), 3. 29.
120. CALNAN, W.L., RUBIE, J., and MOHUN, A.P.: Tuberculous
meningitis - results of treatment with streptomycin and
intrathecal sulphetrone: Brit. M. J. (1951). 1, 792.
121. BROWNLEE, G.: Sulphetrone - therapeutics and toxicology:
Lancet (19L8). 2, 131.
122. ROSSI, VON E.: Tuberculous meningitis: Helvet. paediat.
acta. (1950). 5S 27. —
123. BUXTON, P.A.: Chemotherapy of non-pulmonary tuberculous
conditions: Post, grad. M, J. (1951). 31*4, 599.
12k• MEDICAL RESEARCH COUNCIL: Para-aminosalicylie acid and
streptomycin in pulmonary tuberculosis: Lancet (19L9).
2, 1237.
158
125. CROFTON. J. j Chemotherapy of Tuberculosis: Practitioner
(M> 165, 229.
126. DEMPSEY, T.G., and LOGG, M.H.: Para-aminosalicylic acid
in tuberculosis: Lancet (19*47). 2, 871.
127. WINTER, W.J.: Effect of streptomycin on pathology of
tuberculous meningitis: Asa. Rev. Tubere. (1950). 61,171.
128. DON, A.: Tuberculous meningitis treated with injection
of tuberculin: Brit. M. J. (1907). 1, 1360.
129. HAMMON, L., and WOLMAN, 8.: Tuberculin in diagnosis and
treatment: (1912) Pubs- S.Appleton and Co.. Hew York.
130. TAYLOR, L.M., SMITH, H.V., and VOLLUM, R.L.: Manfcoux
test in tuberculous meningitis: Tubercle (1953). 3*4,296.
131. 3V7ITHINBANK, J., VOLLUM, R.L., and SMITH, H.V. s Intra¬
thecal tuberculin reactions J. Path. Bact. (1953).
65, 565. """"" ----- —
132. CAIRNS, H.: Surgical aspects of meningitis: Brit, tl. J.
(1W)> 1, 969.
133. TORKILDSEN, A.: Ventriculo-cisternostomy: Grundt (19L7).
Oslo.
I3I4. LORBER, J.: Studies of cerebrospinal fluid circulation
in tuberculous raeningitis in children - Part II Pneumo-
ence uhalogratns: Arch. Pis. Childhood (1951). 26, 28.
135. KOMROWER, 0.: Pontine cisternostomy in tuberculous
meningitis: Arch. Pis. Childhood (1950). 25, 209«
136. LORBER, J.1 Treatment of tuberculous meningitis:
Brit. H. J. (1953). 2, 11(33.
137. HALIKO'YSKI, B.: A.C.T.H. and tuberculous raeningitis:
Brit, M. _J» (1953I, 1, 991.
138. MILLER, H.O.: Acute disseminated encephalomyelitis
treated with A.C.T.H.: Brit. M. J. (1953). 1, 177.
139. MILLER, H.G., and GIBBONS, J.L.: Acute disseminated
encephalomyelitis and acute disseminated sclerosis:
Brit. M. J. (1953). 2, 13*45.
1*40. ROQUE, F.T., and CLEVE, E.A.: Tuberculous meningitis in
children treated with combined streptomycin and pot¬
assium iodide: Pis. Chest (1951). 19, 319.
1*41. DEBRE, R., THIEFFRY, ST., BRIS3AUD, E. and NOUFFLAHD, H.:
Streptomycin in tuberculous meningitis in children:
Brit. M.J. (19*47). 2, 897.
159.
ll}2. WALLGRKN, A.: Aspects of tuberculous meningitis and
possibility of preventions J. Pediat. (193*4). 5, 291.
1*43. LORBER, J. s Mortality from childhood tuberculosis in
Sheffield: Possible causes of its decline: Brit. Mj, J.
2S 1122.
1*4*4. SMITH, H.V., and DANIELS, P.: Clinical and pathological
aspects of tuberculosis of the central nervous system:
Tubercle (19*47). 28, 6*4.
1*45. BLACKLOCK, J.V/.S., and GRIFFIN, M.A.: Tuberculous mening¬
itis in children: J. Path. Bact. (1955). *40, *489.
1*46. CHOREMIS, IC., ZERVGS, N., C0NSTANTINIDS3, V. , and
PABTAZIS, 3.: Streptomycin therapy of tuberculous
meningitis in children: Lancet (19*48)« 2, 595.
1*4?. HERBEN, B.3., and ASSERSON, M.A.: Tuberculous meningitis
in children: Am. Rev. Tuberc. (1925). 11, 18*4.
H48. CROWS, S.J.: Pathologic changes in meningitis of the
internal ear* Arch. Otolarym. (1930). 11, 537.
1*49. LORBER, J.: Contact history of 150 cases of miliary and
meningeal tuberculosis: Arch. Pis. Childhood (1950).
25, 209.
150. WILSON, G.S., BLACKLOCK, J.W., and REILLY, L.U.: Non-
pulmonary tuberculosis of bovine origin in Q-t. Britain,
and Nth. Ireland: National Association for Prevention
of Tuberculosis, London. 1952. "
151. MOLLARET, P., RENNARD, G., AND TRAN03, MDME,: Ocular
symptoms in tuberculous raeningifiip either untreated or
treated with streptomycin: Ann, roed. Paris (19*49).50.321.
152. SMITH, H.V., STEVENS, H., and PILE, G.C.L.: Treatment
of pulmonary tuberculosis complicated by meningitis:
Lancet, (1951), 2, *42*4.
153. MACGREGOR, A.R., and GREEN, C.A.: Tuberculosis of central
nervous system with special reference to tuberculous
meningitis: J. Path. Baet. (1937). *45, 613.
15*4. GRIFFITH, A.S.: Tubercle bacilli in tuberculous meningitis:
Lancet (193*4). 1, 1382.
155. MUNRO, W.T., and SCOTT, H.: Meningeal tuberculosis:
Lancet (1936), 1, 393.
156. MCDOUGALL, J.B.: Global study in social pathology:
Pub.- E» & 3. Livingstone. Edinburgh I9*i9.
157. LEADER: Tubercle bacilli in the cerebrospinal fluid:
Lancet (1950). 2, 297.
160.
158. CHOREMIS, K., and VRAGHNQS, G.: Primary tuberculosis
with raeningisra and hacilli in the cerebrospinal fluid:
Lancet (19*48). 2, U08.
159. MACGREGOR, A.R., KIRKPATRICK, H.J.R., and CRAIG, W.8.S
Meningeal tuberculosis: Edinburgh M.J. (1935). i|2, 138.
160. CHOREMIS, K., CONSTANTINIDSS, V., PANTAZIS, S.,
KYRIAKIDOS, B., and ZERV08, N.: Tuberculous meningitis:
Halvet. paediat. acta. (1950), 5, 5.
161. COHEN, R.C., and WOOD, W«B.: Cerebral paratuberculosis:
Lancet (1938). 2, 13kh*
162. LEADER: Prognosis after streptomycin therapy: Brit.M.J.
iml. i, so?.
163. COMPAHETTI, A.M., PASQUINBCCI, G., and ZOLI, A.: New
diagnostic guide as a guide to local streptomycin
therapy in tuberculous meningitis: Rev, elln. pediat.
(Wl» 539.
16h. LQRBER, J.: Studies of cerebrospinal fluid circulation
in tuberculous meningitis in children - Ft. I. Peni¬
cillin as tracer substance: Arch. Pis. Childhood (1950).
25, kOk.
165. FLORI, A.G.: Results of therapy in 265 cases of tuber¬
culous meningitis: Pediatrics (1950). 6, 391.
166. LINCOLN, E.M.i Tuberculous meningitis in children:
Am. Rev. Tuberc. (I9L7). 56, 75.
167. LORBER, J.: Ectopic calcification in tuberculous mening¬
itis: Arch. Pis. Childhood (1955). 28, 98.
168. LORBER, J.: Sexual precocity following recovery from
tuberculous meningitis: Proc. R. Soc. Med. (1951),hh«726.
169. CAIRNS, H.: Neurosurgical methods in treatment of
tuberculous meningitis: Arch. Pis. Childhood (1951).
26, 373.
170. RICH, A.R., and McCORDOCK, H.A., Pathogenesis of human
tuberculosis: Bull. John Hopkins Hoso, (1929). kU3 273.
171. HIGH, A.R., nad McCORDGCK, H.A.: Pathogenesis of tuber¬
culous meningitis: IBID (1933). 52, 5.
172. HEKTOEN, L.: Vascular changes in tuberculous meningitis:
J. Exp. Med. (1896). 1, 112.
173. LEADER: Blood vessels in tuberculous meningitis:
Lancet (I9h9). 2, 1090.
161.
17k. WINKNLMAN, N.W., and MOORE, M.T.: Meningeal "block
vessels in tuberculous meningitis: Am. Rev. Tubere.
Imsl ■ 315.
175. DONIACH, I.: Changes in meningeal vessels in acute and
chronic (streptomycin treated) tuberculous meningitis:
J. Path. Bact. (19*49). 61, 253.
176. SCHWARZ. J.: Tuberculous meningitis: Am. Rev. Tuberc.
liakfil, 5i, 63.
177. WALKER, A.S.: Tuberculous meningitis in the adult with
special reference to mechanism of symptoms:
M.J. Austral. (1935). 1, bO.
178. RAQINS, A.B.: Pathogenesis of tuberculous leptomening¬
itis: J. Lab. Clin. Med. (1956). 21, 1217.
179. DANIEL, P.M.; Gross morbid anatomy of central nervous
system of case of tuberculous meningitis treated with
streptomycin: Proc. R. 3oc. led. (I9k9)« 169.
180. QRUNBSRO, E., and SCHNIT2ER, R.J.: Studies on activity
of hydrazine derivatives of isonicotinic acid in
experimental tuberculosis of mice: Quart. Bull. Sea
ViewHosp. (1952), 13, 3.
181. ROBITZEK, E.M., and SELIKOFF, I.T.: Hydrazine derivatives
of isonicotinic acid in therapy of active progressive
caseous pneumonic tuberculosis: Am. Rev. Tuberc. (1952).
182. SELIKOFF, I.T., ROBITZSK, E.M. and ORNSTEIN, G.G.:
Toxicity of hydrazine derivatives of isonicotinie acid
in chemotherapy of human tuberculosis: Quart. Bull.
Sea View Hosp. (1952), lj, 17.
183. FLETCHER, A.P.: Cerebrospinal fluid levels in tuber¬
culous meningitis: Brit. M. J. (1953). 2, 693.
18b. MEDICAL RESEARCH COUNCIL: Isoniazid and resistance:
Brit. M. J. (1953). 1, 521.
185. TUBERCULOSIS CHEMOTHERAPY TRIALS COMMITTEE OF MED.
RESEARCH COUNCIL: Treatment of pulmonary tuberculosis
with isoniazid: Brit. M. J. (1952). 2, 735.
186. JOINER, C.L. , MACLEAN, K.S. , PRITCHARD, E.K. , ANDERSON, K,
and COLLARD, P.: Isoniazid in pulmonary tuberculosis:
Lancet (1952). 2, 8i»3.
187. GOULDING, R., and ROBSON, J.M.: Isoniazid in control of
experimental corneal tuberculosis: Lancet (1952).2.8U9.
188. SINGH, B., and MITCHISON, D.A.; Bacteriocidal activity
of streptomycin and isoniazid against tubercle "bad-
illl! Brit. M. J. (19^). 1, 130.
189. RITCHIE, G.M., TAYLOR, R.M., and DICK, J.C.: Effect of
streptomycin and isoniazid on miliary tuberculosis
and tuberculous meningitis: Lancet (lggg). 2, W9.
190. SWEETHAM, W.P., and MURPHY, E.P.: Isonicotinic acid
hydrazide in tuberculous meningitis; Lancet (1952).
2, 160.
191. KERR, J.G.: Treatment of tuberculous meningitis:
Brit. M. J? (1953)* 2, 1130.
192. WAKSMAN, 3.A., HUTCHISON. D., and KATE, E.:
Am, Rev. Tuberc. (19*49). 60, 78.
193. TSMFKL, C.W.: Present status of specific drug treatment
of tuberculosis: J.A.M.A, (1952). 150, 1165.
19*4. MILLER, P.L., SANDS, J.H., WALKER, R., DYE, W.E., arid
TSMPEL, C.W.: Combined daily terramycin and inter¬
mittent streptomycin in treatment of pulmonary tuber¬
culosis: Am. Rev. Tuberc. (1952). 66, 53*4.
195. PULASKI, E.J.: Neomycin; Practitioner (1955). 170, 669.
196. PERRY, T.L.: Failure of neomycin as an adjuvant to
streptomycin in tuberculous meningitis: Am. Rev. Tuberc.
(1952). 65, 325.
197. CROPTON, J.W.: Chemotherapy of tuberculosis: Proc. R.
Soc. Med. (1955). *46, 58*4.
References Consulted but not quoted in the Text
Streptomycin
198. ADCOCK, J.D., and HETTIG, R.A.: Absorption, distribution
and excretion of streptomycin: Arch. Int. Med.
77, 179.
199. HETTIG, R.A., and ADCOCK, J.D.; Studies on toxicity of
streptomycin for man: Science (19*46). 103, 355.
200. MOLITOR, H., GRAESSLE, O.E., KUNA, S., MUSHETT, C.W. and
SILBER, R.H.: Streptomycin: J. Pharmacol, and Exper.
Therap. (19L6). 86, 151.
201. MADIGAN, D.G., SWIFT, P.N., and BROWNLEE, G.: Clinical
and pharmacological aspects of toxicity of strepto¬
mycin: Lancet (19*47). 9, 1.
202. WAKSMAN, S.H.: Streptomycin: Balllere. Tindall and Cox.
19*49. London.
163
Streptomycin and Bacterial Sensitivity
203. PYLE, M.M.: Relative numbers of resistant tubercle bac¬
illi in sputa of patients before and during strepto¬
mycin therapy: Proc. Staff Meet. Mayo Clin. (19*47).
22, U65*
20k, YOUMANS, G. P., and KARLSON, A.G.: Streptomycin sensitiv¬
ity of tubercle bacillus: Am. Rev. Tube re. (191:7). 55.529.
205. PISHER, M.W,: Streptomycin resistant tubercle bacilli:
Am. Rev. Tub arc. (19*48). 57, 53.
206. FISHER, M.W.: Sensitivity of tubercle bacilli to strepto¬
mycin: IBID (19148). 57, 58.
207. KARLSON, A.G., PFUETZE, K.H., CARR, D.T., FELDMAN, W.H.,
and HINSHAW, H.C.: Effect of combined therapy with
streptomycin, P.A.S. and promin on emergence of
streptomycin resistant strains of tubercle bacilli.
Proc. Staff Meet. Mayo Clin. (I9k9),2k, 83.
Streptomycin in Tuberculous Meningitis
208. APEELBAUM, E,, and HALKIN, C.: Tuberculous meningitis and
miliary tuberculosis arrested with streptomycins
J. A.M. A. (191t6). 135, 153.
209. BORNSTEIN, P.K.: Streptomycin in miliary tuberculosis
with tuberculous meningitis: Quart. Bull. Sea View
Hosp. (19L6). 8, 219.
210. CAIRNS, H., DUTHIE, E.S., and SMITH, H.V.: Intrathecal
streptomycin in meningitis: Lancet (19L6). 2, 153.
211. COOKE, R.E., DtJNPHY, D.L., and BLAKE, F.G.: Streptomycin
in tuberculous meningitis: Yale J. Biol. Med. (I9I46).
18, 221.
212. KEEPER, C.S., BLAKE, F.G., LOCKWOOD, J.S., LONG, P.H.,
MARSHALL, E.K., and BARRY WOOD, W.: J.A.M.A. (19L6).
132, 70.
213. KRAFCHIK, L.: Tuberculous meningitis treated with strepto¬
mycin: J.A.M.A. (I9h6). 132, 375.
21k, MEHA8, C.P., and TRUEX, W.E.: Streptomycin in tuberculous
meningitis: J.A.M.A, (19*46). 135, 155.
215. COUNCIL ON PHARMACY AND CHEMISTRY: Effects of strepto¬
mycin in tuberculosis in man: J.A.M.A. (19*47). 135, 6314.
216. LEADER: Streptomycin in tuberculosis: Brit. M« J. (19*i7).
2, 136.
217. LEADER: Streptomycin in tuberculosis: Lancet (19L7).
1, ikk.
218. McDERMOTT, W., MUSCHENHEIM, C., HADLSY, S.J., BUND, P.A.,
and GORMAN, R.V.: Streptomycin in treatment of tuber¬
culosis in humans - I Meningitis and generalised haeraat-
ogenous tuberculosis: Ann. Int. Med. (19L7). 27, 769.
219. ALP3RIN, L., and TOGMEY, J.A.: Treatment of tuberculous
meningitis: J. Pediat. (19L8). 33, 7k,
220. ANNOTATIONj Streptomycin - present position:
Brit. M. J. (19**8), 2, 831.
221. BAUER, R.B., and BAUER, E.P.: Streptomycin in tuberculous
meningitis: Pis. Chest (19*48). 114, 8ii3.
222. BUNN, P.A*• 100 cases of miliary and meningeal tuber¬
culosis treated with streptomycin: Am, J» M. Sc. (19*48).
216, 286.
223. COUNCIL ON PHARMACY AND CHEMISTRY: Streptomycin in
treatment of tuberculosis: J.A.M.A. (19L8). 135, 58*4.
22k. NAU, O.S., and WENZLER, P.J.: Tuberculous meningitis
treated with streptomycin: J. Pediat. (19L8). 32, i»10.
225. DUBOIS, R., LINZ, R., and VAN WIEN, R.: Experience with
streptomycin treatment of tuberculous meningitis:
Rlv. Hla. Llfaa (19ti9). 14, 3.
226. FOUQUET. J,: Streptomycin and tuberculosis: Presae med.
(Wii 56, 131.
227. BUNN, P.A.: Follow-up report of patients with strepto¬
mycin treated miliary and meningeal tuberculosis:
Am. J.M, 3c. (1950). 219, 217.
228. COUNCIL ON PHARMACY AND CHEMISTRY: Current status of
chemotherapy of tuberculosis in man; J.A.M.A. (1950).
li}2, 650.
229. TACKET, H.S., and LOVEJOY, G.S.: Prolonged survival
following streptomycin therapy for tuberculous mening¬
itis: IBID (1950). 1*42, 6L8.
230. AMERICAN TRUDEAU SOCIETY: Current status of drug therapy
in tuberculosis: Am. Rev. Tuberc. (1950). 61, L3&.
231. CALNAN, W.L.: Tuberculous meningitis: Brit. J. Tuberc.
(1951). U5, 153.
165*
Tuberculous Meningitis In Children
232. CATHALA, J,, and BA8TIN, R.; First trials with streptomycin
in treatment of infanta; Prease med. (19L8). 56, 118.
233. CRAIG, W.S.: Tuberculous meningitis in children:
Brit. M. J. (19*:8). 2, 37U*
23^. FOUQOET, J.: Streptomycin and tuberculous meningitis
in children: Paris rrild. (I9h8)« 29® 9*
235. LINCOLN® E.M., KIRMSE, T.W., and DS VITO. S.: Tuberculous
meningitis in children: J.A.M.A. (19*48). 136, 593*
Use of Adjuvants and Combined Regimes
236. COCCHI, C.: Treatment of tuberculosis with streptomycin,
solphone and vitamin A (miliary and meningeal tuber¬
culosis): Riv. clin. pediat. (I9h8). 2j6, 209-
237» PASQUINUCCI, C.: Notes on 183 cases of tuberculous men¬
ingitis treated with streptomycin, sulphone (promin)
and vitamin A; Riv. clin. pediafc. (19U9). kl9 6.
238. U.S. VETERANS ADMINISTRATION: Minutes of 8th Conference
on streptomycin: (I9ii9). pp. 165 and 287.
239. LEADER; Tuberculous meningitis: Lancet (1953). 2, 712.
Sulphones
2i|0. BROWNLEE, G., GREEN, A.P., and WOODBINE, P.: Sulphetrone -
chemotherapeutic agent for tuberculosis: Brit. J.
Pharmacol. (19h8). 3, 15.
2*41. BROWNLEE, G., and KENNEDY, C.R.: Treatment of experi¬
mental tuberculosis with sulphetrone: IBID (19L8).3.29.
2*42. RIST, N., and CGTTET, J.: Sulphone therapy; Presse taed.
(W> 57, 7*»3.
Isoniazid
2243- CLARK, C.M., ELMENDORP, Du M.P. Unr., CAWTHON, W.U.,
MUSCHENHEIM, C., and McDERMOTT, W.; Isoniazid (isonicot-
inic acid hydraside) in treatment of miliary and men¬
ingeal tuberculosis: Am. Rev. Tuberc. (1952). 66, 391*
22424. RUBIN, B., HASSERT, G.L., THOMAS, B.G.H., and BURKE, J.C.:
Pharmacology of isonicotinic acid hydrazide;
Am. Rev. Tuberc. (1952). 65, 392.
2145. SELIKOFF, I.J., and ROBITZEK, E.H.: Tuberculous chemo¬
therapy with hydrazine derivatives of isonicotinic
acids Pis, Chest (1952), 21, 385.
2146. MITCHISON, D.A.t Tubercle bacilli resistant to iso-
niazid: Brit. M.J. (195li). 1, 128.
Tuberculin. Para-aminosalicyllc acid and Vlomycin
2i}7. FLETCHER, A.P.: Intrathecal tuberculin in tuberculous
meningitis: Lancet (1951). 2, 290.
2I48. LSHMANN, J.: P.A.3. In treatment of tuberculosis:
Lancet (19I46). 1, 15.
2ij9. ANNOTATION: Viomycin: Brit. K, J* (1951:). 1, 38I4.
Bacterial Fibrinolysin
250. MACFARLANE, R.O., and PILLING, G.: Observations on
fibrinolysis - Plasminogen, plaamin, and antiplaamin
content of bloods Lancet (19L6). 2, 562.
251. CATHIE, I.A.B.: Bacterial fibrinolysin: Arch. Pis.
Childhood (191*9). 2k, 233.
252. CATHIE, I.A.B.: Bacterial fibrinolysin - therapeutic
application in tuberculous meningitis: J. Clin. Path.
(19149). 2, 73.
Bacteriology
253. GRIFFITH, A.S.: Relative incidence of human and bovine
tubercle bacilli In tuberculous meningitis in England:
■T. Path, ana Bact. (1952). 35. 97.
25I4. GRIFFITH, A.S., and SMITH, J.; Bovine phthisis:
Lancet (1935). 2, 1339.
255. GRIFFITH, A.S., and MANTON, J.: Human tuberculosis Of
bovine origin in Staffordshire: Brit. M.J. (1936).I.52I4
Pathology and Pathogenesis
256. McCRACKEN, I.: Meningeal tuberculosis: Edinburgh M.J.
(12251* k*. 131.
257. MONTGOMERY, J.L.s Streptomycin in tuberculous meningitis
in childhood: Glasgow. M.J. (19lt8). 29, 235.
258. RIGDEN, R.H., and LEFEBER, E.J.: Vascular lesions in
tuberculous meningitis: Am. Rev. Tubere. (1950). 61,2147
259. RICH, A.R.: Pathogenesis of tuberculosis: Blackwell
Scientific Publications (1951). Oxford pp. 6II4 and 882,
167.
Miscellaneous
260. ROTHSCHILD, H., FRIEDKNWALD, J.3*, and BERNSTEIN, C.:
Relation of allergy to immunity in tuberculosis:
Bull. John Hopkins Hosp. (195^). 5ks 232.
261. RICH, A.R.: Significance of hypersensitivity in in¬
fections: Physiol. Rev. (19^1). 21, 70.
262. HOBSON, L.B., TOMPSKTT, R., MUSCHENHEIM, C., and
McDERMOTT, W.: Laboratory and clinical investigation
of dihydrostreptomycin: Am. Rev. Tuberc. (I9k8). 58,501.
263. MEDICAL RESEARCH COUNCIL REPORT: Streptomycin in acute
miliary tuberculosis: Lancet (195Q). 1, 8Jjl.
26I4. WHITAKER, L.R.j Case of chronic tuberculous meningitis
simulating brain tumour: Arc. Rev. Tuberc. (1925).
11. 175•
265» U.S. VETERANS ADMINISTRATION: Quarterly progress report
on chemotherapy of tuberculosis: (1952).
266. U.S. VETERANS ADMINISTRATION: Transactions of twelfth
conference on chemotherapy of tuberculosis: (1953).
267. FLETCHER, A.P.: Intrathecal fibrinolysis with strepto¬
kinase in tuberculous meningitis: J.Clin.Investigation
(125klf 33, 69.
268. LORBER, J.: Results of treatment of 5*49 cases of tuber¬
culous meningitis: Am. Rev. Tuberc. (195k). 69, 13.
Abreviations for journalt and periodicals are as per
Quarterly Cumulative Index Medlcus.
